LOINC #,Short Name,Long Common Name,CLASS,Rank
14682-9,Creat SerPl-mCnc,Creatinine [Moles/volume] in Serum or Plasma,Chem,1
718-7,Hgb Bld-mCnc,Hemoglobin [Mass/volume] in Blood,HEM/BC,2
2823-3,Potassium SerPl-sCnc,Potassium [Moles/volume] in Serum or Plasma,Chem,3
14749-6,Glucose SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma,Chem,4
2951-2,Sodium SerPl-sCnc,Sodium [Moles/volume] in Serum or Plasma,Chem,5
3094-0,BUN SerPl-mCnc,Urea nitrogen [Mass/volume] in Serum or Plasma,Chem,6
2028-9,CO2 SerPl-sCnc,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",Chem,7
2075-0,Chloride SerPl-sCnc,Chloride [Moles/volume] in Serum or Plasma,Chem,8
789-8,RBC # Bld Auto,Erythrocytes [#/volume] in Blood by Automated count,HEM/BC,9
786-4,MCHC RBC Auto-mCnc,Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count,HEM/BC,10
785-6,MCH RBC Qn Auto,Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count,HEM/BC,11
2000-8,Calcium SerPl-mCnc,Calcium [Moles/volume] in Serum or Plasma,Chem,12
15074-8,Glucose Bld-mCnc,Glucose [Moles/volume] in Blood,Chem,13
4544-3,Hct VFr Bld Auto,Hematocrit [Volume Fraction] of Blood by Automated count,HEM/BC,14
6690-2,WBC # Bld Auto,Leukocytes[#/volume] in Blood by Automated count ,HEM/BC,15
1742-6,ALT SerPl-cCnc,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,Chem,16
787-2,MCV RBC Auto,Erythrocyte mean corpuscular volume [Entitic volume] by Automated count,HEM/BC,17
777-3,Platelet # Bld Auto,Platelets [#/volume] in Blood by Automated count,HEM/BC,18
1920-8,AST SerPl-cCnc,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,Chem,19
1751-7,Albumin SerPl-mCnc,Albumin [Mass/volume] in Serum or Plasma,Chem,20
14631-6,Bilirub SerPl-mCnc,Bilirubin.total [Moles/volume] in Serum or Plasma,Chem,21
2885-2,Prot SerPl-mCnc,Protein [Mass/volume] in Serum or Plasma,Chem,22
6768-6,ALP SerPl-cCnc,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,Chem,23
788-0,RDW RBC Auto-Rto,Erythrocyte distribution width [Ratio] by Automated count,HEM/BC,24
770-8,Neutrophils NFr Bld Auto,Neutrophils/100 leukocytes in Blood by Automated count,HEM/BC,25
33914-3,GFR/BSA.pred SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD),Chem,26
704-7,Basophils # Bld Auto,Basophils [#/volume] in Blood by Automated count,HEM/BC,27
20570-8,Hct VFr Bld,Hematocrit [Volume Fraction] of Blood,HEM/BC,28
48642-3,GFR/BSA pred.non black SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M predicted among non-blacks by Creatinine-based formula (MDRD),Chem,29
48643-1,GFR/BSA pred.black SerPl MDRD-ArVRat,Glomerular filtration rate/1.73 sq M predicted among blacks by Creatinine-based formula (MDRD),Chem,30
26515-7,Platelet # Bld,Platelets [#/volume] in Blood,HEM/BC,31
14647-2,Cholest SerPl-mCnc,Cholesterol [Moles/volume] in Serum or Plasma,Chem,32
26464-8,WBC # Bld,Leukocytes [#/volume] in Blood,HEM/BC,33
30428-7,MCV RBC,Erythrocyte mean corpuscular volume [Entitic volume],HEM/BC,34
731-0,Lymphocytes # Bld Auto,Lymphocytes [#/volume] in Blood by Automated count,HEM/BC,35
14927-8,Trigl SerPl-mCnc,Triglyceride [Moles/volume] in Serum or Plasma,Chem,36
10466-1,Anion Gap3 SerPl-sCnc,Anion gap 3 in Serum or Plasma,Chem,37
14646-4,HDLc SerPl-mCnc,Cholesterol in HDL [Moles/volume] in Serum or Plasma,Chem,38
6463-4,Bacteria XXX Cult,Bacteria identified in Unspecified specimen by Culture,MICRO,39
26485-3,Monocytes NFr Bld,Monocytes/100 leukocytes in Blood,HEM/BC,40
736-9,Lymphocytes NFr Bld Auto,Lymphocytes/100 leukocytes in Blood by Automated count,HEM/BC,41
706-2,Basophils NFr Bld Auto,Basophils/100 leukocytes in Blood by Automated count,HEM/BC,42
713-8,Eosinophil NFr Bld Auto,Eosinophils/100 leukocytes in Blood by Automated count,HEM/BC,43
5905-5,Monocytes NFr Bld Auto,Monocytes/100 leukocytes in Blood by Automated count,HEM/BC,44
26478-8,Lymphocytes NFr Bld,Lymphocytes/100 leukocytes in Blood,HEM/BC,45
751-8,Neutrophils # Bld Auto,Neutrophils [#/volume] in Blood by Automated count,HEM/BC,46
5902-2,Prothrombin time,Prothrombin time (PT),COAG,47
5902-2,PT Time PPP,Prothrombin time (PT) in Platelet poor plasma by Coagulation assay,COAG,47
33069-6,Fet Width.translucency US.meas,Fetal Neck.soft tissue Translucency width US,OB.US,48
26450-7,Eosinophil NFr Bld,Eosinophils/100 leukocytes in Blood,HEM/BC,49
711-2,Eosinophil # Bld Auto,Eosinophils [#/volume] in Blood by Automated count,HEM/BC,50
22637-3,Path report.final Dx Spec,Pathology report final diagnosis,TUMRRGT,51
742-7,Monocytes # Bld Auto,Monocytes [#/volume] in Blood by Automated count,HEM/BC,52
6301-6,INR PPP,INR in Platelet poor plasma by Coagulation assay,COAG,53
30180-4,Basophils NFr Bld,Basophils/100 leukocytes in Blood,HEM/BC,54
3097-3,BUN/Creat SerPl-mRto,Urea nitrogen/Creatinine [Mass ratio] in Serum or Plasma,Chem,55
5802-4,Nitrite Ur Ql Strip,Nitrite [Presence] in Urine by Test strip,UA,56
26499-4,Neutrophils # Bld,Neutrophils [#/volume] in Blood,HEM/BC,57
5778-6,Color Ur,Color of Urine,SPEC,58
5803-2,pH Ur Strip,pH of Urine by Test strip,UA,59
1759-0,Albumin/Glob SerPl-mRto,Albumin/Globulin [Mass ratio] in Serum or Plasma,Chem,60
26484-6,Monocytes # Bld,Monocytes [#/volume] in Blood,HEM/BC,61
10834-0,Globulin Ser Calc-mCnc,Globulin [Mass/volume] in Serum by calculation,Chem,62
39469-2,LDLc SerPl Calc-mCnc,Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation,Chem,63
5770-3,Bilirub Ur Ql Strip,Bilirubin [Presence] in Urine by Test strip,UA,64
5799-2,Leukocyte esterase Ur Ql Strip,Leukocyte esterase [Presence] in Urine by Test strip,UA,65
5767-9,Appearance Ur,Appearance of Urine,SPEC,66
26449-9,Eosinophil # Bld,Eosinophils [#/volume] in Blood,HEM/BC,67
66126-4,VLDLc SerPl Calc-mCnc,Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation,Chem,68
14879-1,Phosphate SerPl-mCnc,Phosphate [Moles/volume] in Serum or Plasma,Chem,69
26474-7,Lymphocytes # Bld,Lymphocytes [#/volume] in Blood,HEM/BC,70
5811-5,Sp Gr Ur Strip,Specific gravity of Urine by Test strip,UA,71
5794-3,Hgb Ur Ql Strip,Hemoglobin [Presence] in Urine by Test strip,UA,72
22705-8,Glucose Ur Strip-mCnc,Glucose [Moles/volume] in Urine by Test strip,UA,73
5804-0,Prot Ur Strip-mCnc,Protein [Mass/volume] in Urine by Test strip,UA,74
11579-0,TSH SerPl DL<=0.05 mIU/L-aCnc,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,Chem,75
26511-6,Neutrophils NFr Bld,Neutrophils/100 leukocytes in Blood,HEM/BC,76
3173-2,aPTT Time Bld,Activated partial thromboplastin time (aPTT) in Blood by Coagulation assay,COAG,77
2601-3,Magnesium SerPl-sCnc,Magnesium [Moles/volume] in Serum or Plasma,Chem,78
5821-4,WBC #/area UrnS HPF,Leukocytes [#/area] in Urine sediment by Microscopy high power field,UA,79
22702-5,Ketones Ur Strip-mCnc,Ketones [Moles/volume] in Urine by Test strip,UA,80
4548-4,Hgb A1c MFr Bld,Hemoglobin A1c/Hemoglobin.total in Blood,HEM/BC,81
14629-0,Bilirub Direct SerPl-mCnc,Bilirubin.direct [Moles/volume] in Serum or Plasma,Chem,82
2336-6,Globulin Ser-mCnc,Globulin [Mass/volume] in Serum,Chem,83
11555-0,Base excess Bld-sCnc,Base excess in Blood,Chem,84
47527-7,Cytology Cvx/Vag Doc Thin Prep,Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep,CYTO,85
11557-6,pCO2 Bld,Carbon dioxide [Partial pressure] in Blood,Chem,86
11556-8,pO2 Bld,Oxygen [Partial pressure] in Blood,Chem,87
22636-5,Path report.relevant Hx Spec,Pathology report relevant history,TUMRRGT,88
5769-5,Bacteria #/area UrnS HPF,Bacteria [#/area] in Urine sediment by Microscopy high power field,UA,89
2157-6,CK SerPl-cCnc,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,Chem,90
32309-7,Cholest/HDLc SerPl-mRto,Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma,Chem,91
22748-8,LDLc SerPl-mCnc,Cholesterol in LDL [Moles/volume] in Serum or Plasma,Chem,92
630-4,Bacteria Ur Cult,Bacteria identified in Urine by Culture,MICRO,93
2601-3,Magnesium SerPl-mCnc,Magnesium [Moles/volume] in Serum or Plasma,Chem,94
2713-6,SaO2% from pO2 Bld,Oxygen saturation.calculated from oxygen partial pressure in Blood,Chem,95
22638-1,Path report.comments Imp Spec,Pathology report comments,TUMRRGT,96
11558-4,pH Bld,pH of Blood,Chem,97
22639-9,Path report.supplemental reports Spec,Pathology report supplemental reports,TUMRRGT,98
20454-5,Prot Ur Ql Strip,Protein [Presence] in Urine by Test strip,UA,99
13945-1,RBC #/area UrnS HPF,Erythrocytes [#/area] in Urine sediment by Microscopy high power field,UA,100
738-5,Macrocytes Bld Ql Smear,Macrocytes [Presence] in Blood by Light microscopy,HEM/BC,101
2514-8,Ketones Ur Ql Strip,Ketones [Presence] in Urine by Test strip,Chem,102
741-9,Microcytes Bld Ql Smear,Microcytes [Presence] in Blood by Light microscopy,HEM/BC,103
19146-0,Ref Lab Test Results,Reference lab test results,MISC,104
3016-3,TSH SerPl-aCnc,Thyrotropin [Units/volume] in Serum or Plasma,Chem,105
6298-4,Potassium Bld-sCnc,Potassium [Moles/volume] in Blood,Chem,106
34927-4,Urobilinogen Ur-mCnc,Urobilinogen [Moles/volume] in Urine,Chem,107
19764-0,Stat of Adq Cvx/Vag Cyto-Imp,Statement of adequacy [interpretation] of Cervical or vaginal smear or scraping by Cyto stain,CYTO,108
19767-3,Cytologist Cvx/Vag Cyto,Cytologist who read Cyto stain of Cervical or vaginal smear or scraping,CYTO,109
19763-2,Specimen source Cvx/Vag Cyto,Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain,CYTO,110
13969-1,CK MB SerPl-mCnc,Creatine kinase.MB [Mass/volume] in Serum or Plasma,Chem,111
18314-5,Morphology Bld-Imp,Morphology [interpretation] in Blood Narrative,HEM/BC,112
10839-9,Troponin I SerPl-mCnc,Troponin I.cardiac [Mass/volume] in Serum or Plasma,Chem,113
19773-1,Recom F/U Cvx/Vag Cyto,Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain,CYTO,114
19769-9,Pathologist Cvx/Vag Cyto,Pathologist who read Cyto stain of Cervical or vaginal smear or scraping,CYTO,115
2349-9,Glucose Ur Ql,Glucose [Presence] in Urine,Chem,116
34928-2,Urobilinogen Ur Strip-mCnc,Urobilinogen [Moles/volume] in Urine by Test strip,UA,117
33037-3,Anion Gap SerPl-sCnc,Anion gap in Serum or Plasma,Chem,118
728-6,Hypochromia Bld Ql Smear,Hypochromia [Presence] in Blood by Light microscopy,HEM/BC,119
1959-6,HCO3 Bld-sCnc,Bicarbonate [Moles/volume] in Blood,Chem,120
26444-0,Basophils # Bld,Basophils [#/volume] in Blood,HEM/BC,121
2965-2,Sp Gr Ur,Specific gravity of Urine,Chem,122
23658-8,Other Antibiotic Susc Islt,Other Antibiotic [Susceptibility],ABXBACT,123
2857-1,PSA SerPl-mCnc,Prostate specific Ag [Mass/volume] in Serum or Plasma,Chem,124
14630-8,Bilirub Indirect SerPl-mCnc,Bilirubin.indirect [Moles/volume] in Serum or Plasma,Chem,125
20409-9,RBC # Ur Strip,Erythrocytes [#/volume] in Urine by Test strip,UA,126
14635-7,25(OH)D3 SerPl-mCnc,Calcidiol [Moles/volume] in Serum or Plasma,Chem,127
8247-9,Mucous Threads UrnS Ql Micro,Mucus [Presence] in Urine sediment by Light microscopy,UA,128
2947-0,Sodium Bld-sCnc,Sodium [Moles/volume] in Blood,Chem,129
1994-3,Ca-I Bld-sCnc,Calcium.ionized [Moles/volume] in Blood,Chem,130
600-7,Bacteria Bld Cult,Bacteria identified in Blood by Culture,MICRO,131
6742-1,RBC morph Bld,Erythrocyte morphology finding [Identifier] in Blood,HEM/BC,132
14920-3,T4 Free SerPl-mCnc,Thyroxine (T4) free [Moles/volume] in Serum or Plasma,Chem,133
5818-0,Urobilinogen Ur Ql Strip,Urobilinogen [Presence] in Urine by Test strip,Chem,134
44915-7,LDLc/HDLc SerPl-mRto,Cholesterol in LDL/Cholesterol in HDL [Molar ratio] in Serum or Plasma,Chem,135
764-1,Neuts Band NFr Bld Manual,Neutrophils.band form/100 leukocytes in Blood by Manual count,HEM/BC,136
4537-7,ESR Bld Qn Westrgrn,Erythrocyte sedimentation rate by Westergren method,HEM/BC,137
8310-5,Body temperature,Body temperature,BDYTMP.ATOM,138
3040-3,Lipase SerPl-cCnc,Lipase [Enzymatic activity/volume] in Serum or Plasma,Chem,139
14798-3,Iron SerPl-mCnc,Iron [Moles/volume] in Serum or Plasma,Chem,140
9317-9,Platelet Bld Ql Smear,Platelets [Presence] in Blood by Light microscopy,HEM/BC,141
14933-6,Urate SerPl-mCnc,Urate [Moles/volume] in Serum or Plasma,Chem,142
20565-8,CO2 Bld-sCnc,"Carbon dioxide, total [Moles/volume] in Blood",Chem,143
925-8,Bld Prod Disposition BPU,Blood product disposition [Type],BLDBK,144
14921-1,T4 SerPl-mCnc,Thyroxine (T4) [Moles/volume] in Serum or Plasma,Chem,145
13317-3,MRSA XXX Ql Cult,Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture,MICRO,146
14979-9,aPTT Time PPP,Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay,COAG,147
11277-1,Squamous #/area UrnS HPF,Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field,UA,148
32623-1,PMV Bld Auto,Platelet mean volume [Entitic volume] in Blood by Automated count,HEM/BC,149
14685-2,Vit B12 Ser-mCnc,Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma,Chem,150
20453-7,Epi Cells UrnS Ql Micro,Epithelial cells [Presence] in Urine sediment by Light microscopy,UA,151
1798-8,Amylase SerPl-cCnc,Amylase [Enzymatic activity/volume] in Serum or Plasma,Chem,152
2276-4,Ferritin SerPl-mCnc,Ferritin [Mass/volume] in Serum or Plasma,Chem,153
1988-5,CRP SerPl-mCnc,C reactive protein [Mass/volume] in Serum or Plasma,Chem,154
5808-1,RBC # UrnS HPF,Erythrocytes [#/volume] in Urine sediment by Microscopy high power field,UA,155
2532-0,LDH SerPl-cCnc,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,Chem,156
14800-7,TIBC SerPl-mCnc,Iron binding capacity [Moles/volume] in Serum or Plasma,Chem,157
5782-8,Crystals UrnS Micro,Crystals [type] in Urine sediment by Light microscopy,UA,158
21000-5,RDW RBC Auto,Erythrocyte distribution width [Entitic volume] by Automated count,HEM/BC,159
2753-2,pH SerPl,pH of Serum or Plasma,Chem,160
14683-7,Creat Ur-mCnc,Creatinine [Moles/volume] in Urine,Chem,161
20408-1,WBC # Ur Strip,Leukocytes [#/volume] in Urine by Test strip,UA,162
27045-4,Microscopic Ur-Imp,Microscopic exam [interpretation] of Urine by Cytology,CYTO,163
31100-1,Hct VFr Bld Imped,Hematocrit [Volume Fraction] of Blood by Impedance,HEM/BC,164
11580-8,TSH SerPl DL<=0.005 mIU/L-aCnc,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L,Chem,165
5787-7,Epi Cells #/area UrnS HPF,Epithelial cells [#/area] in Urine sediment by Microscopy high power field,UA,166
735-1,Variant Lymphs NFr Bld Manual,Lymphocytes Variant/100 leukocytes in Blood by Manual count,HEM/BC,167
934-0,BPU ID,Blood product unit ID [#],BLDBK,168
882-1,ABO+Rh Gp Bld,ABO & Rh group [Type] in Blood,BLDBK,169
19161-9,Urobilinogen Ur Strip-aCnc,Urobilinogen [Units/volume] in Urine by Test strip,UA,170
70199-5,Bilirub Ur-mCnc,Bilirubin.total [Moles/volume] in Urine,Chem,171
30167-1,HPV I/H Risk 1 DNA Cervix Ql bDNA,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe & signal amplification method,MICRO,172
20507-0,RPR Ser Ql,Reagin Ab [Presence] in Serum by RPR,MICRO,173
3151-8,Inhaled O2 flow rate,Inhaled oxygen flow rate,CLIN,174
14957-5,Microalbumin Ur-mCnc,Microalbumin [Mass/volume] in Urine,Chem,175
58448-2,Microalbumin ug/min 24H Ur-mRate,Microalbumin ug/min [Mass/time] in 24 hour Urine,Chem,176
26508-2,Neuts Band NFr Bld,Neutrophils.band form/100 leukocytes in Blood,HEM/BC,177
24111-7,N gonorrhoea DNA XXX Ql PCR,Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,178
11279-7,UrnS Cmnt Micro,Urine sediment comments by Light microscopy Narrative,UA,179
21613-5,C trach DNA XXX Ql PCR,Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,180
14732-2,Folate SerPl-mCnc,Folate [Moles/volume] in Serum or Plasma,Chem,181
1995-0,Ca-I SerPl-sCnc,Calcium.ionized [Moles/volume] in Serum or Plasma,Chem,182
11282-1,Total Cells Counted Bld,Cells Counted Total [#] in Blood,HEM/BC,183
2106-3,HCG Preg Ur Ql,Choriogonadotropin (pregnancy test) [Presence] in Urine,Chem,184
933-2,Bld Prod Typ BPU,Blood product type,BLDBK,185
737-7,Lymphocytes NFr Bld Manual,Lymphocytes/100 leukocytes in Blood by Manual count,HEM/BC,186
2744-1,pH BldA,pH of Arterial blood,Chem,187
30313-1,Hgb BldA-mCnc,Hemoglobin [Mass/volume] in Arterial blood,HEM/BC,188
10378-8,Polychromasia Bld Ql Smear,Polychromasia [Presence] in Blood by Light microscopy,HEM/BC,189
2324-2,GGT SerPl-cCnc,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,Chem,190
25162-9,Hyaline Casts UrnS Ql Micro,Hyaline casts [Presence] in Urine sediment by Light microscopy,UA,191
14801-5,Iron Satn MFr SerPl,Iron saturation [Molar fraction] in Serum or Plasma,Chem,192
2703-7,pO2 BldA,Oxygen [Partial pressure] in Arterial blood,Chem,193
664-3,Gram Stn XXX,Microscopic observation [Identifier] in Unspecified specimen by Gram stain,MICRO,194
3879-4,Opiates Ur Ql,Opiates [Presence] in Urine,DRUG/TOX,195
3390-2,Benzodiaz Ur Ql,Benzodiazepines [Presence] in Urine,DRUG/TOX,196
53553-4,Est. average glucose Bld gHb Est-mCnc,Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin,Chem,197
890-4,Bld gp Ab Scn SerPl Ql,Blood group antibody screen [Presence] in Serum or Plasma,BLDBK,198
26507-4,Neuts Band # Bld,Neutrophils.band form [#/volume] in Blood,HEM/BC,199
3050-2,T3RU NFr SerPl,Triiodothyronine resin uptake (T3RU) in Serum or Plasma,Chem,200
30405-5,WBC # Ur,Leukocytes [#/volume] in Urine,HEM/BC,201
48345-3,HIV 1+O+2 Ab SerPl Ql,HIV 1+O+2 Ab [Presence] in Serum or Plasma,MICRO,202
14913-8,Testost SerPl-mCnc,Testosterone [Moles/volume] in Serum or Plasma,Chem,203
30934-4,BNP SerPl-mCnc,Natriuretic peptide B [Mass/volume] in Serum or Plasma,Chem,204
2019-8,pCO2 BldA,Carbon dioxide [Partial pressure] in Arterial blood,Chem,205
34714-6,INR Bld,INR in Blood by Coagulation assay,COAG,206
3377-9,Barbiturates Ur Ql,Barbiturates [Presence] in Urine,DRUG/TOX,207
8061-4,ANA Ser Ql,Nuclear Ab [Presence] in Serum,SERO,208
11529-5,,Surgical pathology study,ATTACH.CLINRPT,209
5196-1,HBV surface Ag Ser Ql EIA,Hepatitis B virus surface Ag [Presence] in Serum by Immunoassay,MICRO,210
49136-5,CK MB SerPl-Rto,Creatine kinase.MB/Creatine kinase.total [Ratio] in Serum or Plasma,Chem,211
14959-1,Microalbumin/Creat Ur-mRto,Microalbumin/Creatinine [Mass ratio] in Urine,Chem,212
48346-1,HIV 1+O+2 Ab SerPl-aCnc,HIV 1+O+2 Ab [Units/volume] in Serum or Plasma,MICRO,213
3349-8,Amphetamines Ur Ql,Amphetamines [Presence] in Urine,DRUG/TOX,214
17856-6,Hgb A1c MFr Bld HPLC,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,HEM/BC,215
11253-2,Tacrolimus Bld-mCnc,Tacrolimus [Mass/volume] in Blood,DRUG/TOX,216
33903-6,Ketones Ur Ql,Ketones [Presence] in Urine,Chem,217
883-9,ABO Group Bld,ABO group [Type] in Blood,BLDBK,218
25371-6,VLDLc SerPl-mCnc,Cholesterol in VLDL [Moles/volume] in Serum or Plasma,Chem,219
2458-8,IgA Ser-mCnc,IgA [Mass/volume] in Serum,Chem,220
22753-8,UIBC SerPl-mCnc,Iron binding capacity.unsaturated [Moles/volume] in Serum or Plasma,Chem,221
32215-6,FTI SerPl-aCnc,Thyroxine (T4) free index in Serum or Plasma,Chem,222
14930-2,T3 SerPl-mCnc,Triiodothyronine (T3) [Moles/volume] in Serum or Plasma,Chem,223
18282-4,Cannabinoids Ur Ql Scn,Cannabinoids [Presence] in Urine by Screen method,DRUG/TOX,224
744-3,Monocytes NFr Bld Manual,Monocytes/100 leukocytes in Blood by Manual count,HEM/BC,225
5195-3,HBV surface Ag Ser Ql,Hepatitis B virus surface Ag [Presence] in Serum,MICRO,226
1003-3,IAT Comp-Sp Reag SerPl Ql,Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma,BLDBK,227
769-0,Neuts Seg NFr Bld Manual,Neutrophils.segmented/100 leukocytes in Blood by Manual count,HEM/BC,228
714-6,Eosinophil NFr Bld Manual,Eosinophils/100 leukocytes in Blood by Manual count,HEM/BC,229
15067-2,FSH SerPl-aCnc,Follitropin [Units/volume] in Serum or Plasma,Chem,230
14715-7,Estradiol SerPl-mCnc,Estradiol (E2) [Moles/volume] in Serum or Plasma,Chem,231
53927-0,N gonorrhoea rRNA Urth Ql PCR,Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe & target amplification method,MICRO,232
60256-5,N gonorrhoea rRNA Ur Ql PCR,Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe & target amplification method,MICRO,233
702-1,Anisocytosis Bld Ql Smear,Anisocytosis [Presence] in Blood by Light microscopy,HEM/BC,234
707-0,Basophils NFr Bld Manual,Basophils/100 leukocytes in Blood by Manual count,HEM/BC,235
19145-2,Ref Lab Test Name,Reference lab test name,MISC,236
29265-6,Calcium Album cor SerPl-sCnc,Calcium [Moles/volume] corrected for albumin in Serum or Plasma,Chem,237
5796-8,Hyaline Casts #/area UrnS LPF,Hyaline casts [#/area] in Urine sediment by Microscopy low power field,UA,238
5198-7,HCV Ab Ser EIA-aCnc,Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay,MICRO,239
14866-8,PTH-Intact SerPl-sCnc,Parathyrin.intact [Moles/volume] in Serum or Plasma,Chem,240
2731-8,PTH-Intact SerPl-mCnc,Parathyrin.intact [Mass/volume] in Serum or Plasma,Chem,240
2465-3,IgG Ser-mCnc,IgG [Mass/volume] in Serum,Chem,241
53925-4,C trach rRNA Urth Ql PCR,Chlamydia trachomatis rRNA [Presence] in Urethra by Probe & target amplification method,MICRO,242
774-0,Ovalocytes Bld Ql Smear,Ovalocytes [Presence] in Blood by Light microscopy,HEM/BC,243
12454-5,Amorph Urate Cry UrnS Ql Micro,Urate crystals amorphous [Presence] in Urine sediment by Light microscopy,UA,244
30341-2,ESR Bld Qn,Erythrocyte sedimentation rate,HEM/BC,245
798-9,RBC # Ur Auto,Erythrocytes [#/volume] in Urine by Automated count,HEM/BC,246
1250-0,Maj XM SerPl-Imp,Major crossmatch [interpretation],BLDBK,247
22634-0,Path report.gross Spec,Pathology report gross observation,TUMRRGT,248
69419-0,LDLc SerPl Direct Assay-mCnc,Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay,Chem,249
56598-6,EBV EA IgM Ser EIA-aCnc,Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,250
11572-5,Rheumatoid fact Ser-aCnc,Rheumatoid factor [Units/volume] in Serum,SERO,251
19080-1,HCG SerPl-aCnc,Choriogonadotropin [Units/volume] in Serum or Plasma,Chem,252
18998-5,TMP SMX Susc Islt,Trimethoprim+Sulfamethoxazole [Susceptibility],ABXBACT,253
43304-5,C trach rRNA XXX Ql PCR,Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,254
10331-7,Rh Bld,Rh [Type] in Blood,BLDBK,255
43305-2,N gonorrhoea rRNA XXX Ql PCR,Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,256
10701-1,O+P Stl Conc,Ova+Parasites identified in Stool by Concentration,MICRO,257
13362-9,Collect duration Time Ur,Collection duration of Urine,SPEC,258
11125-2,Plat morph Bld,Platelet morphology finding [Identifier] in Blood,HEM/BC,259
15180-3,Hypochromia Bld Ql Auto,Hypochromia [Presence] in Blood by Automated count,HEM/BC,260
12258-0,Squamous UrnS Ql HPF,Epithelial cells.squamous [Presence] in Urine sediment by Microscopy high power field,UA,261
22633-2,Path report.site of origin Spec,Pathology report site of origin,TUMRRGT,262
2472-9,IgM Ser-mCnc,IgM [Mass/volume] in Serum,Chem,263
31208-2,Specimen source XXX,Specimen source [Identifier] of Unspecified specimen,SPEC,264
18928-2,Gentamicin Susc Islt,Gentamicin [Susceptibility],ABXBACT,265
14807-2,Lead Bld-mCnc,Lead [Moles/volume] in Blood,DRUG/TOX,266
3255-7,Fibrinogen PPP-mCnc,Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,COAG,267
3184-9,ACT Time Bld,Activated clotting time in Blood by Coagulation assay,COAG,268
19139-5,Pathologist name,Pathologist name,CLIN,269
6462-6,Bacteria Wnd Cult,Bacteria identified in Wound by Culture,MICRO,270
10501-5,LH SerPl-aCnc,Lutropin [Units/volume] in Serum or Plasma,Chem,271
19244-3,Character Ur,Character of Urine,SPEC,272
19659-2,PCP Ur Ql Scn,Phencyclidine [Presence] in Urine by Screen method,DRUG/TOX,273
14928-6,T3Free SerPl-mCnc,Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma,Chem,274
624-7,Bacteria Spt Resp Cult,Bacteria identified in Sputum by Respiratory culture,MICRO,275
634-6,Bacteria XXX Aerobe Cult,Bacteria identified in Unspecified specimen by Aerobe culture,MICRO,276
50387-0,C trach rRNA Cvx Ql PCR,Chlamydia trachomatis rRNA [Presence] in Cervix by Probe & target amplification method,MICRO,277
50388-8,N gonorrhoea rRNA Cvx Ql PCR,Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe & target amplification method,MICRO,278
35691-5,Other microorganism DNA XXX Ql PCR,XXX microorganism DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,279
51656-7,HCV Ab s/co Fld-Rto,Hepatitis C virus Ab Signal/Cutoff [Ratio] in Body fluid,MICRO,280
4679-7,Retics/100 RBC NFr,Reticulocytes/100 erythrocytes in Blood,HEM/BC,281
22635-7,Path report.microscopic Spec Other Stn,Pathology report microscopic observation Other stain,TUMRRGT,282
59826-8,Creat Bld-mCnc,Creatinine [Moles/volume] in Blood,Chem,283
15150-6,Anisocytosis Bld Ql Auto,Anisocytosis [Presence] in Blood by Automated count,HEM/BC,284
14338-8,Prealb SerPl-mCnc,Prealbumin [Mass/volume] in Serum or Plasma,Chem,285
15198-5,Macrocytes Bld Ql Auto,Macrocytes [Presence] in Blood by Automated count,HEM/BC,286
33051-4,RBC Ur Ql,Erythrocytes [Presence] in Urine,UA,287
6299-2,BUN Bld-mCnc,Urea nitrogen [Mass/volume] in Blood,Chem,288
70204-3,NonHDLc SerPl-mCnc,Cholesterol non HDL [Moles/volume] in Serum or Plasma,Chem,289
2842-3,Prolactin SerPl-mCnc,Prolactin [Mass/volume] in Serum or Plasma,Chem,290
6598-7,Troponin T SerPl-mCnc,Troponin T.cardiac [Mass/volume] in Serum or Plasma,Chem,291
2888-6,Prot Ur-mCnc,Protein [Mass/volume] in Urine,UA,292
3393-6,BZE Ur Ql,Benzoylecgonine [Presence] in Urine,DRUG/TOX,293
9842-6,Casts #/area UrnS LPF,Casts [#/area] in Urine sediment by Microscopy low power field,UA,294
2069-3,Chloride Bld-sCnc,Chloride [Moles/volume] in Blood,Chem,295
5334-8,RUBV IgG Ser EIA-aCnc,Rubella virus IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,296
20569-0,CK MB CFr SerPl,Creatine kinase.MB/Creatine kinase.total in Serum or Plasma,Chem,297
42931-6,C trach rRNA Ur Ql PCR,Chlamydia trachomatis rRNA [Presence] in Urine by Probe & target amplification method ,MICRO,298
15199-3,Microcytes Bld Ql Auto,Microcytes [Presence] in Blood by Automated count,HEM/BC,299
20629-2,Levofloxacin Susc Islt,Levofloxacin [Susceptibility],ABXBACT,300
3397-7,Cocaine Ur Ql,Cocaine [Presence] in Urine,DRUG/TOX,301
779-9,Poikilocytosis Bld Ql Smear,Poikilocytosis [Presence] in Blood by Light microscopy,HEM/BC,302
35591-7,Creat Cl predicted SerPl C-G-vRate,Creatinine renal clearance predicted by Cockcroft-Gault formula,Chem,303
32356-8,Yeast UrnS Ql Micro,Yeast [Presence] in Urine sediment by Light microscopy,UA,304
18878-9,Cefazolin Susc Islt,Cefazolin [Susceptibility],ABXBACT,305
740-1,Metamyelocytes NFr Bld Manual,Metamyelocytes/100 leukocytes in Blood by Manual count,HEM/BC,306
12851-2,Prot Pattern SerPl Elph-Imp,Protein Fractions [interpretation] in Serum or Plasma by Electrophoresis,Chem,307
31147-2,RPR Ser-Titr,Reagin Ab [Titer] in Serum by RPR,MICRO,308
25428-4,Glucose Ur Ql Strip,Glucose [Presence] in Urine by Test strip,UA,309
1960-4,HCO3 BldA-sCnc,Bicarbonate [Moles/volume] in Arterial blood,Chem,310
2111-3,B-HCG SerPl-sCnc,Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma,Chem,311
2039-6,CEA SerPl-mCnc,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,Chem,312
2862-1,Albumin SerPl Elph-mCnc,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Chem,313
2871-2,B-Globulin SerPl Elph-mCnc,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Chem,314
2865-4,Alpha1 Glob SerPl Elph-mCnc,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Chem,315
2868-8,Alpha2 Glob SerPl Elph-mCnc,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Chem,316
18906-8,Ciprofloxacin Susc Islt,Ciprofloxacin [Susceptibility],ABXBACT,317
14890-8,Progest SerPl-mCnc,Progesterone [Moles/volume] in Serum or Plasma,Chem,318
13950-1,HAV IgM Ser Ql EIA,Hepatitis A virus IgM Ab [Presence] in Serum by Immunoassay,MICRO,319
28541-1,Metamyelocytes NFr Bld,Metamyelocytes/100 leukocytes in Blood,HEM/BC,320
3936-2,PCP Ur Ql,Phencyclidine [Presence] in Urine,DRUG/TOX,321
48159-8,HCV Ab s/co SerPl EIA-Rto,Hepatitis C virus Ab Signal/Cutoff [Ratio] in Serum or Plasma by Immunoassay,MICRO,322
2874-6,Gamma glob SerPl Elph-mCnc,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Chem,323
31201-7,HIV1+2 Ab Ser Ql EIA,HIV 1+2 Ab [Presence] in Serum by Immunoassay,MICRO,324
14914-6,Testost Free SerPl-mCnc,Testosterone Free [Moles/volume] in Serum or Plasma,Chem,325
58413-6,nRBC/100 WBC Bld Auto-Rto,Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Automated count,HEM/BC,326
36903-3,C trach+GC DNA XXX PCR,Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by Probe & target amplification method,MICRO,327
580-1,Fungus XXX Cult,Fungus identified in Unspecified specimen by Culture,MICRO,328
2692-2,Osmolality SerPl,Osmolality of Serum or Plasma,Chem,329
18865-6,Ampicillin+Sulbac Susc Islt,Ampicillin+Sulbactam [Susceptibility],ABXBACT,330
18864-9,Ampicillin Susc Islt,Ampicillin [Susceptibility],ABXBACT,331
14771-0,Glucose p fast SerPl-mCnc,Fasting glucose [Moles/volume] in Serum or Plasma,CHAL,332
635-3,Bacteria XXX Anaerobe Cult,Bacteria identified in Unspecified specimen by Anaerobe culture,MICRO,333
547-0,B-Hem Strep XXX Ql Cult,Streptococcus.beta-hemolytic [Presence] in Unspecified specimen by Organism specific culture,MICRO,334
5194-6,HBV surface Ab Ser RIA-aCnc,Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA),MICRO,335
18955-5,Nitrofurantoin Susc Islt,Nitrofurantoin [Susceptibility],ABXBACT,336
18481-2,S pyo Ag Throat Ql,Streptococcus pyogenes Ag [Presence] in Throat,MICRO,337
14754-6,Glucose 1H p 50 g Glc PO SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO,CHAL,338
12235-8,Micro UrnS,Microscopic observation [Identifier] in Urine sediment by Light microscopy,UA,339
7791-7,Dacryocytes Bld Ql Smear,Dacrocytes [Presence] in Blood by Light microscopy,HEM/BC,340
14675-3,Cortis SerPl-mCnc,Cortisol [Moles/volume] in Serum or Plasma,Chem,341
14611-8,ANA Pat Ser-Imp,Nuclear Ab pattern [interpretation] in Serum,SERO,343
8099-4,Thyroperoxidase Ab SerPl-aCnc,Thyroperoxidase Ab [Units/volume] in Serum or Plasma,SERO,344
5048-4,ANA Titr Ser IF,Nuclear Ab [Titer] in Serum by Immunofluorescence,SERO,345
2524-7,Lactate SerPl-sCnc,Lactate [Moles/volume] in Serum or Plasma,Chem,346
763-3,Neuts Band # Bld Manual,Neutrophils.band form [#/volume] in Blood by Manual count,HEM/BC,347
30522-7,CRP SerPl HS-mCnc,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,Chem,348
11156-7,WBC morph Bld,Leukocyte morphology finding [Identifier] in Blood,HEM/BC,349
19000-9,Vancomycin Susc Islt,Vancomycin [Susceptibility],ABXBACT,350
2335-8,Hemocult Stl Ql,Hemoglobin.gastrointestinal [Presence] in Stool,Chem,351
6824-7,Color Fld,Color of Body fluid,SPEC,352
24113-3,HBV core IgM Ser Ql EIA,Hepatitis B virus core IgM Ab [Presence] in Serum by Immunoassay,MICRO,353
14578-9,ABO Group Bld BPU,ABO group [Type] in Blood from Blood product unit,BLDBK,354
14907-0,Rh Bld BPU,Rh [Type] in Blood from Blood product unit,BLDBK,355
14877-5,Phenytoin SerPl-mCnc,Phenytoin [Moles/volume] in Serum or Plasma,DRUG/TOX,356
14698-5,Digoxin SerPl-mCnc,Digoxin [Moles/volume] in Serum or Plasma,DRUG/TOX,357
13965-9,Homocysteine SerPl-sCnc,Homocysteine [Moles/volume] in Serum or Plasma,Chem,358
55593-8,Creat ?Tm Ur-mCnc,Creatinine [Moles/volume] in unspecified time Urine,Chem,359
18893-8,Ceftazidime Susc Islt,Ceftazidime [Susceptibility],ABXBACT,360
18970-4,Piperacillin+Tazobac Susc Islt,Piperacillin+Tazobactam [Susceptibility],ABXBACT,361
54218-3,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CELLMARK,362
800-3,Schistocytes Bld Ql Smear,Schistocytes [Presence] in Blood by Light microscopy,HEM/BC,363
21198-7,B-HCG SerPl-aCnc,Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma,Chem,364
14719-9,Ethanol SerPl-mCnc,Ethanol [Moles/volume] in Serum or Plasma,DRUG/TOX,365
22763-7,Ammonia Plas-mCnc,Ammonia [Mass/volume] in Plasma,Chem,366
16362-6,Ammonia Plas-sCnc,Ammonia [Moles/volume] in Plasma,Chem,367
3426-4,THC Ur Ql,Tetrahydrocannabinol [Presence] in Urine,DRUG/TOX,368
26487-9,Monocytes NFr Fld,Monocytes/100 leukocytes in Body fluid,HEM/BC,369
11031-2,Lymphocytes NFr Fld,Lymphocytes/100 leukocytes in Body fluid,HEM/BC,370
749-2,Myelocytes NFr Bld Manual,Myelocytes/100 leukocytes in Blood by Manual count,HEM/BC,371
18932-4,Imipenem Susc Islt,Imipenem [Susceptibility],ABXBACT,372
18943-1,Meropenem Susc Islt,Meropenem [Susceptibility],ABXBACT,373
32673-6,CK MB SerPl-cCnc,Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma,Chem,374
22322-2,HBV surface Ab Ser Ql,Hepatitis B virus surface Ab [Presence] in Serum,MICRO,375
13655-6,WBC Stl Ql Micro,Leukocytes [Presence] in Stool by Light microscopy,HEM/BC,376
8123-2,CD3+CD4+ Cells NFr Bld,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CELLMARK,377
26498-6,Myelocytes NFr Bld,Myelocytes/100 leukocytes in Blood,HEM/BC,378
19162-7,VZV IgG Ser Ql,Varicella zoster virus IgG Ab [Presence] in Serum,MICRO,379
18879-7,Cefepime Susc Islt,Cefepime [Susceptibility],ABXBACT,380
5783-6,Unident Crys UrnS Ql Micro,Unidentified crystals [Presence] in Urine sediment by Light microscopy,UA,381
39797-6,Vancomycin Trough SerPl-sCnc,Vancomycin [Moles/volume] in Serum or Plasma --trough,DRUG/TOX,382
4092-3,Vancomycin Trough SerPl-mCnc,Vancomycin [Mass/volume] in Serum or Plasma --trough,DRUG/TOX,382
8124-0,CD3 Cells NFr Bld,CD3 cells/100 cells in Blood,CELLMARK,383
31017-7,tTG IgA Ser-aCnc,Tissue transglutaminase IgA Ab [Units/volume] in Serum,SERO,384
3150-0,Inhaled O2 concentration,Inhaled oxygen concentration,CLIN,385
1834-1,AFP SerPl-mCnc,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,Chem,386
3167-4,Specimen vol 24H Ur,Volume of 24 hour Urine,SPEC,387
18895-3,Ceftriaxone Susc Islt,Ceftriaxone [Susceptibility],ABXBACT,388
1925-7,Base excess BldA-sCnc,Base excess in Arterial blood,Chem,389
1990-1,Vitamin D3 SerPl-mCnc,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Chem,390
47094-8,Vitamin D2 SerPl-mCnc,Calciferol (Vit D2) [Moles/volume] in Serum or Plasma,Chem,391
14796-7,Insulin SerPl-aCnc,Insulin [Moles/volume] in Serum or Plasma,Chem,392
18993-6,Tetracycline Susc Islt,Tetracycline [Susceptibility],ABXBACT,393
17790-7,WBC Left Shift Bld Ql Auto,Leukocytes Left Shift [Presence] in Blood by Automated count,HEM/BC,394
13955-0,HCV Ab Ser Ql EIA,Hepatitis C virus Ab [Presence] in Serum by Immunoassay,MICRO,395
18996-9,Tobramycin Susc Islt,Tobramycin [Susceptibility],ABXBACT,396
8101-8,CD3+CD8+ Cells NFr Bld,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CELLMARK,397
13451-0,Creat Cl Dial fld+SerPl-vRate,Creatinine dialysis fluid clearance,Chem,398
1305-2,D Ag Bld Ql,D Ag [Presence] in Blood,BLDBK,399
5130-0,dsDNA Ab Ser-aCnc,DNA double strand Ab [Units/volume] in Serum,SERO,400
14581-3,Acetamin SerPl-mCnc,Acetaminophen [Moles/volume] in Serum or Plasma,DRUG/TOX,402
14895-7,Prot Pattern SerPl IFE-Imp,Protein Fractions [interpretation] in Serum or Plasma by Immunofixation,Chem,403
18886-2,Cefotaxime Susc Islt,Cefotaxime [Susceptibility],ABXBACT,404
35492-8,MRSA DNA XXX Ql PCR,Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] by Probe & target amplification method,ABXBACT,406
14946-8,Valproate SerPl-mCnc,Valproate [Moles/volume] in Serum or Plasma,DRUG/TOX,408
34148-7,B burgdor IgG+IgM Ser-aCnc,Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum,MICRO,410
18969-6,Piperacillin Susc Islt,Piperacillin [Susceptibility],ABXBACT,411
2955-3,Sodium Ur-sCnc,Sodium [Moles/volume] in Urine,Chem,412
10381-2,Targets Bld Ql Smear,Target cells [Presence] in Blood by Light microscopy,HEM/BC,413
18860-7,Amikacin Susc Islt,Amikacin [Susceptibility],ABXBACT,414
12238-2,Neutrophils NFr Fld Manual,Neutrophils/100 leukocytes in Body fluid by Manual count,HEM/BC,415
8098-6,Thyroglob Ab SerPl-aCnc,Thyroglobulin Ab [Units/volume] in Serum or Plasma,SERO,416
3773-9,Methadone Ur Ql,Methadone [Presence] in Urine,DRUG/TOX,417
26452-3,Eosinophil NFr Fld,Eosinophils/100 leukocytes in Body fluid,HEM/BC,418
18961-3,Oxacillin Susc Islt,Oxacillin [Susceptibility],ABXBACT,419
10352-3,Bacteria Genital Aerobe Cult,Bacteria identified in Genital specimen by Aerobe culture,MICRO,420
4073-3,Tricyclics SerPl Ql,Tricyclic antidepressants [Presence] in Serum or Plasma,DRUG/TOX,421
1006-6,DAT IgG-Sp Reag RBC-Imp,Direct antiglobulin test.IgG specific reagent [interpretation] on Red Blood Cells,BLDBK,422
31160-5,Polys NFr Bld Manual,Polymorphonuclear cells/100 leukocytes in Blood by Manual count,HEM/BC,423
7790-9,Burr Cells Bld Ql Smear,Burr cells [Presence] in Blood by Light microscopy,HEM/BC,424
543-9,Mycobacterium XXX Cult,Mycobacterium sp identified in Unspecified specimen by Organism specific culture,MICRO,425
20564-1,SaO2% Bld,Oxygen saturation in Blood,HEMODYN.MOLEC,426
8122-4,CD3 Cells # Bld,CD3 cells [#/volume] in Blood,CELLMARK,427
21667-1,F5 gene Mut Anal Bld/T,F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,MOLPATH.MUT,428
584-3,Gp B Strep Vag Ql Cult,Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture,MICRO,429
10334-1,Cancer Ag125 SerPl-aCnc,Cancer Ag 125 [Units/volume] in Serum or Plasma,Chem,430
34713-8,C dif Tox A+B Stl Ql,Clostridium difficile toxin A+B [Presence] in Stool,MICRO,431
26510-8,Neuts Band NFr Fld,Neutrophils.band form/100 leukocytes in Body fluid,HEM/BC,432
8246-1,Amorph Sed UrnS Ql Micro,Amorphous sediment [Presence] in Urine sediment by Light microscopy,UA,433
18919-1,Erythromycin Susc Islt,Erythromycin [Susceptibility],ABXBACT,434
26455-6,RBC # Fld,Erythrocytes [#/volume] in Body fluid,HEM/BC,435
4485-9,C3 SerPl-mCnc,Complement C3 [Mass/volume] in Serum or Plasma,HEM/BC,436
4498-2,C4 SerPl-mCnc,Complement C4 [Mass/volume] in Serum or Plasma,HEM/BC,437
57845-0,WBC # Fld Auto,Leukocytes [#/volume] in Body fluid by Automated count,HEM/BC,438
5176-3,H pylori IgG Ser EIA-aCnc,Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,439
16128-1,HCV Ab Ser Ql,Hepatitis C virus Ab [Presence] in Serum,MICRO,440
14135-8,CD3+CD8+ Cells # Bld,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CELLMARK,441
7918-6,HIV1+2 Ab Ser Ql,HIV 1+2 Ab [Presence] in Serum,MICRO,442
19312-8,Tricyclics Ur Ql Scn,Tricyclic antidepressants [Presence] in Urine by Screen method,DRUG/TOX,443
18908-4,Clindamycin Susc Islt,Clindamycin [Susceptibility],ABXBACT,444
14684-5,Creat 24H Ur-mRate,Creatinine [Moles/time] in 24 hour Urine,Chem,445
13518-6,Variant Lymphs NFr Fld Manual,Lymphocytes Variant/100 leukocytes in Body fluid by Manual count,HEM/BC,446
12179-8,Basophils NFr Fld Manual,Basophils/100 leukocytes in Body fluid by Manual count,HEM/BC,447
6864-3,Hgb S Bld Ql Soly,Hemoglobin S [Presence] in Blood by Solubility test,HEM/BC,448
49563-0,Troponin I SerPl DL=0.01 ng/mL-mCnc,Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit = 0.01 ng/mL,Chem,449
33255-1,Cell Fract Bld-Imp,Cell Fractions/Differential [interpretation] in Blood,HEM/BC,450
2708-6,SaO2 % BldA,Oxygen saturation in Arterial blood,Chem,451
5209-2,HSV2 IgG Ser EIA-aCnc,Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,452
18964-7,Penicillin Susc Islt,Penicillin [Susceptibility],ABXBACT,453
18868-0,Aztreonam Susc Islt,Aztreonam [Susceptibility],ABXBACT,454
1863-0,Anion Gap4 SerPl-sCnc,Anion gap 4 in Serum or Plasma,Chem,455
19994-3,O2/Inspired gas setting VFr Vent,Oxygen/Inspired gas setting [Volume Fraction] Ventilator,PULM,457
21654-9,CFTR Mut Anal Bld/T,CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,MOLPATH.MUT,460
14909-6,Salicylates SerPl-mCnc,Salicylates [Moles/volume] in Serum or Plasma,DRUG/TOX,464
70200-1,HDLc SerPl-mRto,Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma,Chem,465
19113-0,IgE Ser-aCnc,IgE [Units/volume] in Serum,Chem,466
12232-5,MeV Ag XXX Ql IF,Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence,MICRO,467
14688-6,DHEA-S SerPl-mCnc,Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma,Chem,468
625-4,Bacteria Stl Cult,Bacteria identified in Stool by Culture,MICRO,469
24475-6,F2 p.G20210A Bld/T Ql,F2 gene p.G20210A [Presence] in Blood or Tissue by Molecular genetics method,MOLPATH.MUT,470
30318-0,Base deficit Bld-sCnc,Base deficit in Blood,Chem,471
743-5,Monocytes # Bld Manual,Monocytes [#/volume] in Blood by Manual count,HEM/BC,472
5569-9,Acetone Ur Ql,Acetone [Presence] in Urine,DRUG/TOX,473
3520-4,Cyclosporin Bld-mCnc,Cyclosporine [Mass/volume] in Blood,DRUG/TOX,474
32693-4,Lactate Bld-sCnc,Lactate [Moles/volume] in Blood,Chem,475
48065-7,D dimer FEU PPP-mCnc,Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma,COAG,476
2110-5,B-HCG Preg SerPl Ql,Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma,Chem,477
13952-7,HBV core Ab Ser Ql EIA,Hepatitis B virus core Ab [Presence] in Serum by Immunoassay,MICRO,478
610-6,Bacteria Fld Aerobe Cult,Bacteria identified in Body fluid by Aerobe culture,MICRO,479
5403-1,VZV IgG Ser EIA-aCnc,Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,480
803-7,Toxic Granules Bld Ql Smear,Toxic granules [Presence] in Blood by Light microscopy,HEM/BC,481
33358-3,M Protein SerPl Elph-mCnc,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,Chem,482
65633-0,HBV surface Ag SerPl Ql Cfm,Hepatitis B virus surface Ag [Presence] in Serum by Confirmatory method,MICRO,483
10524-7,Cyto Cervix,Microscopic observation [Identifier] in Cervix by Cyto stain,CYTO,484
29247-4,Sirolimus Bld-mCnc,Sirolimus [Mass/volume] in Blood,DRUG/TOX,485
739-3,Metamyelocytes # Bld Manual,Metamyelocytes [#/volume] in Blood by Manual count,HEM/BC,486
2889-4,Prot 24H Ur-mRate,Protein [Mass/time] in 24 hour Urine,Chem,487
18887-0,Cefotetan Susc Islt,Cefotetan [Susceptibility],ABXBACT,488
10335-8,Color CSF,Color of Cerebral spinal fluid,SPEC,489
39778-6,Iron/TIBC SerPl-mRto,Iron/Iron binding capacity.total [Molar ratio] in Serum or Plasma,Chem,490
30089-7,Trans Cells #/area UrnS HPF,Transitional cells [#/area] in Urine sediment by Microscopy high power field,UA,491
20761-3,C dif Stl Ql Aggl,Clostridium difficile [Presence] in Stool by Agglutination,MICRO,492
2828-2,Potassium Ur-sCnc,Potassium [Moles/volume] in Urine,Chem,493
29891-9,Urea Breath Test Ql,Helicobacter pylori [Presence] in Stomach by urea breath test,MICRO,494
19107-2,H capsul Ag Ser RIA-aCnc,Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA),MICRO,495
2639-3,Myoglobin SerPl-mCnc,Myoglobin [Mass/volume] in Serum or Plasma,Chem,496
5028-6,N gonorrhoea rRNA XXX Ql Prb,Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe,MICRO,497
1922-4,Base deficit BldA-sCnc,Base deficit in Arterial blood,Chem,498
48058-2,D dimer DDU PPP EIA-mCnc,Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay,COAG,499
35365-6,Vit D+metab SerPl-mCnc,Vitamin D+Metabolites [Mass/volume] in Serum or Plasma,Chem,500
772-4,nRBC # Bld Manual,Nucleated erythrocytes [#/volume] in Blood by Manual count,HEM/BC,501
806-0,WBC # CSF Manual,Leukocytes [#/volume] in Cerebral spinal fluid by Manual count,HEM/BC,502
14566-4,"1,25(OH)2D3 SerPl-mCnc",Calcitriol [Moles/volume] in Serum or Plasma,Chem,503
3181-5,Cardiolipin IgG Ser IA-aCnc,Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay,COAG,504
3182-3,Cardiolipin IgM Ser IA-aCnc,Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay,COAG,505
4546-8,Hgb A MFr Bld,Hemoglobin A/Hemoglobin.total in Blood,HEM/BC,506
49541-6,Fasting status Patient Ql Reported,Fasting status [Presence] - Reported,MISC,507
4576-5,Hgb F MFr Bld,Hemoglobin F/Hemoglobin.total in Blood,HEM/BC,508
2890-2,Prot/Creat Ur-mRto,Protein/Creatinine [Mass ratio] in Urine,Chem,509
33935-8,cCP IgG Ser-aCnc,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum,SERO,510
16935-9,HBV surface Ab Ser-aCnc,Hepatitis B virus surface Ab [Units/volume] in Serum,MICRO,511
5193-8,HBV surface Ab Ser EIA-aCnc,Hepatitis B virus surface Ab [Units/volume] in Serum by Immunoassay,MICRO,512
20399-2,ANA nucleolar Titr Ser,Nuclear Ab pattern.nucleolar [Titer] in Serum,SERO,513
25145-4,Bacteria UrnS Ql Micro,Bacteria [Presence] in Urine sediment by Light microscopy,UA,514
24467-3,CD3+CD4+ Cells # Bld,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CELLMARK,515
33762-6,proBNP SerPl-mCnc,Natriuretic peptide.B prohormone [Mass/volume] in Serum or Plasma,Chem,516
48066-5,D dimer DDU PPP-mCnc,Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma,COAG,517
4625-0,Hgb S MFr Bld,Hemoglobin S/Hemoglobin.total in Blood,HEM/BC,518
2746-6,pH BldV,pH of Venous blood,Chem,519
3376-1,Barbiturates SerPlBld Ql,"Barbiturates [Presence] in Serum, Plasma or Blood",DRUG/TOX,520
546-2,B-Hem Strep Throat Ql Cult,Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture,MICRO,521
21484-1,Mother's race,Mother's race,CLIN,522
2021-4,pCO2 BldV,Carbon dioxide [Partial pressure] in Venous blood,Chem,523
30446-9,Myelocytes # Bld,Myelocytes [#/volume] in Blood,HEM/BC,524
748-4,Myelocytes # Bld Manual,Myelocytes [#/volume] in Blood by Manual count,HEM/BC,525
17898-8,Bacteria Throat Aerobe Cult,Bacteria identified in Throat by Aerobe culture,MICRO,526
673-4,O and P Prep XXX,Microscopic observation [Identifier] in Unspecified specimen by Ova & Parasite Preparation,MICRO,527
5064-1,B burgdor IgM Ser EIA-aCnc,Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,528
32998-7,tTG IgG Ser-aCnc,Tissue transglutaminase IgG Ab [Units/volume] in Serum,SERO,529
56537-4,tTG IgG Ser EIA-aCnc,Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay,SERO,530
11011-4,HCV RNA SerPl PCR-aCnc,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,531
12841-3,PSA Free MFr SerPl,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,Chem,532
11006-4,B burgdor Ab Ser Ql,Borrelia burgdorferi Ab [Presence] in Serum,MICRO,533
2880-3,Prot CSF-mCnc,Protein [Mass/volume] in Cerebral spinal fluid,Chem,534
33944-0,Lambda LC Free SerPl-mCnc,Immunoglobulin light chains.lambda.free [Mass/volume] in Serum or Plasma,Chem,535
3389-4,Benzodiaz SerPl Ql,Benzodiazepines [Presence] in Serum or Plasma,DRUG/TOX,536
5206-8,HSV1 IgG Ser EIA-aCnc,Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,537
19066-0,Blood Bank Cmnt Patient-Imp,Blood bank comment,BLDBK,538
48803-1,Neural tube defect risk Fetus,Neural tube defect risk in Fetus,Chem,539
4563-3,Hgb C MFr Bld,Hemoglobin C/Hemoglobin.total in Blood,HEM/BC,540
49049-0,Collect Tme XXX,Collection time of Unspecified specimen,SPEC,541
13503-8,B burgdor IgM Patrn Ser IB-Imp,Borrelia burgdorferi Ab.IgM band pattern [interpretation] in Serum by Immunoblot (IB),MICRO,542
14725-6,Body fld type,[Type] of Body fluid,SPEC,543
21299-3,GA method,Gestational age method,OB.US,544
4545-0,Hct VFr Bld Spun,Hematocrit [Volume Fraction] of Blood by Centrifugation,HEM/BC,545
10362-2,Endomysium IgA Ser Ql,Endomysium IgA Ab [Presence] in Serum,SERO,547
18862-3,Amoxicillin+Clav Susc Islt,Amoxicillin+Clavulanate [Susceptibility],ABXBACT,549
14744-7,Glucose CSF-mCnc,Glucose [Moles/volume] in Cerebral spinal fluid,Chem,550
18965-4,Penicillin G Susc Islt,Penicillin G [Susceptibility],ABXBACT,551
9587-7,B burgdor41kD IgM Ser Ql IB,Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot (IB),MICRO,552
18390-5,Opiates Ur Ql Cfm,Opiates [Presence] in Urine by Confirmatory method,DRUG/TOX,553
10886-0,PSA Free SerPl-mCnc,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,Chem,554
14196-0,Retics #,Reticulocytes [#/volume] in Blood,HEM/BC,555
2695-5,Osmolality Ur,Osmolality of Urine,Chem,556
42481-2,HPV Low Risk DNA Cervix Ql bDNA,Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe & signal amplification method,MICRO,557
13951-9,HAV Ab Ser Ql EIA,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,MICRO,558
13502-0,B burgdor IgG Patrn Ser IB-Imp,Borrelia burgdorferi Ab.IgG band pattern [interpretation] in Serum by Immunoblot (IB),MICRO,559
11090-8,ENA SM Ab Ser-aCnc,Smith extractable nuclear Ab [Units/volume] in Serum,SERO,560
606-4,Bacteria CSF Cult,Bacteria identified in Cerebral spinal fluid by Culture,MICRO,561
6561-5,T pallidum IgG Ser Ql,Treponema pallidum IgG Ab [Presence] in Serum,MICRO,562
47238-1,T pallidum IgG Ser Ql EIA,Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay,MICRO,563
18185-9,GA,Gestational age,OB.US,564
9597-6,B burgdor93kD IgG Ser Ql IB,Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,565
31418-7,Heteroph Ab Ser Ql,Heterophile Ab [Presence] in Serum,MICRO,566
17792-3,ENA SS-A Ab Ser-aCnc,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum,SERO,567
11004-9,Tricyclics Ur Ql,Tricyclic antidepressants [Presence] in Urine,DRUG/TOX,568
17791-5,ENA SS-B Ab Ser-aCnc,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum,SERO,569
9593-5,B burgdor41kD IgG Ser Ql IB,Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,570
9590-1,B burgdor28kD IgG Ser Ql IB,Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,571
9594-3,B burgdor45kD IgG Ser Ql IB,Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,572
9589-3,B burgdor23kD IgG Ser Ql IB,Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,573
9591-9,B burgdor30kD IgG Ser Ql IB,Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,574
9592-7,B burgdor39kD IgG Ser Ql IB,Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,575
9599-2,B burgdor39kD IgM Ser Ql IB,Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot (IB),MICRO,576
9598-4,B burgdor23kD IgM Ser Ql IB,Borrelia burgdorferi 23kD IgM Ab [Presence] in Serum by Immunoblot (IB),MICRO,577
9595-0,B burgdor58kD IgG Ser Ql IB,Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,578
9596-8,B burgdor66kD IgG Ser Ql IB,Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,579
47000-5,Candida rRNA Vag Ql Prb,Candida sp rRNA [Presence] in Vaginal fluid by DNA probe,MICRO,580
9588-5,B burgdor18kD IgG Ser Ql IB,Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot (IB),MICRO,581
44357-2,Galactomannan Ag SerPl EIA-aCnc,Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay,MICRO,582
6410-5,G vaginalis rRNA Genital Ql Prb,Gardnerella vaginalis rRNA [Presence] in Genital specimen by DNA probe,MICRO,583
6568-0,T vaginalis rRNA Genital Ql Prb,Trichomonas vaginalis rRNA [Presence] in Genital specimen by DNA probe,MICRO,584
14564-9,Hemocult sp2 Stl Ql,Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen,Chem,585
2164-2,Creat Cl 24H Ur+SerPl-vRate,Creatinine renal clearance in 24 hour,Chem,586
43371-4,Salm/Shig Stl Cult,Salmonella sp/Shigella sp identified in Stool by Organism specific culture,MICRO,587
6331-3,Campylobacter Stl Cult,Campylobacter sp identified in Stool by Organism specific culture,MICRO,588
21262-1,E coli SLTEC Stl Ql EIA,Escherichia coli shiga-like [Presence] in Stool by Immunoassay,MICRO,589
29374-6,ENA RNP Ab Ser-aCnc,Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum,SERO,590
9335-1,Appearance Fld,Appearance of Body fluid,SPEC,591
19157-7,Tube # CSF,Tube number of Cerebral spinal fluid,SPEC,592
29463-7,Weight,Body weight,BDYWGT.ATOM,593
36916-5,Kappa LC Free Ser-mCnc,Immunoglobulin light chains.kappa.free [Mass/volume] in Serum,Chem,594
15189-4,Kappa LC/Lambda Ser-mRto,Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda [Mass ratio] in Serum,Chem,595
70209-2,Haptoglob SerPl-mCnc,Haptoglobin [Moles/volume] in Serum or Plasma,HEM/BC,596
15120-9,Ethanol Bld-mCnc,Ethanol [Moles/volume] in Blood,DRUG/TOX,597
19993-5,FIO2 Gas Dil.rebreath,Oxygen/Inspired gas Inhaled gas by Gas dilution.rebreath,PULM,598
6420-4,H pylori IgA Ser EIA-aCnc,Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay,MICRO,599
14565-6,Hemocult sp3 Stl Ql,Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen,Chem,600
17842-6,Cancer Ag27-29 SerPl-aCnc,Cancer Ag 27-29 [Units/volume] in Serum or Plasma,Chem,601
32515-9,CD3+CD4+ Cells # XXX,CD3+CD4+ (T4 helper) cells [#/volume] in Unspecified specimen,CELLMARK,602
7886-5,EBV VCA IgM Ser-aCnc,Epstein Barr virus capsid IgM Ab [Units/volume] in Serum,MICRO,603
5159-9,EBV VCA IgM Ser EIA-aCnc,Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,604
26052-1,Renal Epi Cells #/area UrnS HPF,Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field,UA,605
7885-7,EBV VCA IgG Ser-aCnc,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum,MICRO,606
5157-3,EBV VCA IgG Ser EIA-aCnc,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,607
33768-3,WBC clumps # Ur Auto,Leukocyte clumps [#/volume] in Urine by Automated count,UA,608
23811-3,AFP adj MoM SerPl,Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma,Chem,609
3013-0,Thyroglob SerPl-mCnc,Thyroglobulin [Mass/volume] in Serum or Plasma,Chem,610
6206-7,Peanut IgE Qn,Peanut IgE Ab [Units/volume] in Serum,Allergy,611
2756-5,pH Ur,pH of Urine,Chem,612
2484-4,IGF-I SerPl-mCnc,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma,Chem,614
2118-8,HCG Preg SerPl Ql,Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma,Chem,615
18974-6,Rifampin Susc Islt,Rifampin [Susceptibility],ABXBACT,616
12710-0,Hgb Fract Bld-Imp,Hemoglobin pattern [interpretation] in Blood,HEM/BC,617
34705-4,pCO2 temp adj Bld,Carbon dioxide [Partial pressure] adjusted to patients actual temperature in Blood,Chem,618
19254-2,pO2 temp adj Bld,Oxygen [Partial pressure] adjusted to patients actual temperature in Blood,Chem,619
4993-2,C trach rRNA XXX Ql Prb,Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by DNA probe,MICRO,620
1977-8,Bilirub Ur Ql,Bilirubin [Presence] in Urine,Chem,621
44877-9,IDDM Patient Ql,Insulin dependent diabetes mellitus [Presence],MISC,622
23641-4,Quinupristin+Dalfoprist Islt MIC,Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC),ABXBACT,623
14563-1,Hemocult sp1 Stl Ql,Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen,Chem,625
20447-9,HIV1 RNA # SerPl PCR,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,626
5244-9,MeV IgG Ser EIA-aCnc,Measles virus IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,627
15064-9,u Estriol SerPl-mCnc,Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma,Chem,628
19550-3,Methadone Ur Ql Scn,Methadone [Presence] in Urine by Screen method,DRUG/TOX,629
49090-4,Ts 21risk-age Fetus,Trisomy 21 risk based on maternal age in Fetus,Chem,630
21026-0,Path Interp Bld-Imp,Pathologist interpretation of Blood tests,PATH,631
62292-8,Calcidiol+Calciferol SerPl-mCnc,25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma,Chem,632
2761-5,Phenylketones Bld Ql,Phenylketones [Presence] in Blood,Chem,633
3779-6,Methamphet Ur Ql,Methamphetamine [Presence] in Urine,DRUG/TOX,634
35663-4,Prot ?Tm Ur-mCnc,Protein [Mass/volume] in unspecified time Urine,UA,635
20506-2,Specimen drawn from Patient,Specimen drawn from,SPEC,636
19057-9,ABO+Rh Gp Bld NB,ABO & Rh group [Type] in Blood from newborn,BLDBK,637
626-2,Bacteria Throat Cult,Bacteria identified in Throat by Culture,MICRO,638
13532-7,Xanthochromia CSF Ql,Xanthochromia [Presence] of Cerebral spinal fluid,SPEC,639
34660-1,Hgb A2 MFr Bld Column Chrom,Hemoglobin A2/Hemoglobin.total in Blood by Chromatography column,HEM/BC,640
26454-9,RBC # CSF,Erythrocytes [#/volume] in Cerebral spinal fluid,HEM/BC,641
10333-3,Appearance CSF,Appearance of Cerebral spinal fluid,SPEC,642
5822-2,Yeast #/area UrnS HPF,Yeast [#/area] in Urine sediment by Microscopy high power field,UA,643
49092-0,2nd trimester 4 screen SerPl-Imp,Second trimester quad maternal screen [interpretation] in Serum or Plasma Narrative,Chem,644
6276-0,Wheat IgE Qn,Wheat IgE Ab [Units/volume] in Serum,Allergy,645
6248-9,Soybean IgE Qn,Soybean IgE Ab [Units/volume] in Serum,Allergy,646
75882-1,LA 3 screen W Reflex-Imp,Lupus anticoagulant three screening tests W Reflex [interpretation],COAG,647
6095-4,D farinae IgE Qn,American house dust mite IgE Ab [Units/volume] in Serum,Allergy,648
25160-3,Gran Casts UrnS Ql Micro,Granular casts [Presence] in Urine sediment by Light microscopy,UA,649
33804-6,RBC Casts UrnS Ql Micro,RBC casts [Presence] in Urine sediment by Light microscopy,UA,650
703-9,Baso Stipl Bld Ql Smear,Basophilic stippling [Presence] in Blood by Light microscopy,HEM/BC,651
6020-2,A alternata IgE Qn,Alternaria alternata IgE Ab [Units/volume] in Serum,Allergy,652
20496-6,Gliadin IgG Ser EIA-aCnc,Gliadin IgG Ab [Units/volume] in Serum by Immunoassay,SERO,653
29541-0,HIV1 RNA Plas PCR-Log#,HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe & target amplification method,MICRO,654
6584-7,Virus XXX Cult,Virus identified in Unspecified specimen by Culture,MICRO,655
19343-3,Amphet Ur Ql Scn,Amphetamine [Presence] in Urine by Screen method,DRUG/TOX,656
13964-2,Methylmalonate SerPl-sCnc,Methylmalonate [Moles/volume] in Serum or Plasma,Chem,657
802-9,Spherocytes Bld Ql Smear,Spherocytes [Presence] in Blood by Light microscopy,HEM/BC,658
10704-5,O+P Stl Micro,Ova+Parasites identified in Stool by Light microscopy,MICRO,659
5185-4,HBV core IgM Ser EIA-aCnc,Hepatitis B virus core IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,660
46269-7,25(OH)D2 SerPl-mCnc,25-Hydroxycalciferol [Moles/volume] in Serum or Plasma,Chem,661
7258-7,Cow Milk IgE Qn,Cow milk IgE Ab [Units/volume] in Serum,Allergy,662
19554-5,Methamphet Ur Ql Scn,Methamphetamine [Presence] in Urine by Screen method,DRUG/TOX,663
10328-3,Lymphocytes NFr CSF Manual,Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,664
2705-2,pO2 BldV,Oxygen [Partial pressure] in Venous blood,Chem,665
43994-3,Ts 18 risk Fetus,Trisomy 18 risk in Fetus,Chem,666
14334-7,Lithium SerPl-sCnc,Lithium [Moles/volume] in Serum or Plasma,DRUG/TOX,667
41477-1,Bacterial sialidase XXX Ql,Bacterial sialidase [Presence] in Unspecified specimen,MICRO,668
33254-4,pH temp adj BldA,pH of Arterial blood adjusted to patients actual temperature,Chem,669
21612-7,Age Time Patient Reported,Age - Reported,MISC,670
14639-9,Carbamazepine SerPl-mCnc,Carbamazepine [Moles/volume] in Serum or Plasma,DRUG/TOX,671
43995-0,Ts 21 risk Fetus,Trisomy 21 risk in Fetus,Chem,672
5124-3,CMV IgG Ser EIA-aCnc,Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,673
10366-3,Cotinine Ur-mCnc,Cotinine [Mass/volume] in Urine,DRUG/TOX,674
6096-2,D pteronyss IgE Qn,European house dust mite IgE Ab [Units/volume] in Serum,Allergy,675
26473-9,WBC Other NFr Fld,Leukocytes other/100 leukocytes in Body fluid,HEM/BC,676
24108-3,Cancer Ag19-9 SerPl-aCnc,Cancer Ag 19-9 [Units/volume] in Serum or Plasma,Chem,677
5859-4,HSV XXX Cult,Herpes simplex virus identified in Unspecified specimen by Organism specific culture,MICRO,678
5774-5,CaOx Cry UrnS Ql Micro,Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy,UA,679
49121-7,RBC inclusions Bld,Erythrocyte inclusion bodies [Identifier] in Blood,HEM/BC,680
13967-5,SHBG SerPl-sCnc,Sex hormone binding globulin [Moles/volume] in Serum or Plasma,Chem,681
3095-7,UUN Ur-mCnc,Urea nitrogen [Mass/volume] in Urine,Chem,682
6025-1,A fumigatus IgE Qn,Aspergillus fumigatus IgE Ab [Units/volume] in Serum,Allergy,683
21264-7,u Estriol adj MoM SerPl,Estriol (E3).unconjugated [Multiple of the median] adjusted in Serum or Plasma,Chem,684
25836-8,HIV1 RNA # XXX PCR,HIV 1 RNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method,MICRO,685
46640-9,,Secondary diagnosis RFC,SURVEY.RFC,686
42216-2,Ref Lab Name,Reference lab name [Identifier],MISC,687
48391-7,CO2 BldV Calc-sCnc,"Carbon dioxide, total [Moles/volume] in Venous blood by calculation",Chem,688
35678-2,Sodium ?Tm Ur-sCnc,Sodium [Moles/volume] in unspecified time Urine,Chem,689
10459-6,AFP Ag Tiss Ql ImStn,Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain,PATH,690
5793-5,Gran Casts #/area UrnS LPF,Granular casts [#/area] in Urine sediment by Microscopy low power field,UA,691
6099-6,Dog Epith IgE Qn,Dog epithelium IgE Ab [Units/volume] in Serum,Allergy,692
34701-3,Heparin Ind Platelet Ab Ser Ql,Platelet Ab.heparin induced [Presence] in Serum,SERO,693
20495-8,Gliadin IgA Ser EIA-aCnc,Gliadin IgA Ab [Units/volume] in Serum by Immunoassay,SERO,694
1761-6,Aldolase SerPl-cCnc,Aldolase [Enzymatic activity/volume] in Serum or Plasma,Chem,695
8248-7,Sperm UrnS Ql Micro,Spermatozoa [Presence] in Urine sediment by Light microscopy,UA,696
2078-4,Chloride Ur-sCnc,Chloride [Moles/volume] in Urine,Chem,697
31374-2,EBV NA IgG Ser-aCnc,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum,MICRO,698
30083-0,EBV NA IgG Ser EIA-aCnc,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,699
47223-3,Ts 18 risk-Age Fetus,Trisomy 18 risk based on maternal age in Fetus,Chem,700
14633-2,C peptide SerPl-mCnc,C peptide [Moles/volume] in Serum or Plasma,Chem,701
23883-2,Inhibin A Ser-mCnc,Inhibin A [Mass/volume] in Serum,Chem,702
34468-9,C dif Tox A+B Stl Ql EIA,Clostridium difficile toxin A+B [Presence] in Stool by Immunoassay,MICRO,703
2881-1,Prot Fld-mCnc,Protein [Mass/volume] in Body fluid,Chem,704
3243-3,Thrombin time,Thrombin time,COAG,705
3243-3,TT Time PPP,Thrombin time in Platelet poor plasma by Coagulation assay,COAG,705
19270-8,Barbiturates Ur Ql Scn,Barbiturates [Presence] in Urine by Screen method,DRUG/TOX,706
15432-8,Testost Free MFr SerPl,Testosterone Free/Testosterone.total in Serum or Plasma,Chem,707
26466-3,WBC # Fld,Leukocytes [#/volume] in Body fluid,HEM/BC,708
21440-3,HPV I/H Risk DNA Cervix Ql Prb,Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by DNA probe,MICRO,709
14874-2,Phenobarb SerPl-mCnc,Phenobarbital [Moles/volume] in Serum or Plasma,DRUG/TOX,710
10835-7,LPa SerPl-mCnc,Lipoprotein a [Mass/volume] in Serum or Plasma,Chem,711
22330-5,HDV Ab Ser-aCnc,Hepatitis D virus Ab [Units/volume] in Serum,MICRO,712
38526-0,# Spec Tst Stl,Number of specimens tested of Stool,SPEC,713
40752-8,EBV EA IgG Ser Ql EIA,Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay,MICRO,714
6833-8,Cat Dander IgE Qn,Cat dander IgE Ab [Units/volume] in Serum,Allergy,715
5813-1,T vaginalis UrnS Ql Micro,Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy,UA,716
6189-5,White Oak IgE Qn,White Oak IgE Ab [Units/volume] in Serum,Allergy,717
6075-6,C herbarum IgE Qn,Cladosporium herbarum IgE Ab [Units/volume] in Serum,Allergy,718
14314-9,BZE Ur Ql Scn,Benzoylecgonine [Presence] in Urine by Screen method,DRUG/TOX,719
5332-2,RUBV Ab Ser Ql LA,Rubella virus Ab [Presence] in Serum by Latex agglutination,MICRO,720
12248-1,Renal Epi Cells UrnS Ql Micro,Epithelial cells.renal [Presence] in Urine sediment by Light microscopy,UA,721
5892-5,Prot S PPP-aCnc,Protein S [Units/volume] in Platelet poor plasma by Coagulation assay,COAG,722
4552-6,Hgb A2 MFr Bld Elph,Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis,HEM/BC,723
22314-9,HAV IgM Ser Ql,Hepatitis A virus IgM Ab [Presence] in Serum,MICRO,724
46154-1,T vaginalis rRNA XXX Ql PCR,Trichomonas vaginalis rRNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,725
6357-8,C trach DNA Ur Ql PCR,Chlamydia trachomatis DNA [Presence] in Urine by Probe & target amplification method,MICRO,726
36904-1,Inhibin A adj MoM Ser,Inhibin A [Multiple of the median] adjusted in Serum,Chem,727
5862-8,FLUAV Ag XXX Ql EIA,Influenza virus A Ag [Presence] in Unspecified specimen by Immunoassay,MICRO,728
45371-2,Multiple Pregancy,Multiple pregancy,CLIN,729
2742-5,ACE SerPl-cCnc,Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma,Chem,730
32764-3,Clue Cells XXX Ql Wet Prep,Clue cells [Presence] in Unspecified specimen by Wet preparation,MICRO,731
42247-7,Hgb Fract Bld HPLC-Imp,Hemoglobin pattern [interpretation] in Blood by HPLC Narrative,HEM/BC,732
11153-4,Hct VFr Fld,Hematocrit [Volume Fraction] of Body fluid,HEM/BC,733
6875-9,Cancer Ag15-3 SerPl-aCnc,Cancer Ag 15-3 [Units/volume] in Serum or Plasma,Chem,734
32166-1,HCG adj MoM SerPl,Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma,Chem,735
6741-3,RBC # Fld Manual,Erythrocytes [#/volume] in Body fluid by Manual count,HEM/BC,736
7900-4,H pylori Ab Ser-aCnc,Helicobacter pylori Ab [Units/volume] in Serum,MICRO,737
6087-1,Corn IgE Qn,Corn IgE Ab [Units/volume] in Serum,Allergy,738
14955-9,Zinc SerPl-mCnc,Zinc [Moles/volume] in Serum or Plasma,DRUG/TOX,739
11259-9,HCV RNA SerPl Ql PCR,Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe & target amplification method,MICRO,740
38180-6,HCV RNA SerPl PCR-Log IU,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,741
3299-5,Acetamin Ur Ql,Acetaminophen [Presence] in Urine,DRUG/TOX,742
14731-4,Folate RBC-mCnc,Folate [Moles/volume] in Red Blood Cells,Chem,743
5370-2,ASO Ab Ser-aCnc,Streptolysin O Ab [Units/volume] in Serum,MICRO,744
6041-8,Bermuda grass IgE Qn,Bermuda grass IgE Ab [Units/volume] in Serum,Allergy,745
53962-7,AFP-TM SerPl-mCnc,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,Chem,746
17859-0,H pylori IgG Ser Ql EIA,Helicobacter pylori IgG Ab [Presence] in Serum by Immunoassay,MICRO,747
6212-5,P notatum IgE Qn,Penicillium notatum IgE Ab [Units/volume] in Serum,Allergy,748
22496-4,RUBV Ab Ser Ql,Rubella virus Ab [Presence] in Serum,MICRO,749
49050-8,Cyto Endocvx brush,Microscopic observation [Identifier] in Endocervical brush by Cyto stain,CYTO,750
21190-4,C trach DNA Cvx Ql PCR,Chlamydia trachomatis DNA [Presence] in Cervix by Probe and target amplification method,MICRO,751
30457-6,Nonhematic Cells NFr Fld,Nonhematic cells/100 leukocytes in Body fluid,HEM/BC,752
34985-2,Unident Cells NFr Fld,Unidentified cells/100 leukocytes in Body fluid,HEM/BC,753
7966-5,MuV IgG Ser-aCnc,Mumps virus IgG Ab [Units/volume] in Serum,MICRO,754
20512-0,Turbidity CSF Ql,Turbidity [Presence] of Cerebral spinal fluid,SPEC,755
32198-4,N gonorrhoea rRNA Cvx Ql Prb,Neisseria gonorrhoeae rRNA [Presence] in Cervix by DNA probe,MICRO,756
6085-5,Common Ragweed IgE Qn,Common Ragweed IgE Ab [Units/volume] in Serum,Allergy,757
6110-1,Engl Plantain IgE Qn,English Plantain IgE Ab [Units/volume] in Serum,Allergy,758
6303-2,Screen dRVVT,dRVVT LA screen,COAG,759
27811-9,AT III Act/Nor PPP Chro,Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,COAG,760
47213-4,LDLc real size Pat SerPl,Cholesterol in LDL real size pattern [Identifier] in Serum or Plasma,Chem,761
70201-9,IDLc SerPl-mCnc,Cholesterol in IDL [Moles/volume] in Serum or Plasma,Chem,763
70202-7,IDLc+VLDL3c SerPl-mCnc,Cholesterol in IDL+Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma,Chem,764
70203-5,VLDL3c SerPl-mCnc,Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma,Chem,765
49062-3,Lipid risk factors Patient,Lipid risk factors [Finding],Chem,766
32046-5,PAPP-A SerPl-aCnc,Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma,Chem,767
26760-9,Cannabinoids Ur-aCnc,Cannabinoids [Units/volume] in Urine,DRUG/TOX,768
13183-9,White Elm IgG Qn,White Elm IgG Ab [Units/volume] in Serum,Allergy,769
29967-7,ANCA IgG Titr Ser IF,Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence,SERO,770
1795-4,Amylase Fld-cCnc,Amylase [Enzymatic activity/volume] in Body fluid,Chem,771
1871-3,Apo B100 SerPl-mCnc,Apolipoprotein B-100 [Mass/volume] in Serum or Plasma,Chem,772
33716-2,,Non-gynecological cytology method study,ATTACH.CLINRPT,773
14586-2,Aldost SerPl-mCnc,Aldosterone [Moles/volume] in Serum or Plasma,Chem,774
34574-4,Path report.final Dx Spec,Pathology report final diagnosis,TUMRRGT,775
45353-0,Date Of Analysis XXX,Date of analysis of unspecified specimen,MISC,776
2064-4,Ceruloplasmin SerPl-mCnc,Ceruloplasmin [Mass/volume] in Serum or Plasma,Chem,777
792-2,RBC # CSF Manual,Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count,HEM/BC,778
29771-3,Occult Bld Stl Ql Imm,Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method,Chem,779
30170-5,Amer Roach IgE Qn,American Cockroach IgE Ab [Units/volume] in Serum,Allergy,780
14627-4,HCO3 BldV-sCnc,Bicarbonate [Moles/volume] in Venous blood,Chem,781
31204-1,HBV core IgM Ser Ql,Hepatitis B virus core IgM Ab [Presence] in Serum,MICRO,782
14626-6,B2 Microglob Ser-sCnc,Beta-2-Microglobulin [Moles/volume] in Serum,Chem,783
1952-1,B2 Microglob Ser-mCnc,Beta-2-Microglobulin [Mass/volume] in Serum,Chem,783
13514-5,Hgb Fract Bld Elph-Imp,Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative,HEM/BC,784
24012-7,HIV1 Ag Ser Ql,HIV 1 Ag [Presence] in Serum,MICRO,785
5222-5,HIV1 Ag Ser Ql EIA,HIV 1 Ag [Presence] in Serum by Immunoassay,MICRO,786
13953-5,HBV e Ab Ser Ql EIA,Hepatitis B virus e Ab [Presence] in Serum by Immunoassay,MICRO,787
14745-4,Glucose Fld-mCnc,Glucose [Moles/volume] in Body fluid,Chem,788
15205-8,Rheumatoid fact Ser Neph-aCnc,Rheumatoid factor [Units/volume] in Serum by Nephlometry,SERO,789
29770-5,Karyotyp Bld/T,Karyotype [Identifier] in Blood or Tissue Nominal,MOLPATH,790
709-6,Blasts NFr Bld Manual,Blasts/100 leukocytes in Blood by Manual count,HEM/BC,791
20444-6,HSV1+2 DNA XXX Ql PCR,Herpes simplex virus 1+2 DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,792
19153-6,Specimen vol ?Tm Ur,Volume of unspecified time Urine,SPEC,793
3209-4,Fact VIII Act/Nor PPP,Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay,COAG,794
7155-5,Boxelder IgE Qn,Boxelder IgE Ab [Units/volume] in Serum,Allergy,795
5866-9,FLUBV Ag XXX Ql EIA,Influenza virus B Ag [Presence] in Unspecified specimen by Immunoassay,MICRO,796
13590-5,aPCR PPP,Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay,COAG,797
47528-5,Cytology Cvx/Vag Doc Cyto,Cytology report of Cervical or vaginal smear or scraping Cyto stain,CYTO,798
6106-9,Egg White IgE Qn,Egg white IgE Ab [Units/volume] in Serum,Allergy,799
2006-5,Cancer Ag125 SerPl Ql,Cancer Ag 125 [Presence] in Serum or Plasma,Chem,800
655-1,Acid fast Mod Kiny Stn XXX,Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Kinyoun modified,MICRO,801
3854-7,Nicotine Ur-mCnc,Nicotine [Mass/volume] in Urine,DRUG/TOX,802
16131-5,HSV2 DNA XXX Ql PCR,Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,803
13954-3,HBV e Ag Ser Ql EIA,Hepatitis B virus e Ag [Presence] in Serum by Immunoassay,MICRO,804
26446-5,Blasts NFr Bld,Blasts/100 leukocytes in Blood,HEM/BC,805
7792-5,Dohle Bod Bld Ql Smear,Dohle body [Presence] in Blood by Light microscopy,HEM/BC,806
2529-6,LDH Fld-cCnc,Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid,Chem,807
41399-7,HSV1+2 IgM Ser EIA-aCnc,Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,808
22674-6,Transferrin SerPl-sCnc,Transferrin [Moles/volume] in Serum or Plasma,Chem,809
3034-6,Transferrin SerPl-mCnc,Transferrin [Mass/volume] in Serum or Plasma,Chem,809
10900-9,HBV surface Ab Ser Ql EIA,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,MICRO,810
3284-7,LA Nt Platelet PPP,Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay,COAG,811
3414-0,Buprenorphine Ur Ql,Buprenorphine [Presence] in Urine,DRUG/TOX,812
20404-0,Fibronectin Fetal Vag Ql,Fibronectin.fetal [Presence] in Vaginal fluid,Chem,813
10998-3,Oxycodone Ur Ql,Oxycodone [Presence] in Urine,DRUG/TOX,814
10976-9,6MAM Ur Ql,6-Monoacetylmorphine (6-MAM) [Presence] in Urine,DRUG/TOX,815
14674-6,ACTH Plas-mCnc,Corticotropin [Moles/volume] in Plasma,Chem,816
13046-8,Variant Lymphs NFr Bld,Lymphocytes Variant/100 leukocytes in Blood,HEM/BC,817
5351-2,ENA SS-A Ab Ser Ql EIA,Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay,SERO,818
6412-1,G lamblia Ag Stl Ql EIA,Giardia lamblia Ag [Presence] in Stool by Immunoassay,MICRO,819
2614-6,MetHgb MFr Bld,Methemoglobin/Hemoglobin.total in Blood,Chem,820
5353-8,ENA SS-B Ab Ser Ql EIA,Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay,SERO,821
2915-7,Renin Plas-cCnc,Renin [Enzymatic activity/volume] in Plasma,Chem,822
27416-7,ENA Scl70 Ab Ser-aCnc,SCL-70 extractable nuclear Ab [Units/volume] in Serum,SERO,823
6565-6,T vaginalis Genital Wet Prep,Trichomonas vaginalis [Identifier] in Genital specimen by Wet preparation,MICRO,824
21003-9,Fungus XXX Fungus Stn,Fungus identified in Unspecified specimen by Fungus stain,MICRO,825
5639-0,Ethanol Bld Ql,Ethanol [Presence] in Blood,DRUG/TOX,826
6182-0,M racemosus IgE Qn,Mucor racemosus IgE Ab [Units/volume] in Serum,Allergy,827
3297-9,Acetamin SerPl Ql,Acetaminophen [Presence] in Serum or Plasma,DRUG/TOX,829
5177-1,H pylori IgM Ser EIA-aCnc,Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,830
13516-0,Neutrophils NFr CSF Manual,Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,831
4023-8,Salicylates SerPl Ql,Salicylates [Presence] in Serum or Plasma,DRUG/TOX,832
15054-0,DHEA SerPl-mCnc,Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma,Chem,833
30243-0,HGC Intact SerPl-aCnc,Choriogonadotropin.intact [Units/volume] in Serum or Plasma,Chem,834
14995-5,Glucose 2H p 75 g Glc PO SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO,CHAL,835
4547-6,Hgb A1 MFr Bld,Hemoglobin A1/Hemoglobin.total in Blood,HEM/BC,836
51724-3,Cefuroxime Susc Islt,Cefuroxime [Susceptibility],ABXBACT,837
15061-5,EPO SerPl-aCnc,Erythropoietin (EPO) [Units/volume] in Serum or Plasma,Chem,838
6152-3,Johnson grass IgE Qn,Johnson grass IgE Ab [Units/volume] in Serum,Allergy,839
6252-1,S botryosum IgE Qn,Stemphylium botryosum IgE Ab [Units/volume] in Serum,Allergy,841
32286-7,HCV Gentyp SerPl PCR,Hepatitis C virus genotype [Identifier] in Serum or Plasma by Probe & target amplification method,MICRO,842
17948-1,Fungus XXX Cult org #3,Fungus # 3 identified in Unspecified specimen by Culture,MICRO,843
5199-5,HCV Ab Ser Ql IB,Hepatitis C virus Ab [Presence] in Serum by Immunoblot (IB),MICRO,844
17947-3,Fungus XXX Cult org #2,Fungus # 2 identified in Unspecified specimen by Culture,MICRO,845
17949-9,Fungus XXX Cult org #4,Fungus # 4 identified in Unspecified specimen by Culture,MICRO,846
42637-9,BNP Bld-mCnc,Natriuretic peptide B [Mass/volume] in Blood,Chem,847
9327-8,PS IgM Ser Ql IA,Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay,COAG,848
14679-5,Cortis AM SerPl-mCnc,Cortisol [Moles/volume] in Serum or Plasma --morning specimen,Chem,849
14569-8,17OHP SerPl-mCnc,17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma,Chem,850
14604-3,Bld gp Ab present SerPl BPU,Blood group antibodies present [Identifier] in Serum or Plasma from Blood product unit,BLDBK,851
20513-8,Turbidity Fld Ql,Turbidity [Presence] of Body fluid,SPEC,852
48035-0,Hgb CSF Ql,Hemoglobin [Presence] in Cerebral spinal fluid,HEM/BC,853
1825-9,A1AT SerPl-mCnc,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,Chem,854
5213-4,Heteroph Ab Ser Ql LA,Heterophile Ab [Presence] in Serum by Latex agglutination,MICRO,855
13440-3,Interpretation Ur IFE-Imp,Immunofixation [interpretation] for Urine,Chem,856
6039-2,Beef IgE Qn,Beef IgE Ab [Units/volume] in Serum,Allergy,857
18929-0,Gentamicin Synergy Susc Islt,Gentamicin.high potency [Susceptibility],ABXBACT,858
2004-0,Calcium Ur-mCnc,Calcium [Moles/volume] in Urine,Chem,859
6034-3,Bahia grass IgE Qn,Bahia grass IgE Ab [Units/volume] in Serum,Allergy,860
5358-7,Smooth muscle Ab Titr Ser IF,Smooth muscle Ab [Titer] in Serum by Immunofluorescence,SERO,861
5388-4,T gondii IgG Ser EIA-aCnc,Toxoplasma gondii IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,862
27948-9,HSV1+2 IgG Ser EIA-aCnc,Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,863
9439-1,Casts #/area UrnS HPF,Casts [#/area] in Urine sediment by Microscopy high power field,UA,864
2745-8,pH BldC,pH of Capillary blood,Chem,865
33022-5,pCO2 BldC TcCo2,Carbon dioxide [Partial pressure] in Capillary blood by Transcutaneous CO2 monitor,Chem,866
13438-7,Prot Pattern Ur Elph-Imp,Protein Fractions [interpretation] in Urine by Electrophoresis,Chem,867
8117-4,CD19 Cells NFr Bld,CD19 cells/100 cells in Blood,CELLMARK,868
38527-8,# Spec Recd Stl,Number of specimens received of Stool,SPEC,869
70216-7,Salicylates SerPl Scn-mCnc,Salicylates [Moles/volume] in Serum or Plasma by Screen method,DRUG/TOX,870
22747-0,Gentamicin Trough SerPl-sCnc,Gentamicin [Moles/volume] in Serum or Plasma --trough,DRUG/TOX,871
3665-7,Gentamicin Trough SerPl-mCnc,Gentamicin [Mass/volume] in Serum or Plasma --trough,DRUG/TOX,871
14753-8,Glucose 1H p 100 g Glc PO SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO,CHAL,872
13527-7,Unident Cells NFr CSF Manual,Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,873
32765-0,Yeast XXX Ql Wet Prep,Yeast [Presence] in Unspecified specimen by Wet preparation,MICRO,874
20563-3,COHgb MFr Bld,Carboxyhemoglobin/Hemoglobin.total in Blood,Chem,875
51597-3,Glucose 1H p 75 g Glc PO SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO,CHAL,876
14836-1,MTX SerPl-sCnc,Methotrexate [Moles/volume] in Serum or Plasma,DRUG/TOX,877
6924-5,Gliadin IgA Ser-aCnc,Gliadin IgA Ab [Units/volume] in Serum,SERO,878
18983-7,Streptomycin High Pot Susc Islt,Streptomycin.high potency [Susceptibility],ABXBACT,879
14765-2,Glucose 3H p Glc SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose,CHAL,880
5876-8,RSV Ag XXX Ql EIA,Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunoassay,MICRO,881
56490-6,Occult Bld sp2 Stl Ql Imm,Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method --2nd specimen,Chem,882
56491-4,Occult Bld sp3 Stl Ql Imm,Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method --3rd specimen,Chem,883
14759-5,Glucose 2H p Glc SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose,CHAL,884
8665-2,Date LMP,Date last menstrual period,H&P.HX,885
27819-2,Prot C Act/Nor PPP,Protein C actual/normal in Platelet poor plasma by Coagulation assay,COAG,886
5076-5,Cardiolipin IgA Ser IA-aCnc,Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay,COAG,887
26486-1,Monocytes NFr CSF,Monocytes/100 leukocytes in Cerebral spinal fluid,HEM/BC,888
1884-6,Apo B SerPl-mCnc,Apolipoprotein B [Mass/volume] in Serum or Plasma,Chem,889
29953-7,ANA Titr Ser,Nuclear Ab [Titer] in Serum,SERO,890
7291-8,Whole Egg IgE Qn,Whole Egg IgE Ab [Units/volume] in Serum,Allergy,891
22745-4,Ethanol Ur-mCnc,Ethanol [Moles/volume] in Urine,DRUG/TOX,892
11545-1,Acid fast Stn XXX,Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain,MICRO,893
6473-3,Tri Stn Tiss,Microscopic observation [Identifier] in Tissue by Trichrome stain,MICRO,894
20460-2,Cefuroxime Oral Islt MIC,Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC),ABXBACT,895
14757-9,Glucose 2H p 100 g Glc PO SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO,CHAL,896
21033-6,Yeast Budding UrnS Ql,Yeast.budding [Presence] in Urine sediment,UA,897
19941-4,Gas flow.O2 O2 delivery sys,Oxygen gas flow Oxygen delivery system,PULM,898
6073-1,Chocolate IgE Qn,Chocolate IgE Ab [Units/volume] in Serum,Allergy,899
12208-5,Eosinophil NFr CSF Manual,Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,900
12278-8,Neuts Band NFr CSF Manual,Neutrophils.band form/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,901
14637-3,Calcium 24H Ur-mRate,Calcium [Moles/time] in 24 hour Urine,Chem,902
13519-4,Basophils NFr CSF Manual,Basophils/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,903
3160-9,Specimen vol Smn,Volume of Semen,FERT,904
38908-0,Poikilocytosis Bld Ql Auto,Poikilocytosis [Presence] in Blood by Automated count,HEM/BC,905
13517-8,Variant Lymphs NFr CSF Manual,Lymphocytes Variant/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,906
41016-7,Bilirub Ur Strip-mCnc,Bilirubin.total [Moles/volume] in Urine by Test strip,UA,907
13529-3,nRBC # CSF Manual,Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count,HEM/BC,908
10329-1,Monocytes NFr CSF Manual,Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,909
26472-1,WBC Other NFr CSF,Leukocytes other/100 leukocytes in Cerebral spinal fluid,HEM/BC,910
13508-7,Hct VFr CSF Spun,Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation,HEM/BC,911
11135-1,Appearance spun CSF,Appearance of Spun Cerebral spinal fluid,SPEC,912
13525-1,Nonhematic Cells NFr CSF Manual,Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,913
14764-5,Glucose 3H p 100 g Glc PO SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO,CHAL,914
28008-1,CMV DNA Bld Ql bDNA,Cytomegalovirus DNA [Presence] in Blood by Probe & signal amplification method,MICRO,915
6244-8,Sheep Sorrel IgE Qn,Sheep Sorrel IgE Ab [Units/volume] in Serum,Allergy,916
6219-0,Pork IgE Qn,Pork IgE Ab [Units/volume] in Serum,Allergy,917
11050-2,Kappa LC Ser-mCnc,Immunoglobulin light chains.kappa [Mass/volume] in Serum,Chem,918
783-1,Promyelocytes NFr Bld Manual,Promyelocytes/100 leukocytes in Blood by Manual count,HEM/BC,919
70207-6,Estrogen SerPl-mCnc,Estrogen [Moles/volume] in Serum or Plasma,Chem,920
11064-3,BUN p dialysis SerPl-mCnc,Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis,Chem,921
6273-7,Walnut IgE Qn,Walnut IgE Ab [Units/volume] in Serum,Allergy,922
14638-1,Stone Analysis-Imp,Calculus analysis [interpretation] in Stone,Chem,923
8191-9,Cocaine SerPl Ql Scn,Cocaine [Presence] in Serum or Plasma by Screen method,DRUG/TOX,924
13068-2,ANA Pat Ser IF-Imp,Nuclear Ab pattern [interpretation] in Serum by Immunofluorescence,SERO,925
8149-7,Amphetamines SerPl Ql Scn,Amphetamines [Presence] in Serum or Plasma by Screen method,DRUG/TOX,926
6153-1,Kent blue grass IgE Qn,Kentucky blue grass IgE Ab [Units/volume] in Serum,Allergy,927
14756-1,Glucose 1H p Glc SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose,CHAL,928
26524-9,Promyelocytes NFr Bld,Promyelocytes/100 leukocytes in Blood,HEM/BC,929
8234-7,PCP Mec Ql Scn,Phencyclidine [Presence] in Meconium by Screen method,DRUG/TOX,930
11065-0,BUN pre dial SerPl-mCnc,Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis,Chem,931
19141-1,Propoxyph Ur Ql,Propoxyphene [Presence] in Urine,DRUG/TOX,932
19415-9,THC Ur Ql Scn,Tetrahydrocannabinol [Presence] in Urine by Screen method,DRUG/TOX,933
35741-8,PSA SerPl DL=0.01 ng/mL-mCnc,Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit = 0.01 ng/mL,Chem,934
6265-3,Timothy IgE Qn,Timothy IgE Ab [Units/volume] in Serum,Allergy,935
6233-1,Rough Pigweed IgE Qn,Rough Pigweed IgE Ab [Units/volume] in Serum,Allergy,936
39796-8,Vancomycin Peak SerPl-sCnc,Vancomycin [Moles/volume] in Serum or Plasma --peak,DRUG/TOX,937
4090-7,Vancomycin Peak SerPl-mCnc,Vancomycin [Mass/volume] in Serum or Plasma --peak,DRUG/TOX,937
2026-3,CO2 BldA-sCnc,"Carbon dioxide, total [Moles/volume] in Arterial blood",Chem,938
2714-4,OxyHgb MFr BldA,Fractional oxyhemoglobin in Arterial blood,Chem,939
22131-7,B burgdor IgG+IgM Ser Ql,Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum,MICRO,940
5404-9,VZV IgM Ser EIA-aCnc,Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,941
14905-4,Vit A SerPl-mCnc,Retinol [Moles/volume] in Serum or Plasma,Chem,942
33718-8,Cytology Tiss FNA Doc Cyto,Cytology report of Tissue fine needle aspirate Cyto stain,CYTO,943
8112-5,CD3-CD16+CD56+ Cells NFr Bld,CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood,CELLMARK,944
19774-9,Cytology Cmnt Cvx/Vag Cyto-Imp,Cytology study comment Cervical or vaginal smear or scraping Cyto stain,CYTO,945
19128-8,Bacteria Cath Tip Cult,Bacteria identified in Catheter tip by Culture,MICRO,946
6281-0,White mulberry IgE Qn,White mulberry IgE Ab [Units/volume] in Serum,Allergy,947
24013-5,HIV1 RNA Ser-Imp,HIV 1 RNA [interpretation] in Serum,MICRO,948
17780-8,H pylori Ag Stl Ql EIA,Helicobacter pylori Ag [Presence] in Stool by Immunoassay,MICRO,949
13169-8,Interpretation SerPl IEP-Imp,Immunoelectrophoresis [interpretation] for Serum or Plasma,Chem,950
15210-8,Thyroglob Ab Ser Ql,Thyroglobulin Ab [Presence] in Serum,SERO,951
4532-8,CH50 SerPl-aCnc,Complement total hemolytic CH50 [Units/volume] in Serum or Plasma,HEM/BC,952
2748-2,pH Fld,pH of Body fluid,Chem,953
26513-2,Neutrophils NFr Fld,Neutrophils/100 leukocytes in Body fluid,HEM/BC,954
8130-7,CD45 Cells NFr Bld,CD45 (Lymphs) cells/100 cells in Blood,CELLMARK,955
11276-3,Tubular Cells UrnS Ql Micro,Tubular cells [Presence] in Urine sediment by Light microscopy,UA,956
25458-1,Lamotrigine SerPl-mCnc,Lamotrigine [Moles/volume] in Serum or Plasma,DRUG/TOX,957
29641-8,Atyp ANCA Ser Ql IF,Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence,SERO,958
5034-4,Gp B Strep rRNA XXX Ql Prb,Streptococcus agalactiae rRNA [Presence] in Unspecified specimen by DNA probe,MICRO,959
773-2,nRBC/100 RBC NFr Bld Manual,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,HEM/BC,960
35383-9,Galactomannan Ag SerPl-aCnc,Galactomannan Ag [Units/volume] in Serum or Plasma,MICRO,961
22587-0,T pallidum Ab Ser Ql,Treponema pallidum Ab [Presence] in Serum,MICRO,962
6178-8,Mt Juniper IgE Qn,Mountain Juniper IgE Ab [Units/volume] in Serum,Allergy,963
11266-4,Gp B Strep Ag XXX Ql,Streptococcus agalactiae Ag [Presence] in Unspecified specimen,MICRO,964
22746-2,Gentamicin Peak SerPl-sCnc,Gentamicin [Moles/volume] in Serum or Plasma --peak,DRUG/TOX,965
3663-2,Gentamicin Peak SerPl-mCnc,Gentamicin [Mass/volume] in Serum or Plasma --peak,DRUG/TOX,965
1927-3,Base excess BldV-sCnc,Base excess in Venous blood,Chem,966
5247-2,Mitochondria Ab Titr Ser IF,Mitochondria Ab [Titer] in Serum by Immunofluorescence,SERO,967
5126-8,CMV IgM Ser EIA-aCnc,Cytomegalovirus IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,968
48378-4,Kappa LC Free/Lambda Ser-mRto,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free [Mass Ratio] in Serum,Chem,969
15069-8,Fructosamine SerPl-sCnc,Fructosamine [Moles/volume] in Serum or Plasma,Chem,970
15218-1,Food Allerg Mix2 IgE Ql,Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk,Allergy,971
28005-7,MTHFR p.C677T Bld/T Ql,MTHFR gene p.C677T [Presence] in Blood or Tissue by Molecular genetics method,MOLPATH.MUT,972
8014-3,RUBV IgG Ser-aCnc,Rubella virus IgG Ab [Units/volume] in Serum,MICRO,973
14912-0,Smudge Cells NFr Bld Manual,Smudge cells/100 leukocytes in Blood by Manual count,HEM/BC,974
12230-9,Macrophages NFr Fld Manual,Macrophages/100 leukocytes in Body fluid by Manual count,HEM/BC,975
27038-9,Endomysium IgA Titr Ser IF,Endomysium IgA Ab [Titer] in Serum by Immunofluorescence,SERO,976
20573-2,H capsul Myc Ab Titr Ser CF,Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation,MICRO,977
6246-3,Shrimp IgE Qn,Shrimp IgE Ab [Units/volume] in Serum,Allergy,978
42176-8,"1,3 beta glucan Ser-mCnc","1,3 beta glucan [Mass/volume] in Serum",MICRO,979
19075-1,Total Cells Counted CSF,Cells Counted Total [#] in Cerebral spinal fluid,HEM/BC,980
33910-1,Rheumatoid fact Ser Ql,Rheumatoid factor [Presence] in Serum,SERO,981
9822-8,Bacteria Dial fld Cult,Bacteria identified in Dialysis fluid by Culture,MICRO,982
931-6,Bld Prod Source BPU,Blood product source [Type],BLDBK,983
32140-6,Hgb F Bld Ql Kleih Betke,Hemoglobin F [Presence] in Blood by Kleihauer-Betke method,HEM/BC,984
53982-5,Centromere B Ab Ser-aCnc,Centromere protein B Ab [Units/volume] in Serum,SERO,985
51775-5,Chromatin Ab SerPl-aCnc,Chromatin Ab [Units/volume] in Serum or Plasma,SERO,986
19295-5,Opiates Ur Ql Scn,Opiates [Presence] in Urine by Screen method,DRUG/TOX,987
24011-9,HCV Ab Patrn Ser IB-Imp,Hepatitis C virus Ab band pattern [interpretation] in Serum by Immunoblot (IB),MICRO,988
5187-0,HBV core Ab Ser EIA-aCnc,Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay,MICRO,989
2963-7,GH SerPl-mCnc,Somatotropin [Mass/volume] in Serum or Plasma,Chem,990
13530-1,nRBC # Fld Manual,Nucleated erythrocytes [#/volume] in Body fluid by Manual count,HEM/BC,991
6082-2,Codfish IgE Qn,Codfish IgE Ab [Units/volume] in Serum,Allergy,992
6156-4,Goosefoot IgE Qn,Goosefoot IgE Ab [Units/volume] in Serum,Allergy,993
6186-1,Nettle IgE Qn,Nettle IgE Ab [Units/volume] in Serum,Allergy,994
11565-9,ENA Jo1 Ab Ser-aCnc,Jo-1 extractable nuclear Ab [Units/volume] in Serum,SERO,995
30376-8,Blasts # Bld,Blasts [#/volume] in Blood,HEM/BC,996
35676-6,Chloride ?Tm Ur-sCnc,Chloride [Moles/volume] in unspecified time Urine,Chem,997
32637-1,Urease Tiss Ql,Urease [Presence] in Tissue,MICRO,998
46248-1,B burgdor IgG+IgM Ser EIA-Imp,Borrelia burgdorferi IgG & IgM [interpretation] in Serum by Immunoassay,MICRO,999
1721-0,ATP Bld-mCnc,Adenosine triphosphate [Mass/volume] in Blood,Chem,1000
9780-8,Sperm # Smn,Spermatozoa [#/volume] in Semen,FERT,1001
6002-0,PF4 PPP-aCnc,Platelet factor 4 [Units/volume] in Platelet poor plasma,COAG,1002
6014-5,vWf:RCo Act/Nor PPP Aggr,von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Aggregation,COAG,1003
20475-0,CMV IgG Ser-Imp,Cytomegalovirus IgG Ab [interpretation] in Serum,MICRO,1004
33248-6,Diabetes status Patient,Diabetes status [Identifier],MISC,1005
33006-8,CMV DNA # XXX PCR,Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method,MICRO,1006
22415-4,MuV IgG Ser Ql,Mumps virus IgG Ab [Presence] in Serum,MICRO,1007
6476-6,MuV IgG Ser Ql EIA,Mumps virus IgG Ab [Presence] in Serum by Immunoassay,MICRO,1008
49053-2,Neural tube defect Hx Patient,History of neural tube defect Narrative,Chem,1009
21024-5,Path Interp CSF-Imp,Pathologist interpretation of Cerebral spinal fluid tests,PATH,1010
13522-8,Blasts NFr Fld Manual,Blasts/100 leukocytes in Body fluid by Manual count,HEM/BC,1012
5274-6,B19V IgM Ser EIA-aCnc,Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,1013
5273-8,B19V IgG Ser EIA-aCnc,Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,1014
13992-3,Albumin MFr Ur Elph,Albumin/Protein.total in Urine by Electrophoresis,Chem,1015
5393-4,T pallidum Ab Ser Ql IF,Treponema pallidum Ab [Presence] in Serum by Immunofluorescence,MICRO,1016
13990-7,Alpha1 Glob MFr Ur Elph,Alpha 1 globulin/Protein.total in Urine by Electrophoresis,Chem,1017
801-1,Sickle Cells Bld Ql Smear,Sickle cells [Presence] in Blood by Light microscopy,HEM/BC,1018
14582-1,Acetone SerPl-mCnc,Acetone [Moles/volume] in Serum or Plasma,DRUG/TOX,1019
7407-0,White Hickory IgE Qn,White Hickory IgE Ab [Units/volume] in Serum,Allergy,1020
46420-6,WBC clumps #/area UrnS HPF,Leukocyte clumps [#/area] in Urine sediment by Microscopy high power field,UA,1021
30471-7,Levetiracetam SerPl-mCnc,Levetiracetam [Mass/volume] in Serum or Plasma,DRUG/TOX,1022
40750-2,EBV VCA IgG Ser Ql IF,Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence,MICRO,1023
6019-4,Almond IgE Qn,Almond IgE Ab [Units/volume] in Serum,Allergy,1024
41874-9,White Birch IgE Qn,White Birch IgE Ab [Units/volume] in Serum,Allergy,1025
2466-1,IgG1 Ser-mCnc,IgG subclass 1 [Mass/volume] in Serum,Chem,1026
6968-2,Proteinase3 Ab Ser-aCnc,Proteinase 3 Ab [Units/volume] in Serum,SERO,1027
42768-2,HIV 1 & 2 Ab Ser-Imp,HIV 1 & 2 Ab [interpretation] in Serum Narrative,MICRO,1028
16126-5,H pylori IgG Ser Ql,Helicobacter pylori IgG Ab [Presence] in Serum,MICRO,1029
11258-1,HBV DNA Ser-aCnc,Hepatitis B virus DNA [Units/volume] in Serum,MICRO,1030
667-6,KOH Prep XXX,Microscopic observation [Identifier] in Unspecified specimen by KOH preparation,MICRO,1031
1747-5,Albumin Fld-mCnc,Albumin [Mass/volume] in Body fluid,Chem,1032
9586-9,B burgdor Ab Ser-Imp,Borrelia burgdorferi Ab [interpretation] in Serum,MICRO,1033
681-7,Wright Stn XXX,Microscopic observation [Identifier] in Unspecified specimen by Wright stain,MICRO,1034
6942-7,Albumin Ur Elph-mCnc,Albumin [Mass/volume] in Urine by Electrophoresis,Chem,1035
6969-0,Myeloperoxidase Ab Ser-aCnc,Myeloperoxidase Ab [Units/volume] in Serum,SERO,1036
6183-8,Mugwort IgE Qn,Mugwort IgE Ab [Units/volume] in Serum,Allergy,1037
3719-2,Lithium SerPl-mCnc,Lithium [Mass/volume] in Serum or Plasma,DRUG/TOX,1038
2469-5,IgG4 Ser-mCnc,IgG subclass 4 [Mass/volume] in Serum,Chem,1039
2467-9,IgG2 Ser-mCnc,IgG subclass 2 [Mass/volume] in Serum,Chem,1040
2468-7,IgG3 Ser-mCnc,IgG subclass 3 [Mass/volume] in Serum,Chem,1041
32146-3,Lg Platelets Bld Ql Smear,Platelets Large [Presence] in Blood by Light microscopy,HEM/BC,1042
14277-8,c-ANCA Titr Ser IF,Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence,SERO,1043
14278-6,p-ANCA Titr Ser IF,Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence,SERO,1044
12180-6,Ca-I SerPl ISE-mCnc,Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE),Chem,1045
48344-6,KC time Time PPP,Kaolin activated time in Platelet poor plasma,COAG,1046
28637-7,Base deficit BldCoV-sCnc,Base deficit in Venous cord blood,Chem,1047
18500-9,Thin Prep Cervix,Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep,CYTO,1048
13987-3,Alpha2 Glob 24H MFr Ur Elph,Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis,Chem,1049
13989-9,Gamma glob 24H MFr Ur Elph,Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis,Chem,1050
78012-2,S pyo Ag Throat Ql EIA,Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay,MICRO,1051
34661-9,Actin IgG SerPl-aCnc,Actin IgG Ab [Units/volume] in Serum or Plasma,SERO,1052
41274-2,AFP Interp SerPl-Imp,Alpha-1-Fetoprotein interpretation [interpretation] in Serum or Plasma,Chem,1053
33719-6,,Flow cytometry study,ATTACH.CLINRPT,1054
5158-1,EBV VCA IgG Titr Ser IF,Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence,MICRO,1055
24476-4,F2 gene Mut Anal Bld/T,F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,MOLPATH.MUT,1056
14929-4,T3Reverse SerPl-mCnc,Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma,Chem,1057
25700-6,Interpretation SerPl IFE-Imp,Immunofixation [interpretation] for Serum or Plasma,Chem,1058
14915-3,Theophylline SerPl-mCnc,Theophylline [Moles/volume] in Serum or Plasma,DRUG/TOX,1059
11878-6,# Fetuses US,Number of fetuses by US,OB.US,1060
14676-1,Cortis F 24H Ur-mRate,Cortisol Free [Moles/time] in 24 hour Urine,Chem,1061
21020-3,Bacteria XXX Anaerobe+Aerobe Cult,Bacteria identified in Unspecified specimen by Anaerobe+Aerobe culture,MICRO,1062
19108-0,H capsul Ag Ser Ql,Histoplasma capsulatum Ag [Presence] in Serum,MICRO,1063
44525-4,H capsul Ag Ser Ql EIA,Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay,MICRO,1064
2115-4,B-HCG Free SerPl-sCnc,Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma,Chem,1065
32167-9,Clarity Ur,Clarity of Urine,SPEC,1066
26518-1,Polys NFr Fld,Polymorphonuclear cells/100 leukocytes in Body fluid,HEM/BC,1067
19076-9,Total Cells Counted XXX,Cells Counted Total [#] in Unspecified specimen,HEM/BC,1068
33673-5,TT imm SO4 PPP,Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate,COAG,1069
32133-1,Lactate PlasV-sCnc,Lactate [Moles/volume] in Plasma venous,Chem,1070
12286-1,Drugs Ur Scn,Drugs identified in Urine by Screen method,DRUG/TOX,1071
6263-8,Amer Sycamore IgE Qn,American Sycamore IgE Ab [Units/volume] in Serum,Allergy,1072
5095-5,C immitis Ab Ser Ql ID,Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID),MICRO,1073
8187-7,BZE Mec Ql,Benzoylecgonine [Presence] in Meconium,DRUG/TOX,1074
13994-9,B-Globulin MFr Ur Elph,Beta globulin/Protein.total in Urine by Electrophoresis,Chem,1075
26523-1,Promyelocytes # Bld,Promyelocytes [#/volume] in Blood,HEM/BC,1076
6098-8,Dog Dander IgE Qn,Dog dander IgE Ab [Units/volume] in Serum,Allergy,1077
22310-7,H pylori Ab Ser Ql,Helicobacter pylori Ab [Presence] in Serum,MICRO,1078
20124-4,Ventilation mode Vent,Ventilation mode [Identifier] Ventilator,PULM,1079
6107-7,Egg Yolk IgE Qn,Egg yolk IgE Ab [Units/volume] in Serum,Allergy,1080
6604-3,FLUV XXX Cult,Influenza virus identified in Unspecified specimen by Organism specific culture,MICRO,1081
28647-6,pH BldCoV,pH of Venous cord blood,Chem,1082
6800-7,Sperm Motile NFr Smn,Spermatozoa Motile/100 spermatozoa in Semen,FERT,1083
6718-1,Cashew Nut IgE Qn,Cashew Nut IgE Ab [Units/volume] in Serum,Allergy,1084
5181-3,HAV IgM Ser EIA-aCnc,Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,1085
1961-2,HCO3 BldC-sCnc,Bicarbonate [Moles/volume] in Capillary blood,Chem,1086
28646-8,pH BldCoA,pH of Arterial cord blood,Chem,1087
11051-0,Lambda LC Ser-mCnc,Immunoglobulin light chains.lambda [Mass/volume] in Serum,Chem,1088
32032-5,PS IgG Ser IA-aCnc,Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay,COAG,1089
25362-5,Calcium 24H Ur-mCnc,Calcium [Moles/volume] in 24 hour Urine,Chem,1090
7793-3,Howell-Jolly Bod Bld Ql Smear,Howell-Jolly bodies [Presence] in Blood by Light microscopy,HEM/BC,1091
35668-3,Gentamicin SerPl-mCnc,Gentamicin [Mass/volume] in Serum or Plasma,DRUG/TOX,1092
47109-4,Gentamicin SerPl-sCnc,Gentamicin [Moles/volume] in Serum or Plasma,DRUG/TOX,1092
11274-8,Elliptocytes Bld Ql Smear,Elliptocytes [Presence] in Blood by Light microscopy,HEM/BC,1093
46995-7,HLA-DP+DQ+DR Ab NFr Ser,HLA-DP+DQ+DR (class II) Ab in Serum,HLA,1094
46994-0,HLA-A+B+C Ab NFr Ser,HLA-A+B+C (class I) Ab in Serum,HLA,1095
6208-3,Pecan/Hick Nut IgE Qn,Pecan or Hickory Nut IgE Ab [Units/volume] in Serum,Allergy,1096
17851-7,HSV2 IgG Ser Ql,Herpes simplex virus 2 IgG Ab [Presence] in Serum,MICRO,1097
43180-9,HSV2 IgG Ser Ql EIA,Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoassay,MICRO,1098
30166-3,TSI Act/Nor Ser,Thyroid stimulating immunoglobulins actual/normal in Serum,Chem,1099
9631-3,Visc Smn,Viscosity of Semen,SPEC,1100
10585-8,Round Cells # Smn,Round cells [#/volume] in Semen,FERT,1101
33217-1,Sperm Agglutinated Smn Ql,Spermatozoa Agglutinated [Presence] in Semen,FERT,1102
5218-3,H capsul Ab Ser Ql ID,Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID),MICRO,1103
27822-6,Prot S Act/Nor PPP,Protein S actual/normal in Platelet poor plasma by Coagulation assay,COAG,1104
17793-1,BJ Protein 24H Ur-mCnc,Immunoglobulin light chains [Mass/volume] in 24 hour Urine,Chem,1105
17850-9,HSV1 IgG Ser Ql,Herpes simplex virus 1 IgG Ab [Presence] in Serum,MICRO,1106
51916-5,HSV1 IgG Ser Ql EIA,Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoassay,MICRO,1107
31844-4,HBV e Ag Ser Ql,Hepatitis B virus e Ag [Presence] in Serum,MICRO,1108
20450-3,AFP MoM SerPl,Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma,Chem,1109
48343-8,Hgb Other MFr Bld,Hemoglobin.other/Hemoglobin.total in Blood,HEM/BC,1110
5160-7,EBV VCA IgM Titr Ser IF,Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence,MICRO,1111
29615-2,HBV DNA # SerPl PCR,Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,1112
21032-8,TT Bld-Imp,Thrombin time [interpretation] in Blood,COAG,1113
5791-9,Yeast Like Fungi #/area UrnS HPF,Fungi.yeastlike [#/area] in Urine sediment by Microscopy high power field,UA,1114
20423-0,B-Lactamase Organism Islt,Beta lactamase organism identified in Isolate,MICRO,1115
8146-3,Amphetamines Mec Ql Scn,Amphetamines [Presence] in Meconium by Screen method,DRUG/TOX,1116
20991-6,AT III PPP-Imp,Antithrombin [interpretation] in Platelet poor plasma,COAG,1117
33720-4,,Blood bank consult,ATTACH.CLINRPT,1118
2483-6,IGF BP3 SerPl-mCnc,Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma,Chem,1119
34712-0,C dif Stl Ql,Clostridium difficile [Presence] in Stool,MICRO,1120
33594-3,PF4 PPP Ql,Platelet factor 4 [Presence] in Platelet poor plasma,COAG,1121
8169-5,THC Mec Ql Scn,Tetrahydrocannabinol [Presence] in Meconium by Screen method,DRUG/TOX,1122
22663-9,Estrone SerPl-mCnc,Estrone (E1) [Moles/volume] in Serum or Plasma,Chem,1123
17849-1,Retics/100 RBC NFr Auto,Reticulocytes/100 erythrocytes in Blood by Automated count,HEM/BC,1124
8216-4,Opiates Mec Ql Scn,Opiates [Presence] in Meconium by Screen method,DRUG/TOX,1125
27816-8,vWF Ag Act/Nor PPP Imm,von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunologic method,COAG,1126
8116-6,CD19 Cells # Bld,CD19 cells [#/volume] in Blood,CELLMARK,1127
7798-2,Smudge Cells Bld Ql Smear,Smudge cells [Presence] in Blood by Light microscopy,HEM/BC,1128
9795-6,Compn Stone,Composition in Stone,PATH,1129
5390-0,T gondii IgM Ser EIA-aCnc,Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,1130
32218-0,cCP Ab Ser EIA-aCnc,Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay,SERO,1131
46266-3,Myeloperoxidase Ab Ser EIA-aCnc,Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay,SERO,1132
20479-2,MeV IgG Ser Ql,Measles virus IgG Ab [Presence] in Serum,MICRO,1133
35275-7,MeV IgG Ser Ql EIA,Measles virus IgG Ab [Presence] in Serum by Immunoassay,MICRO,1134
5781-0,Crystals Snv Micro,Crystals [type] in Synovial fluid by Light microscopy,HEM/BC,1135
26043-0,HLA-B27 Ql PCR,HLA-B27 [Presence] by Probe & target amplification method,HLA,1136
16136-4,B2 Glycoprot1 IgM Ser-aCnc,Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum,SERO,1137
44449-7,B2 Glycoprot1 IgM Ser EIA-aCnc,Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum by Immunoassay,SERO,1138
19296-3,Opiates Tested Ur Scn,Opiates tested for in Urine by Screen method Nominal,DRUG/TOX,1139
14115-0,Collagen NTx/Creat Ur-sRto,Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine,Chem,1140
14761-1,Glucose 2H p meal SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --2 hours post meal,CHAL,1141
5290-2,VDRL CSF Ql,Reagin Ab [Presence] in Cerebral spinal fluid by VDRL,MICRO,1142
5817-2,Urate Cry UrnS Ql Micro,Urate crystals [Presence] in Urine sediment by Light microscopy,UA,1143
46267-1,Proteinase3 Ab Ser EIA-aCnc,Proteinase 3 Ab [Units/volume] in Serum by Immunoassay,SERO,1144
2270-7,Fat Stl Ql,Fat [Presence] in Stool,Chem,1145
6278-6,White Ash IgE Qn,White Ash IgE Ab [Units/volume] in Serum,Allergy,1146
7369-2,Per rye grass IgE Qn,Perennial rye grass IgE Ab [Units/volume] in Serum,Allergy,1147
8091-1,ENA RNP Ab Ser Ql,Ribonucleoprotein extractable nuclear Ab [Presence] in Serum,SERO,1148
41222-1,Yeast Fld Ql Micro,Yeast [Presence] in Body fluid by Light microscopy,MICRO,1149
38505-4,Thyroglob Recovery MFr SerPl,Thyroglobulin recovery in Serum or Plasma,Chem,1150
16135-6,B2 Glycoprot1 IgG Ser-aCnc,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum,SERO,1151
44448-9,B2 Glycoprot1 IgG Ser EIA-aCnc,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum by Immunoassay,SERO,1152
6076-4,Clam IgE Qn,Clam IgE Ab [Units/volume] in Serum,Allergy,1153
593-4,Legionella XXX Cult,Legionella sp identified in Unspecified specimen by Organism specific culture,MICRO,1154
33437-5,pO2 BldC TcO2,Oxygen [Partial pressure] in Capillary blood by Transcutaneous O2 monitor,Chem,1155
48683-7,Gp B Strep DNA XXX Ql PCR,Streptococcus agalactiae DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1156
20574-0,H capsul Yst Ab Titr Ser CF,Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation,MICRO,1157
49539-0,CMV IgM Ser Ql IF,Cytomegalovirus IgM Ab [Presence] in Serum by Immunofluorescence,MICRO,1158
33721-2,,Bone marrow Pathology biopsy report,ATTACH.CLINRPT,1159
5127-6,CMV IgM Titr Ser IF,Cytomegalovirus IgM Ab [Titer] in Serum by Immunofluorescence,MICRO,1160
33773-3,Karyotyp Amn,Karyotype [Identifier] in Amniotic fluid Nominal,MOLPATH,1161
49051-6,GA (weeks),Gestational age in weeks,OB.US,1162
7789-1,Acanthocytes Bld Ql Smear,Acanthocytes [Presence] in Blood by Light microscopy,HEM/BC,1163
8338-6,Weight ante partum Measured,Body weight Measured --ante partum,BDYWGT.MOLEC,1164
5117-7,Cryoglob Ser Ql,Cryoglobulin [Presence] in Serum,Chem,1165
2752-4,pH Smn,pH of Semen,Chem,1166
15359-3,Screen dRVVT/normal,dRVVT actual/?normal (normalized LA screen),COAG,1167
2077-6,Chloride Sweat-sCnc,Chloride [Moles/volume] in Sweat,Chem,1168
41499-5,L pneumo1 Ag Ur Ql EIA,Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay,MICRO,1169
3141-9,Weight Measured,Body weight Measured,BDYWGT.ATOM,1170
5348-8,ENA Scl70 Ab Ser Ql EIA,SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay,SERO,1171
15761-0,Sweetgum IgE RAST Ql,Sweetgum IgE Ab RAST class in Serum,Allergy,1172
2615-3,MetHgb MFr BldA,Methemoglobin/Hemoglobin.total in Arterial blood,Chem,1173
5053-4,Aspergillus Ab Titr Ser CF,Aspergillus sp Ab [Titer] in Serum by Complement fixation,MICRO,1174
33247-8,Specimen wt Sweat Qn,Weight of Sweat,SPEC,1175
5183-9,HAV Ab Ser EIA-aCnc,Hepatitis A virus Ab [Units/volume] in Serum by Immunoassay,MICRO,1176
29893-5,HIV1 Ab Ser Ql EIA,HIV 1 Ab [Presence] in Serum by Immunoassay,MICRO,1177
20465-1,HCG MoM SerPl,Choriogonadotropin [Multiple of the median] in Serum or Plasma,Chem,1178
20466-9,u Estriol MoM SerPl,Estriol (E3).unconjugated [Multiple of the median] in Serum or Plasma,Chem,1179
38404-0,CFTR Mut Anal Bld/T,CFTR gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,MOLPATH.MUT,1180
27923-2,Ubiquinone10 SerPl-mCnc,Ubiquinone 10 [Mass/volume] in Serum or Plasma,Chem,1181
26512-4,Neutrophils NFr CSF,Neutrophils/100 leukocytes in Cerebral spinal fluid,HEM/BC,1182
48039-2,Fibronectin Fetal XXX Ql,Fibronectin.fetal [Presence] in Unspecified specimen,Chem,1183
14665-4,Copper SerPl-mCnc,Copper [Moles/volume] in Serum or Plasma,DRUG/TOX,1184
5880-0,RV Ag Stl Ql EIA,Rotavirus Ag [Presence] in Stool by Immunoassay,MICRO,1185
15083-9,Normetanephrine 24H Ur-mRate,Normetanephrine [Moles/time] in 24 hour Urine,Chem,1186
1924-0,Base deficit BldV-sCnc,Base deficit in Venous blood,Chem,1187
49573-9,HIV Gentyp Islt,HIV genotype [Susceptibility] in Isolate by Genotype method Narrative,ABXBACT,1188
15191-0,LA Nt dPL PPP Ql,Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma,COAG,1189
5356-1,ENA SM Ab Ser Ql EIA,Smith extractable nuclear Ab [Presence] in Serum by Immunoassay,SERO,1190
23761-0,Neutrophils NFr Bld Manual,Neutrophils/100 leukocytes in Blood by Manual count,HEM/BC,1191
5297-7,Rheumatoid fact Ser Ql LA,Rheumatoid factor [Presence] in Serum by Latex agglutination,SERO,1192
5301-7,ENA RNP Ab Ser Ql EIA,Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay,SERO,1193
9783-2,E chaffeensis IgG Titr Ser,Ehrlichia chaffeensis IgG Ab [Titer] in Serum,MICRO,1194
25156-1,Eosinophil UrnS Ql Micro,Eosinophils [Presence] in Urine sediment by Light microscopy,UA,1195
19839-0,Breaths.spontaneous on vent,Breath rate spontaneous --on ventilator,PULM,1196
13539-2,Phosphate Ur-mCnc,Phosphate [Moles/volume] in Urine,Chem,1197
13988-1,B-Globulin 24H MFr Ur Elph,Beta globulin/Protein.total in 24 hour Urine by Electrophoresis,Chem,1198
4621-9,Hgb S Bld Ql,Hemoglobin S [Presence] in Blood,HEM/BC,1199
26471-3,WBC Other NFr Bld,Leukocytes other/100 leukocytes in Blood,HEM/BC,1200
46082-4,FLUAV Ag Nph Ql EIA,Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay,MICRO,1201
46083-2,FLUBV Ag Nph Ql EIA,Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay,MICRO,1202
2357-2,G6PD RBC-cCnc,Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells,Chem,1203
28645-0,pCO2 BldCoV,Carbon dioxide [Partial pressure] in Venous cord blood,Chem,1204
39786-9,Vit B6 SerPl-mCnc,Pyridoxine [Moles/volume] in Serum or Plasma,Chem,1205
5809-9,Reducing Subs Ur Ql,Reducing substances [Presence] in Urine,UA,1206
28649-2,pO2 BldCoV,Oxygen [Partial pressure] in Venous cord blood,Chem,1207
6825-4,Crystals Fld Micro,Crystals [type] in Body fluid by Light microscopy,HEM/BC,1208
20458-6,RUBV IgG Ser-Imp,Rubella virus IgG Ab [interpretation] in Serum,MICRO,1209
27818-4,Prot C Act/Nor PPP Chro,Protein C actual/normal in Platelet poor plasma by Chromogenic method,COAG,1210
7691-9,Scallop IgE Qn,Scallop IgE Ab [Units/volume] in Serum,Allergy,1211
20474-3,Bacteria Tiss Bx Cult,Bacteria identified in Tissue by Biopsy culture,MICRO,1212
28641-9,HCO3 BldCoV-sCnc,Bicarbonate [Moles/volume] in Venous cord blood,Chem,1213
12234-1,Mesothl Cell NFr Fld Manual,Mesothelial cells/100 leukocytes in Body fluid by Manual count,HEM/BC,1214
23877-4,A phagocytoph IgG Titr Ser IF,Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence,MICRO,1215
28644-3,pCO2 BldCoA,Carbon dioxide [Partial pressure] in Arterial cord blood,Chem,1216
2956-1,Sodium 24H Ur-sRate,Sodium [Moles/time] in 24 hour Urine,Chem,1217
28648-4,pO2 BldCoA,Oxygen [Partial pressure] in Arterial cord blood,Chem,1218
14252-1,Smooth muscle Ab Ser Ql,Smooth muscle Ab [Presence] in Serum,SERO,1219
21108-6,B2 Glycoprot1 IgA Ser-aCnc,Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum,SERO,1220
44447-1,B2 Glycoprot1 IgA Ser EIA-aCnc,Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum by Immunoassay,SERO,1221
9784-0,E chaffeensis IgM Titr Ser,Ehrlichia chaffeensis IgM Ab [Titer] in Serum,MICRO,1222
49701-6,pH temp adj Bld,pH of Blood adjusted to patients actual temperature,Chem,1223
6891-6,Testost Bioavail MFr SerPl,Testosterone.bioavailable/Testosterone.total in Serum or Plasma,Chem,1224
11261-5,Bacteria Vag Aerobe Cult,Bacteria identified in Vaginal fluid by Aerobe culture,MICRO,1225
23878-2,A phagocytoph IgM Titr Ser IF,Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence,MICRO,1226
2112-1,B-HCG Preg Ur Ql,Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine,Chem,1227
49047-4,Globulin Ur Elph-mCnc,Globulin [Mass/volume] in Urine by Electrophoresis,Chem,1228
28640-1,HCO3 BldCoA-sCnc,Bicarbonate [Moles/volume] in Arterial cord blood,Chem,1229
32319-6,Glucose 30M p 75 g Glc PO SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --30 minutes post 75 g glucose PO,CHAL,1230
25459-9,Lead SerPl-mCnc,Lead [Moles/volume] in Serum or Plasma,DRUG/TOX,1231
57804-7,# Occ bld spec recommended Stl,Number of occult blood specimens recommended by testing kit protocol [#] in Stool,Chem,1232
32207-3,PDW Bld Auto,Platelet distribution width [Entitic volume] in Blood by Automated count,HEM/BC,1233
25386-4,Creat Fld-mCnc,Creatinine [Moles/volume] in Body fluid,Chem,1234
3174-0,AT III PPP Chro-aCnc,Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method,COAG,1235
33393-0,Coarse Gran Casts #/area UrnS LPF,Coarse Granular Casts [#/area] in Urine sediment by Microscopy low power field,UA,1236
9490-4,A flavus Ab Ser Ql,Aspergillus flavus Ab [Presence] in Serum,MICRO,1237
26447-3,Blasts NFr CSF,Blasts/100 leukocytes in Cerebral spinal fluid,HEM/BC,1238
8095-2,Smooth muscle Ab Titr Ser,Smooth muscle Ab [Titer] in Serum,SERO,1239
14712-4,Epineph 24H Ur-mRate,Epinephrine [Moles/time] in 24 hour Urine,Chem,1240
6136-6,Hazelnut IgE Qn,Hazelnut IgE Ab [Units/volume] in Serum,Allergy,1241
9660-2,HIV1 gp160 Ab Ser Ql IB,HIV 1 gp160 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1242
2873-8,Gamma glob CSF Elph-mCnc,Gamma globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis,Chem,1243
9668-5,HIV1 p55 Ab Ser Ql IB,HIV 1 p55 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1244
9667-7,HIV1 p51 Ab Ser Ql IB,HIV 1 p51 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1245
24469-9,Hgb XXX MFr Bld Elph,Hemoglobin XXX/Hemoglobin.total in Blood by Electrophoresis,HEM/BC,1246
771-6,nRBC # Bld Auto,Nucleated erythrocytes [#/volume] in Blood by Automated count,HEM/BC,1247
9664-4,HIV1 p24 Ab Ser Ql IB,HIV 1 p24 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1248
9661-0,HIV1 gp120 Ab Ser Ql IB,HIV 1 gp120 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1249
9666-9,HIV1 p31 Ab Ser Ql IB,HIV 1 p31 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1250
11070-0,Cyto Ur,Microscopic observation [Identifier] in Urine by Cyto stain,CYTO,1251
14650-6,Citrate 24H Ur-mRate,Citrate [Moles/time] in 24 hour Urine,Chem,1252
14603-5,Androst SerPl-mCnc,Androstenedione [Moles/volume] in Serum or Plasma,Chem,1253
13993-1,Alpha2 Glob MFr Ur Elph,Alpha 2 globulin/Protein.total in Urine by Electrophoresis,Chem,1254
5785-1,Eosinophil #/area UrnS HPF,Eosinophils [#/area] in Urine sediment by Microscopy high power field,UA,1255
13995-6,Gamma glob MFr Ur Elph,Gamma globulin/Protein.total in Urine by Electrophoresis,Chem,1256
14854-4,Norepineph 24H Ur-mRate,Norepinephrine [Moles/time] in 24 hour Urine,Chem,1257
5354-6,ENA SS-B Ab Ser Ql ID,Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),SERO,1258
85991-8,S pneum Da 14 IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum,MICRO,1259
85992-6,S pneum Da 14 IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1260
1869-7,Apo A-I SerPl-mCnc,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Chem,1261
33332-8,Linezolid Islt Grad Strip,Linezolid [Susceptibility] by Gradient strip,ABXBACT,1262
5352-0,ENA SS-A Ab Ser Ql ID,Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),SERO,1263
2640-1,Myoglobin Ur Ql,Myoglobin [Presence] in Urine,Chem,1264
2998-3,Vit B1 Bld-mCnc,Thiamine [Mass/volume] in Blood,Chem,1265
38544-3,Sperm Pre Wash # Smn,Spermatozoa [#/volume] in Semen --pre washing,FERT,1266
38540-1,Sperm Motile Pre Wash NFr Smn,Spermatozoa Motile/100 spermatozoa in Semen --pre washing,FERT,1267
3746-5,Meperidine Ur Ql,Meperidine [Presence] in Urine,DRUG/TOX,1268
12195-4,Creat Cl/1.73 sq M 24H Ur+SerPl-ArVRat,Creatinine renal clearance/1.73 sq M in 24 hour,Chem,1269
15059-9,Dopamine 24H Ur-mRate,Dopamine [Moles/time] in 24 hour Urine,Chem,1270
11140-1,Metaneph 24H Ur-mRate,Metanephrine [Moles/time] in 24 hour Urine,Chem,1271
28643-5,SaO2% BldCoV,Oxygen saturation in Venous cord blood,Chem,1272
5057-5,B dermat Ab Titr Ser CF,Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation,MICRO,1273
6092-1,Crab IgE Qn,Crab IgE Ab [Units/volume] in Serum,Allergy,1274
13926-1,GAD65 Ab Ser-aCnc,Glutamate decarboxylase 65 Ab [Units/volume] in Serum,SERO,1275
2513-0,Ketones SerPl Ql,Ketones [Presence] in Serum or Plasma,Chem,1276
2518-9,Lactate BldA-sCnc,Lactate [Moles/volume] in Arterial blood,Chem,1277
6007-9,Prot C PPP-aCnc,Protein C [Units/volume] in Platelet poor plasma by Coagulation assay,COAG,1278
14708-2,Endomysium Ab Titr Ser,Endomysium Ab [Titer] in Serum,SERO,1279
7984-8,B19V IgM Ser-aCnc,Parvovirus B19 IgM Ab [Units/volume] in Serum,MICRO,1280
11039-5,CRP SerPl Ql,C reactive protein [Presence] in Serum or Plasma,Chem,1281
32680-1,Fine Gran Casts #/area UrnS LPF,Fine Granular Casts [#/area] in Urine sediment by Microscopy low power field,UA,1282
30340-4,EBV VCA IgM Ser Ql,Epstein Barr virus capsid IgM Ab [Presence] in Serum,MICRO,1283
24115-8,EBV VCA IgM Ser Ql EIA,Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay,MICRO,1284
28642-7,SaO2% BldCoA,Oxygen saturation in Arterial cord blood,Chem,1285
25489-6,Normetanephrine SerPl-sCnc,Normetanephrine [Moles/volume] in Serum or Plasma,Chem,1286
19942-2,Gas flow.O2 setting Oxymiser,Oxygen gas flow setting Oxymizer,PULM,1287
18319-4,Neuts Vac Bld Ql Smear,Neutrophils.vacuolated [Presence] in Blood by Light microscopy,HEM/BC,1288
15530-9,A alternata IgE RAST Ql,Alternaria alternata IgE Ab RAST class in Serum,Allergy,1289
3256-5,Fibrinogen Ag PPP Imm-mCnc,Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunologic method,COAG,1290
35789-7,Daptomycin Susc Islt,Daptomycin [Susceptibility],ABXBACT,1291
21365-2,Leptin SerPl-mCnc,Leptin [Mass/volume] in Serum or Plasma,Chem,1292
21441-1,HPV Low Risk DNA Cervix Ql Prb,Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by DNA probe,MICRO,1293
14956-7,Microalbumin 24H Ur-mRate,Microalbumin [Mass/time] in 24 hour Urine,Chem,1294
14935-1,Urate 24H Ur-mRate,Urate [Moles/time] in 24 hour Urine,Chem,1295
5863-6,FLUAV Ag XXX Ql IF,Influenza virus A Ag [Presence] in Unspecified specimen by Immunofluorescence,MICRO,1296
34524-9,Neuts Band Bld Ql Auto,Neutrophils.band form [Presence] in Blood by Automated count,HEM/BC,1297
23841-0,B-HCG adj MoM SerPl,Choriogonadotropin.beta subunit [Multiple of the median] adjusted in Serum or Plasma,Chem,1298
1857-2,ACE Bld-cCnc,Angiotensin converting enzyme [Enzymatic activity/volume] in Blood,Chem,1299
31797-4,CMV Ag XXX Ql,Cytomegalovirus Ag [Presence] in Unspecified specimen,MICRO,1300
6379-2,CMV Ag XXX Ql EIA,Cytomegalovirus Ag [Presence] in Unspecified specimen by Immunoassay,MICRO,1301
16264-4,COM Cry Stone Ql IR,Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy,Chem,1302
49542-4,Pheresis Date&Time,Date and time of pheresis procedure,BLDBK,1303
30339-6,EBV VCA IgG Ser Ql,Epstein Barr virus capsid IgG Ab [Presence] in Serum,MICRO,1304
24114-1,EBV VCA IgG Ser Ql EIA,Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay,MICRO,1305
32554-8,Vit B1 Bld-sCnc,Thiamine [Moles/volume] in Blood,Chem,1306
14316-4,Benzodiaz Ur Ql Scn,Benzodiazepines [Presence] in Urine by Screen method,DRUG/TOX,1307
9796-4,Color Stone,Color of Stone,SPEC,1308
9802-0,Size Stone,Size [Entitic volume] of Stone,PATH,1309
2428-1,Homocysteine SerPl-mCnc,Homocysteine [Mass/volume] in Serum or Plasma,Chem,1310
35538-8,Baker's yeast IgG-mCnc,Baker's yeast IgG Ab [Mass/volume] in Serum,Allergy,1311
48050-9,Neutrophils Stl Ql Wright Stn,Neutrophils [Presence] in Stool by Wright stain,HEM/BC,1312
20593-0,CD19 Cells NFr XXX,CD19 cells/100 cells in Unspecified specimen,CELLMARK,1313
25170-2,Mercury Bld-mCnc,Mercury [Moles/volume] in Blood,DRUG/TOX,1314
2605-4,Meat Fibers Stl Ql Micro,Meat fibers [Presence] in Stool by Light microscopy,Chem,1315
730-2,WBC Other NFr Bld Manual,Leukocytes other/100 leukocytes in Blood by Manual count,HEM/BC,1316
8249-5,Trans Cells UrnS Ql Micro,Transitional cells [Presence] in Urine sediment by Light microscopy,UA,1317
30427-9,Macrophages NFr Fld,Macrophages/100 leukocytes in Body fluid,HEM/BC,1318
19835-8,Breaths setting SIMV,Breath rate setting Ventilator synchronized intermittent mandatory,PULM,1319
27395-3,S pneum Da 18C IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum,MICRO,1320
40913-6,S pneum Da 18C IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1321
15212-4,Lipase Fld-cCnc,Lipase [Enzymatic activity/volume] in Body fluid,Chem,1322
3507-1,Codeine Ur Ql,Codeine [Presence] in Urine,DRUG/TOX,1323
86024-7,S pneum Da sero 19F IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum,MICRO,1324
86021-3,S pneum Da sero 19F IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1325
86064-3,S pneum Da 23F IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum,MICRO,1326
86061-9,S pneum Da 23F IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1327
86107-0,S pneum Da 4 IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum,MICRO,1328
86108-8,S pneum Da 4 IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1329
4575-7,Hgb E MFr Bld,Hemoglobin E/Hemoglobin.total in Blood,HEM/BC,1330
30153-1,S pneum Da 9V IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum,MICRO,1331
40926-8,S pneum Da 9V IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1332
35127-0,Hgb A2.prime MFr Bld,Hemoglobin A2.prime/Hemoglobin.total in Blood,HEM/BC,1333
31156-3,Hgb Barts MFr Bld,Hemoglobin Barts/Hemoglobin.total in Blood,HEM/BC,1334
4569-0,Hgb D MFr Bld,Hemoglobin D/Hemoglobin.total in Blood,HEM/BC,1335
33593-5,Hgb G-Coush MFr Bld,Hemoglobin G - Coushatta/Hemoglobin.total in Blood,HEM/BC,1336
35125-4,Hgb Lepore MFr Bld,Hemoglobin Lepore/Hemoglobin.total in Blood,HEM/BC,1337
35126-2,Hgb O-Arab MFr Bld,Hemoglobin O - Arab/Hemoglobin.total in Blood,HEM/BC,1338
13986-5,Albumin 24H MFr Ur Elph,Albumin/Protein.total in 24 hour Urine by Electrophoresis,Chem,1339
6165-5,Lobster IgE Qn,Lobster IgE Ab [Units/volume] in Serum,Allergy,1340
21709-1,MTHFR gene Mut Anal Bld/T,MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,MOLPATH.MUT,1341
14833-8,MetanephS 24H Ur-mRate,Metanephrines [Moles/time] in 24 hour Urine,Chem,1344
13984-0,Alpha1 Glob 24H MFr Ur Elph,Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis,Chem,1346
38415-6,MTHFR gene Mut Anal Bld/T,MTHFR gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,MOLPATH.MUT,1347
42484-6,M Protein 24H MFr Ur Elph,Protein.monoclonal/Protein.total in 24 hour Urine by Electrophoresis,Chem,1348
10863-9,Endomysium IgA Titr Ser,Endomysium IgA Ab [Titer] in Serum,SERO,1349
3830-7,Morphine Ur Ql,Morphine [Presence] in Urine,DRUG/TOX,1350
14947-6,VMA 24H Ur-mRate,Vanillylmandelate [Moles/time] in 24 hour Urine,Chem,1351
14835-3,Methanol SerPl-mCnc,Methanol [Moles/volume] in Serum or Plasma,DRUG/TOX,1352
13499-9,HIV1 Ab Patrn Ser IB-Imp,HIV 1 Ab band pattern [interpretation] in Serum by Immunoblot (IB),MICRO,1353
49540-8,Acid citrate dextrose Vol BPU,Acid citrate dextrose [Volume] in Blood product unit,BLDBK,1354
5292-8,VDRL Ser Ql,Reagin Ab [Presence] in Serum by VDRL,MICRO,1355
31102-7,Prot S Act/Nor PPP Chro,Protein S actual/normal in Platelet poor plasma by Chromogenic method,COAG,1356
25157-9,Epith Casts UrnS Ql Micro,Epithelial casts [Presence] in Urine sediment by Light microscopy,UA,1357
33333-6,Colistin Islt Grad Strip,Colistin [Susceptibility] by Gradient strip,ABXBACT,1358
71790-0,Calcium ?Tm Ur-mCnc,Calcium [Moles/volume] in unspecified time Urine,Chem,1359
588-4,L pneumo Ag XXX Ql IF,Legionella pneumophila Ag [Presence] in Unspecified specimen by Immunofluorescence,MICRO,1360
8150-5,Amphetamines Ur-mCnc,Amphetamines [Mass/volume] in Urine,DRUG/TOX,1361
40287-5,Glucose 1H p meal SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --1 hour post meal,CHAL,1362
17607-3,Specimen vol CSF,Volume of Cerebral spinal fluid,SPEC,1363
43583-4,LPa SerPl-sCnc,Lipoprotein a [Moles/volume] in Serum or Plasma,Chem,1364
52956-0,Barbiturates Ur-mCnc,Barbiturates [Moles/volume] in Urine,DRUG/TOX,1365
10704-5,O and P Prep Stl,Ova and parasites identified in Stool by Light microscopy,MICRO,1366
52955-2,Benzodiaz Ur-sCnc,Benzodiazepines [Moles/volume] in Urine,DRUG/TOX,1367
9428-4,Benzodiaz Ur-mCnc,Benzodiazepines [Mass/volume] in Urine,DRUG/TOX,1367
31032-6,Baker's yeast IgA Qn,Baker's yeast IgA Ab [Units/volume] in Serum,Allergy,1368
47320-7,Baker's yeast IgA Qn EIA,Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay,ALLERGY,1369
22086-3,A niger Ab Ser Ql,Aspergillus niger Ab [Presence] in Serum,MICRO,1370
6164-8,Virg Live Oak IgE Qn,Virginia Live Oak IgE Ab [Units/volume] in Serum,Allergy,1371
33915-0,Anabasine Ur-mCnc,Anabasine [Mass/volume] in Urine,DRUG/TOX,1372
13358-7,Collect Tme Smn,Collection time of Semen,SPEC,1373
25507-5,Preg SerPl-mCnc,Pregnenolone [Moles/volume] in Serum or Plasma,Chem,1374
34519-9,HFE gene Mut Anal Bld/T,HFE gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,MOLPATH.MUT,1375
28545-2,Mucous Threads #/area UrnS LPF,Mucus [#/area] in Urine sediment by Microscopy low power field,UA,1376
6113-5,Gum-Tree IgE Qn,Gum-Tree IgE Ab [Units/volume] in Serum,Allergy,1377
27118-9,S pneum Da 6B IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum,MICRO,1378
40905-2,S pneum Da 6B IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1379
12856-1,HIV1 p65 Ab Ser Ql IB,HIV 1 p65 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1380
19077-7,Cells Fld,Cells identified in Body fluid,HEM/BC,1381
86080-9,S pneum Da 3 IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum,MICRO,1382
86081-7,S pneum Da 3 IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1383
25296-5,S pneum Da 7F IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum,MICRO,1384
40911-0,S pneum Da 7F IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1385
86147-6,S pneum Da 8 IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum,MICRO,1386
86148-4,S pneum Da 8 IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1387
86169-0,S pneum Da 9N IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum,MICRO,1388
86166-6,S pneum Da 9N IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1389
15048-2,CK BB CFr SerPl Elph,Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis,Chem,1390
12187-1,CK MB CFr SerPl Elph,Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis,Chem,1391
15049-0,CK MM CFr SerPl Elph,Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis,Chem,1392
9662-8,HIV1 gp41 Ab Ser Ql IB,HIV 1 gp41 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1393
85954-6,S pneum Da 1 IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum,MICRO,1394
85955-3,S pneum Da 1 IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1395
26019-0,CK Macro1 CFr SerPl,Creatine Kinase.macromolecular type 1/Creatine kinase.total in Serum or Plasma,Chem,1396
26020-8,CK Macro2 CFr SerPl,Creatine Kinase.macromolecular type 2/Creatine kinase.total in Serum or Plasma,Chem,1397
41763-4,RUBV IgG Titr Ser,Rubella virus IgG Ab [Titer] in Serum,MICRO,1398
42483-8,M Protein MFr Ur Elph,Protein.monoclonal/Protein.total in Urine by Electrophoresis,Chem,1399
12859-5,HIV1 p18 Ab Ser Ql IB,HIV 1 p18 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1400
6050-9,Brazil Nut IgE Qn,Brazil Nut IgE Ab [Units/volume] in Serum,Allergy,1401
85977-7,S pneum Da 12F IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum,MICRO,1402
85974-4,S pneum Da 12F IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1403
21619-2,APOE gene Mut Anal Bld/T,APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,MOLPATH.MUT,1404
14934-4,Urate Ur-mCnc,Urate [Moles/volume] in Urine,Chem,1405
18267-5,CD16+CD56+ Cells NFr Bld,CD16+CD56+ cells/100 cells in Blood,CELLMARK,1406
48560-7,HPV Gentyp XXX PCR,Human papilloma virus genotype [Identifier] in Unspecified specimen by Probe & target amplification method,MICRO,1407
33536-4,Misc Allergen IgE RAST Ql,Miscellaneous allergen IgE Ab RAST class in Serum,Allergy,1408
14288-5,Carnitine SerPl-sCnc,Carnitine [Moles/volume] in Serum or Plasma,Chem,1409
20402-4,CD16+CD56+ Cells # Bld,CD16+CD56+ cells [#/volume] in Blood,CELLMARK,1410
2333-3,Gastrin SerPl-mCnc,Gastrin [Mass/volume] in Serum or Plasma,Chem,1411
11778-8,Delivery date Clin est,Delivery date Estimated,OB.US,1412
42810-2,Hgb Retic Qn,Hemoglobin [Entitic mass] in Reticulocytes,HEM/BC,1413
5191-2,HBV e Ag Ser EIA-aCnc,Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay,MICRO,1414
26458-0,RBC # Snv,Erythrocytes [#/volume] in Synovial fluid,HEM/BC,1415
14664-7,Color Snv,Color of Synovial fluid,SPEC,1416
8214-9,Opiates Mec Ql,Opiates [Presence] in Meconium,DRUG/TOX,1417
14286-9,Carnitine Free SerPl-sCnc,Carnitine free (C0) [Moles/volume] in Serum or Plasma,Chem,1418
27939-8,Collagen NTx Ur-sCnc,Collagen crosslinked N-telopeptide [Moles/volume] in Urine,Chem,1419
16130-7,HSV1 DNA XXX Ql PCR,Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1420
32766-8,T vaginalis XXX Ql Wet Prep,Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation,MICRO,1421
17284-1,Mitochondria Ab Ser Ql IF,Mitochondria Ab [Presence] in Serum by Immunofluorescence,SERO,1422
16268-5,Ca Phos Cry Stone Ql IR,Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy,Chem,1423
7905-3,HBV surface Ag Ser Ql Nt,Hepatitis B virus surface Ag [Presence] in Serum by Neutralization test,MICRO,1424
19126-2,Bacteria Mar Aerobe Cult,Bacteria identified in Bone marrow by Aerobe culture,MICRO,1425
6158-0,Ltx IgE Qn,Latex IgE Ab [Units/volume] in Serum,Allergy,1426
3282-1,aPTT Hex PL PPP,aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay,COAG,1427
32031-7,PS IgA Ser IA-aCnc,Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay,COAG,1428
6266-1,Tomato IgE Qn,Tomato IgE Ab [Units/volume] in Serum,Allergy,1429
6009-5,Prot C Ag PPP Imm-aCnc,Protein C Ag [Units/volume] in Platelet poor plasma by Immunologic method,COAG,1430
936-5,Bld Unit Id BPU,Blood product unit [Identifier],BLDBK,1431
9820-2,C neoform Ag Titr Ser LA,Cryptococcus sp Ag [Titer] in Serum by Latex agglutination,MICRO,1432
11013-0,dsDNA Ab Titr Ser,DNA double strand Ab [Titer] in Serum,SERO,1433
31080-5,Cannabinoids Mec Ql Scn,Cannabinoids [Presence] in Meconium by Screen method,DRUG/TOX,1434
5909-7,Bld Smear Interp,Blood smear finding [Identifier] in Blood by Light microscopy,HEM/BC,1435
22296-8,EBV NA Ab Ser Ql,Epstein Barr virus nuclear Ab [Presence] in Serum,MICRO,1436
575-1,Fungus Skin Cult,Fungus identified in Skin by Culture,MICRO,1437
5820-6,WBC Casts #/area UrnS LPF,WBC casts [#/area] in Urine sediment by Microscopy low power field,UA,1438
2999-1,Vit B1 SerPl-mCnc,Thiamine [Mass/volume] in Serum or Plasma,Chem,1439
35452-2,HIV1 gp40 Ab Ser Ql IB,HIV 1 gp40 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1440
20449-5,B burgdor Ab Ser Ql EIA,Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay,MICRO,1441
6174-7,Milk IgE Qn,Milk IgE Ab [Units/volume] in Serum,Allergy,1442
13047-6,Plasma Cells NFr Bld,Plasma cells/100 leukocytes in Blood,HEM/BC,1443
20999-9,Cell Fract Fld-Imp,Cell Fractions/Differential [interpretation] in Body fluid,HEM/BC,1444
70206-8,Codeine Ur Cfm-mCnc,Codeine [Moles/volume] in Urine by Confirmatory method,DRUG/TOX,1445
15283-5,Silver Birch IgE Qn,Silver Birch IgE Ab [Units/volume] in Serum,Allergy,1446
14622-5,Vit C SerPl-mCnc,Ascorbate [Moles/volume] in Serum or Plasma,Chem,1447
40527-4,Cocaine Mec Ql,Cocaine [Presence] in Meconium,DRUG/TOX,1448
14573-0,5OH-indoleacetate 24H Ur-mRate,5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine,Chem,1449
70208-4,Glucose pre 100 g Glc PO SerPl-mCnc,Glucose [Moles/volume] in Serum or Plasma --pre 100 g glucose PO,CHAL,1450
21525-1,Sodium 24H Ur-sCnc,Sodium [Moles/volume] in 24 hour Urine,Chem,1451
14906-2,Rh BldCo,Rh [Type] in Cord blood,BLDBK,1452
20112-9,VT setting Vent,Tidal volume setting Ventilator,PULM,1453
8144-8,Amphetamines Mec Ql,Amphetamines [Presence] in Meconium,DRUG/TOX,1454
6242-2,Sesame Seed IgE Qn,Sesame Seed IgE Ab [Units/volume] in Serum,Allergy,1455
21023-7,ANCA Ab Titr Ser,Neutrophil cytoplasmic Ab [Titer] in Serum,SERO,1456
7983-0,B19V IgG Ser-aCnc,Parvovirus B19 IgG Ab [Units/volume] in Serum,MICRO,1457
30361-0,HIV2 Ab Ser Ql EIA,HIV 2 Ab [Presence] in Serum by Immunoassay,MICRO,1458
781-5,Promyelocytes # Bld Manual,Promyelocytes [#/volume] in Blood by Manual count,HEM/BC,1459
51892-8,ABO Group BldCo,ABO group [Type] in Cord blood,BLDBK,1460
42803-7,Bacteria Islt,Bacteria identified in Isolate,MICRO,1461
25631-3,B19V IgM Titr Ser,Parvovirus B19 IgM Ab [Titer] in Serum,MICRO,1462
32787-4,p-ANCA Titr Ser,Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum,SERO,1463
19429-0,Propoxyph Ur Ql Scn,Propoxyphene [Presence] in Urine by Screen method,DRUG/TOX,1464
25415-1,Folate Bld-mCnc,Folate [Moles/volume] in Blood,Chem,1465
70210-0,Morphine Ur Cfm-mCnc,Morphine [Moles/volume] in Urine by Confirmatory method,DRUG/TOX,1466
32585-2,EBV DNA # XXX PCR,Epstein Barr virus DNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method,MICRO,1467
15410-4,VZV IgG Ser Ql EIA,Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay,MICRO,1468
5357-9,ENA SM Ab Ser Ql ID,Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),SERO,1469
5036-9,S pyo rRNA XXX Ql Prb,Streptococcus pyogenes rRNA [Presence] in Unspecified specimen by DNA probe,MICRO,1470
40974-8,S pneum Da 19A IgG Ser-mCnc,Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum,MICRO,1471
40915-1,S pneum Da 19A IgG Ser IA-mCnc,Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay,MICRO,1472
48348-7,10OH-Carbazepine SerPl-mCnc,10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma,DRUG/TOX,1473
30173-9,Cortis F Ur-mCnc,Cortisol Free [Moles/volume] in Urine,Chem,1474
9704-8,Sperm Smn,Spermatozoa [Morphology] in Semen,FERT,1475
601-5,Fungus Bld Cult,Fungus identified in Blood by Culture,MICRO,1476
19803-6,Specimen site,Specimen site,ENDO.GI,1477
14881-7,Phosphate 24H Ur-mRate,Phosphate [Moles/time] in 24 hour Urine,Chem,1478
21695-2,HFE p.G845A Bld/T Ql,HFE gene p.C282Y [Presence] in Blood or Tissue by Molecular genetics method,MOLPATH.MUT,1479
38256-4,Total Cells Counted Fld,Cells Counted Total [#] in Body fluid,HEM/BC,1480
10587-4,Sex Abstin duration Time Patient,Sexual abstinence duration,FERT,1481
41479-7,BKV DNA # SerPl PCR,BK virus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,1482
21260-5,EBV NA Ab Titr Ser IF,Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence,MICRO,1483
35270-8,Candida Ab Ser Ql ID,Candida sp Ab [Presence] in Serum by Immune diffusion (ID),MICRO,1484
14194-5,Sperm Prog NFr Smn,Spermatozoa Progressive/100 spermatozoa in Semen,FERT,1485
6190-3,Oat IgE Qn,Oat IgE Ab [Units/volume] in Serum,Allergy,1486
6222-4,Queen Palm IgE Qn,Queen Palm IgE Ab [Units/volume] in Serum,Allergy,1487
27820-0,Prot C Ag Act/Nor PPP Imm,Protein C Ag actual/normal in Platelet poor plasma by Immunologic method,COAG,1488
10579-1,WBC # Smn,Leukocytes [#/volume] in Semen,FERT,1489
30247-1,CMV DNA # SerPl PCR,Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,1490
30165-5,PC/Alb Amn-mRto,Phosphatidylcholine/Albumin [Mass ratio] in Amniotic fluid,Chem,1491
12782-9,Oligoclonal Bands CSF Elph-Imp,Protein fractions.oligoclonal bands [interpretation] in Cerebral spinal fluid by Electrophoresis,Chem,1492
25361-7,Caffeine SerPl-mCnc,Caffeine [Moles/volume] in Serum or Plasma,DRUG/TOX,1493
70217-5,T4 Free SerPl Dialy-mCnc,Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis,Chem,1494
6151-5,Italian Cypress IgE Qn,Italian Cypress IgE Ab [Units/volume] in Serum,Allergy,1495
5946-9,aPTT imm NP PPP,aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma,COAG,1496
6230-7,Rice IgE Qn,Rice IgE Ab [Units/volume] in Serum,Allergy,1497
10525-4,Cyto XXX,Microscopic observation [Identifier] in Unspecified specimen by Cyto stain,CYTO,1498
40692-6,Specimen vol Pre Wash Smn,Volume of Semen--pre washing,FERT,1499
11884-4,GA Clin est,Gestational age Estimated,OB.US,1500
19171-8,AFP Amn-aCnc,Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid,Chem,1501
7287-6,Dog Fennel IgE Qn,Dog Fennel IgE Ab [Units/volume] in Serum,Allergy,1502
44528-8,H capsul M Ab Ser Ql,Histoplasma capsulatum M Ab [Presence] in Serum,MICRO,1503
12227-5,WBC nRBC cor # Bld,Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood,HEM/BC,1504
59960-5,Propoxyph Ur-mCnc,Propoxyphene [Moles/volume] in Urine,DRUG/TOX,1505
20473-5,Polys XXX Ql Wright Stn,Polymorphonuclear cells [Presence] in Unspecified specimen by Wright stain,HEM/BC,1506
35732-7,H capsul H Ab Ser Ql ID,Histoplasma capsulatum H Ab [Presence] in Serum by Immune diffusion (ID),MICRO,1507
19261-7,Amphetamines Ur Ql Scn,Amphetamines [Presence] in Urine by Screen method,DRUG/TOX,1508
11235-9,Fentanyl Ur Ql,Fentanyl [Presence] in Urine,DRUG/TOX,1509
5221-7,HIV1 Ab Ser Ql IB,HIV 1 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1510
6109-3,White Elm IgE Qn,White Elm IgE Ab [Units/volume] in Serum,Allergy,1511
10353-1,Bacteria Nose Aerobe Cult,Bacteria identified in Nose by Aerobe culture,MICRO,1512
7124-1,Bayberry Poln IgE Qn,Bayberry Pollen IgE Ab [Units/volume] in Serum,Allergy,1513
8251-1,Service Cmnt XXX-Imp,Service comment,MISC,1514
38996-5,Neutrophils Ur Ql Micro,Neutrophils [Presence] in Urine by Light microscopy,UA,1515
15197-7,Fiss Lymphs NFr Bld Manual,Lymphocytes Fissured/100 leukocytes in Blood by Manual count,HEM/BC,1516
14207-5,Strep DNAse B Titr Ser,Streptococcal DNAse B [Titer] in Serum,MICRO,1517
44547-8,HPV DNA XXX Ql bDNA,Human papilloma virus DNA [Presence] in Unspecified specimen by Probe & signal amplification method,MICRO,1518
28543-7,Basophils NFr Fld,Basophils/100 leukocytes in Body fluid,HEM/BC,1519
6012-9,vWF Ag PPP Imm-aCnc,von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunologic method,COAG,1520
7902-0,H pylori IgG Ser-aCnc,Helicobacter pylori IgG Ab [Units/volume] in Serum,MICRO,1521
10728-4,Trichomonas Genital Cult,Trichomonas sp identified in Genital specimen by Organism specific culture,MICRO,1522
8118-2,CD2 Cells NFr Bld,CD2 cells/100 cells in Blood,CELLMARK,1523
38496-6,Retinyl Palmitate SerPl-mCnc,Retinyl palmitate [Mass/volume] in Serum or Plasma,Chem,1524
48053-3,Turbidity Snv Ql,Turbidity [Presence] of Synovial fluid,SPEC,1525
33984-6,Fact X Act/Nor PPP Chro,Coagulation factor X activity actual/normal in Platelet poor plasma by Chromogenic method,COAG,1526
49839-4,Eosinophil UrnS Ql Wright Stn,Eosinophils [Presence] in Urine sediment by Wright stain,HEM/BC,1527
14802-3,Isopropanol SerPl-mCnc,Isopropanol [Moles/volume] in Serum or Plasma,DRUG/TOX,1528
7816-2,B dermat Ab Ser Ql,Blastomyces dermatitidis Ab [Presence] in Serum,MICRO,1529
7477-3,Mango Poln IgE Qn,Mango Pollen IgE Ab [Units/volume] in Serum,Allergy,1530
36913-2,FMR1 gene Mut Anal Bld/T,FMR1 gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,MOLPATH.MUT,1531
13943-6,Fructose Smn Ql,Fructose [Presence] in Semen,Chem,1532
34441-6,Sperm Smn Qn,Spermatozoa [Velocity] in Semen,FERT,1533
7110-0,Groundsel Tree IgE Qn,Groundsel Tree IgE Ab [Units/volume] in Serum,Allergy,1534
2464-6,IgG CSF-mCnc,IgG [Mass/volume] in Cerebral spinal fluid,Chem,1535
6195-2,Cocksfoot IgE Qn,Cocksfoot IgE Ab [Units/volume] in Serum,Allergy,1536
22752-0,Tobramycin Trough SerPl-sCnc,Tobramycin [Moles/volume] in Serum or Plasma --trough,DRUG/TOX,1537
4059-2,Tobramycin Trough SerPl-mCnc,Tobramycin [Mass/volume] in Serum or Plasma --trough,DRUG/TOX,1537
48051-7,RBC Vag Ql,Erythrocytes [Presence] in Vaginal fluid,HEM/BC,1538
19710-3,Tramadol Ur Ql Scn,Tramadol [Presence] in Urine by Screen method,DRUG/TOX,1539
22297-6,EBV NA Ab Titr Ser,Epstein Barr virus nuclear Ab [Titer] in Serum,MICRO,1540
27823-4,Prot S Ag Act/Nor PPP Imm,Protein S Ag actual/normal in Platelet poor plasma by Immunologic method,COAG,1541
560-3,Chlamydia XXX Cult,Chlamydia sp identified in Unspecified specimen by Organism specific culture,MICRO,1542
20427-1,AChR Ab Ser-sCnc,Acetylcholine receptor Ab [Moles/volume] in Serum,SERO,1543
48038-4,Path Interp Snv-Imp,Pathologist interpretation of Synovial fluid tests,PATH,1544
4551-8,Hgb A2 MFr Bld,Hemoglobin A2/Hemoglobin.total in Blood,HEM/BC,1545
47383-5,ANA Ser Ql EIA,Nuclear Ab [Presence] in Serum by Immunoassay,SERO,1546
9557-0,CD2 Cells # Bld,CD2 cells [#/volume] in Blood,CELLMARK,1547
41476-3,R rickettsi IgG Ser Ql EIA,Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay,MICRO,1548
9804-6,Wt Stone Qn,Weight of Stone,PATH,1549
20468-5,Vit B1 SerPl-sCnc,Thiamine [Moles/volume] in Serum or Plasma,Chem,1550
33242-9,Filament Fungi Ur Ql Comp Assist,Fungi.filamentous [Presence] in Urine by Computer assisted method,UA,1551
27821-8,Prot S Free Ag Act/Nor PPP Imm,Protein S Free Ag actual/normal in Platelet poor plasma by Immunologic method,COAG,1552
3175-7,AT III Ag PPP Imm-aCnc,Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunologic method,COAG,1553
49572-1,2nd trimester 3 screen SerPl-Imp,Second trimester triple maternal screen [interpretation] in Serum or Plasma Narrative,Chem,1554
23301-5,Mycoplasma DNA XXX Ql PCR,Mycoplasma sp DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1555
5256-3,M pneumo IgM Ser EIA-aCnc,Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,1556
21760-4,FRAXE gene CGG Rpt Bld/T Ql,FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method,MOLPATH.TRINUC,1557
16117-4,Bab microti IgG Titr Ser,Babesia microti IgG Ab [Titer] in Serum,MICRO,1558
41475-5,R rickettsi IgM Ser Ql EIA,Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay,MICRO,1559
21416-3,N gonorrhoea DNA Ur Ql PCR,Neisseria gonorrhoeae DNA [Presence] in Urine by Probe & target amplification method,MICRO,1560
24119-0,CMV IgM Ser Ql EIA,Cytomegalovirus IgM Ab [Presence] in Serum by Immunoassay,MICRO,1561
21582-2,Tryptase SerPl-mCnc,Tryptase [Mass/volume] in Serum or Plasma,Chem,1562
5255-5,M pneumo IgG Ser EIA-aCnc,Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,1563
13947-7,C immitis IgG Ser Ql EIA,Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay,MICRO,1564
14716-5,Estriol SerPl-mCnc,Estriol (E3) [Moles/volume] in Serum or Plasma,Chem,1565
24125-7,Androgen FAI SerPl-sRto,Andorgen free Index in Serum or Plasma,Chem,1566
13948-5,C immitis IgM Ser Ql EIA,Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay,MICRO,1567
25474-8,MetanephS SerPl-sCnc,Metanephrines [Moles/volume] in Serum or Plasma,Chem,1568
49580-4,HIV1+2 Ab XXX Ql Rapid,HIV 1+2 Ab [Presence] in Unspecified specimen by Rapid test,MICRO,1569
6021-0,Apple IgE Qn,Apple IgE Ab [Units/volume] in Serum,Allergy,1570
26451-5,Eosinophil NFr CSF,Eosinophils/100 leukocytes in Cerebral spinal fluid,HEM/BC,1571
5908-9,Giant Platelets Bld Ql Smear,Platelets Giant [Presence] in Blood by Light microscopy,HEM/BC,1572
16118-2,Bab microti IgM Titr Ser,Babesia microti IgM Ab [Titer] in Serum,MICRO,1573
22751-2,Tobramycin Peak SerPl-sCnc,Tobramycin [Moles/volume] in Serum or Plasma --peak,DRUG/TOX,1574
4057-6,Tobramycin Peak SerPl-mCnc,Tobramycin [Mass/volume] in Serum or Plasma --peak,DRUG/TOX,1574
30525-0,Age Time Patient,Age,MISC,1575
32546-4,G6PD RBC-cCnt,Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells,Chem,1576
32164-6,Cells # Snv Manual,Cells [#/volume] in Synovial fluid by Manual count,HEM/BC,1577
9811-1,CgA SerPl-mCnc,Chromogranin A [Mass/volume] in Serum or Plasma,Chem,1578
10355-6,Wright Gie Stn Mar,Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain,MICRO,1579
15057-3,Androstanolone SerPl-mCnc,Androstanolone [Moles/volume] in Serum or Plasma,Chem,1580
32109-1,Phenytoin Free SerPl-mCnc,Phenytoin Free [Moles/volume] in Serum or Plasma,DRUG/TOX,1581
6270-3,Tuna IgE Qn,Tuna IgE Ab [Units/volume] in Serum,Allergy,1582
7613-3,Pistachio IgE Qn,Pistachio IgE Ab [Units/volume] in Serum,Allergy,1583
14083-0,EBV EA Ab Titr Ser IF,Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence,MICRO,1584
18182-6,Osmolality SerPl Calc,Osmolality of Serum or Plasma by calculation,Chem,1585
41279-1,B burgdor IgG/IgM Ser-Rto,Borrelia burgdorferi IgG Ab/IgM Ab [Ratio] in Serum,MICRO,1586
7883-2,EBV NA IgG Ser Ql,Epstein Barr virus nuclear IgG Ab [Presence] in Serum,MICRO,1587
20425-5,Cardiolipin IgM Ser-Imp,Cardiolipin IgM Ab [interpretation] in Serum,COAG,1588
1746-7,Albumin CSF-mCnc,Albumin [Mass/volume] in Cerebral spinal fluid,Chem,1589
20424-8,Cardiolipin IgG Ser-Imp,Cardiolipin IgG Ab [interpretation] in Serum,COAG,1590
26479-6,Lymphocytes NFr CSF,Lymphocytes/100 leukocytes in Cerebral spinal fluid,HEM/BC,1591
70218-3,Trigl Bld-mCnc,Triglyceride [Moles/volume] in Blood,Chem,1592
609-8,Bacteria Eye Aerobe Cult,Bacteria identified in Eye by Aerobe culture,MICRO,1593
15643-0,Clam IgE RAST Ql,Clam IgE Ab RAST class in Serum,Allergy,1594
14869-2,Path Rev Bld -Imp,Pathologist review of Blood tests,BLDBK,1595
5814-9,Tri-Phos Cry UrnS Ql Micro,Triple phosphate crystals [Presence] in Urine sediment by Light microscopy,UA,1596
30193-7,Acylcarnitine/C0 SerPl-sRto,Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Serum or Plasma,Chem,1597
8047-3,VZV IgG Ser-aCnc,Varicella zoster virus IgG Ab [Units/volume] in Serum,MICRO,1598
38476-8,MIS SerPl-mCnc,Mullerian inhibiting substance [Mass/volume] in Serum or Plasma,Chem,1599
5834-7,HAdV Ag XXX Ql IF,Adenovirus Ag [Presence] in Unspecified specimen by Immunofluorescence,MICRO,1600
6257-0,Strawberry IgE Qn,Strawberry IgE Ab [Units/volume] in Serum,Allergy,1601
28009-9,Specimen vol Ur,Volume of Urine,SPEC,1602
13349-6,WBC # Stl Manual,Leukocytes [#/volume] in Stool by Manual count,HEM/BC,1604
1992-7,Calcit SerPl-mCnc,Calcitonin [Mass/volume] in Serum or Plasma,Chem,1605
26607-2,Cystathionin SerPl-sCnc,Cystathionine [Moles/volume] in Serum or Plasma,Chem,1606
16263-6,COD Cry Stone Ql IR,Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy,Chem,1607
47387-6,N gonorrhoea DNA Genital Ql PCR,Neisseria gonorrhoeae DNA [Presence] in Genital specimen by Probe & target amplification method,MICRO,1608
698-1,N gonorrhoea XXX Ql Cult,Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture,MICRO,1609
14721-5,Ethylene Glycol SerPl-mCnc,Ethylene glycol [Moles/volume] in Serum or Plasma,DRUG/TOX,1610
7917-8,HIV1 Ab Ser Ql,HIV 1 Ab [Presence] in Serum,MICRO,1611
17122-3,CD19+Kappa+ Cells NFr Bld,CD19+Kappa+ cells/100 cells in Blood,CELLMARK,1612
32786-6,Thyroperoxidase Ab Titr SerPl,Thyroperoxidase Ab [Titer] in Serum or Plasma,SERO,1613
25521-6,Selenium SerPl-mCnc,Selenium [Moles/volume] in Serum or Plasma,DRUG/TOX,1614
6209-1,Pecan/Hick Tree IgE Qn,Pecan or Hickory Tree IgE Ab [Units/volume] in Serum,Allergy,1615
4633-4,Hgb F MFr Bld Kleih Betke,Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method,HEM/BC,1616
4821-5,HLA-B27 Ql,HLA-B27 [Presence],HLA,1617
22203-4,C tetani IgG Ser-aCnc,Clostridium tetani IgG Ab [Units/volume] in Serum,MICRO,1618
6237-2,Salmon IgE Qn,Salmon IgE Ab [Units/volume] in Serum,Allergy,1619
48049-1,Eosinophil Stl Ql Wright Stn,Eosinophils [Presence] in Stool by Wright stain,HEM/BC,1620
5202-7,HSV Ab Ser EIA-aCnc,Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay,MICRO,1621
12308-3,Hydrocodone Ur Ql,Hydrocodone [Presence] in Urine,DRUG/TOX,1622
9834-3,Hydromorphone Ur Ql,Hydromorphone [Presence] in Urine,DRUG/TOX,1623
42192-5,Nidus Stone Ql,Nidus [Presence] in Stone,PATH,1624
70215-9,Oxycodone Ur Cfm-mCnc,Oxycodone [Moles/volume] in Urine by Confirmatory method,DRUG/TOX,1625
30437-8,Monos+Macros NFr Fld,Monocytes+Macrophages/100 leukocytes in Body fluid,HEM/BC,1626
6035-0,Banana IgE Qn,Banana IgE Ab [Units/volume] in Serum,Allergy,1627
19643-6,Oxycodone Ur Ql Cfm,Oxycodone [Presence] in Urine by Confirmatory method,DRUG/TOX,1628
18325-1,Oxymorphone Ur Ql Cfm,Oxymorphone [Presence] in Urine by Confirmatory method,DRUG/TOX,1629
47226-6,FLM Amn-Imp,Fetal lung maturity [interpretation] in Amniotic fluid,Chem,1630
17395-5,Oxymorphone Ur Cfm-mCnc,Oxymorphone [Mass/volume] in Urine by Confirmatory method,DRUG/TOX,1631
19074-4,Carn esters SerPl-sCnc,Carnitine esters [Moles/volume] in Serum or Plasma,Chem,1632
12598-9,Neutral Fat Stl Ql,Fat.neutral [Presence] in Stool,Chem,1633
17123-1,CD19+Lambda+ Cells NFr Bld,CD19+Lambda+ cells/100 cells in Blood,CELLMARK,1634
36922-3,TPMT gene Mut Anal Bld/T,TPMT gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,MOLPATH.MUT,1635
6194-5,Orange IgE Qn,Orange IgE Ab [Units/volume] in Serum,Allergy,1636
5170-6,Gliadin IgG Ser-aCnc,Gliadin IgG Ab [Units/volume] in Serum,SERO,1637
26536-3,Cortis 1H p ACTH SerPl-mCnc,Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin,CHAL,1638
49581-2,Ref Lab Test ID+Name,Reference lab test identifier and name [Identifier],MISC,1639
12210-1,Eosinophil NFr UrnS Manual,Eosinophils/100 leukocytes in Urine sediment by Manual count,UA,1640
7041-7,Penicillin G Islt Grad Strip,Penicillin G [Susceptibility] by Gradient strip,ABXBACT,1641
7042-5,Penicillin V Islt Grad Strip,Penicillin V [Susceptibility] by Gradient strip,ABXBACT,1641
29901-6,HTLV1+2 Ab Ser Ql EIA,HTLV 1+2 Ab [Presence] in Serum by Immunoassay,MICRO,1642
22110-1,B henselae IgG Titr Ser,Bartonella henselae IgG Ab [Titer] in Serum,MICRO,1643
14251-3,Mitochondria M2 IgG Ser-aCnc,Mitochondria M2 IgG Ab [Units/volume] in Serum,SERO,1644
26535-5,Cortis 30M p ACTH SerPl-mCnc,Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin,CHAL,1645
19593-3,6MAM Ur Cfm-mCnc,6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method,DRUG/TOX,1646
70197-9,6MAM Ur Cfm-sCnc,6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method,DRUG/TOX,1646
59417-6,SaO2 Resting % BldA PulseOx,Oxygen saturation in Arterial blood by Pulse oximetry --resting,HEMODYN.MOLEC,1647
59412-7,SaO2 p Exc % BldA PulseOx,Oxygen saturation in Arterial blood by Pulse oximetry --post exercise,HEMODYN.MOLEC,1648
6448-5,L pneumo Ag Ur Ql RIA,Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA),MICRO,1649
6137-4,Hazelnut Poln IgE Qn,Hazelnut Pollen IgE Ab [Units/volume] in Serum,Allergy,1650
5644-0,Ethanol Ur Ql,Ethanol [Presence] in Urine,DRUG/TOX,1651
3093-2,Urea nit Fld-mCnc,Urea nitrogen [Mass/volume] in Body fluid,Chem,1652
14862-7,Oxalate 24H Ur-mRate,Oxalate [Moles/time] in 24 hour Urine,Chem,1653
1007-4,DAT Poly-Sp Reag RBC Ql,Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells,BLDBK,1654
59841-7,Vendor name XXX,Vendor name [Identifier] in Unspecified specimen,Chem,1655
19768-1,Reviewing cytologist,Reviewing cytologist who read Cyto stain of Cervical or vaginal smear or scraping,CYTO,1656
5381-9,Thyroglob Ab Titr Ser LA,Thyroglobulin Ab [Titer] in Serum by Latex agglutination,SERO,1657
808-6,WBC # Plr Manual,Leukocytes [#/volume] in Pleural fluid by Manual count,HEM/BC,1658
25726-1,Oxcarbazepine SerPl-mCnc,Oxcarbazepine [Moles/volume] in Serum or Plasma,DRUG/TOX,1659
14862-7,Oxalate 24H Ur-sRate,Oxalate [Moles/time] in 24 hour Urine,Chem,1660
25835-0,HIV1 RNA SerPl Ql PCR,HIV 1 RNA [Presence] in Serum or Plasma by Probe & target amplification method,MICRO,1661
35051-2,WBC Other # Fld,Leukocytes other [#/volume] in Body fluid,HEM/BC,1662
7893-1,Gliadin Ab Ser-aCnc,Gliadin Ab [Units/volume] in Serum,SERO,1663
15015-1,ALP Liver CFr SerPl,Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma,Chem,1664
33917-6,Nornicotine Ur-mCnc,Nornicotine [Mass/volume] in Urine,DRUG/TOX,1665
15013-6,ALP Bone CFr SerPl,Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma,Chem,1666
24378-2,PA Epineph PRP Ql,Platelet aggregation epinephrine induced [Presence] in Platelet rich plasma,COAG,1667
6062-4,Casein IgE Qn,Casein IgE Ab [Units/volume] in Serum,Allergy,1668
6220-8,Potato IgE Qn,Potato IgE Ab [Units/volume] in Serum,Allergy,1669
6873-4,B-OH-Butyr SerPl-sCnc,Beta hydroxybutyrate [Moles/volume] in Serum or Plasma,Chem,1670
47440-3,HBV core Ab Ser Donr Ql,Hepatitis B virus core Ab [Presence] in Serum from donor,MICRO,1671
44533-8,HIV1+2 Ab Ser Donr Ql,HIV 1+2 Ab [Presence] in Serum from donor,MICRO,1672
44538-7,HTLV1+2 Ab Ser Donr Ql,HTLV 1+2 Ab [Presence] in Serum from donor,MICRO,1673
5877-6,RSV Ag XXX Ql IF,Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence,MICRO,1674
49846-9,HCV Ag Bld/Mar Donr Ql,Hepatitis C virus Ag [Presence] in Blood or Marrow from donor,MICRO,1675
9632-1,A fumigatus Ab Ser Ql,Aspergillus fumigatus Ab [Presence] in Serum,MICRO,1676
2032-1,COHgb MFr BldV,Carboxyhemoglobin/Hemoglobin.total in Venous blood,Chem,1677
71791-8,MetanephS 24H Ur-mCnc,Metanephrines [Moles/volume] in 24 hour Urine,Chem,1678
47364-5,HBV surface Ag Ser Donr Ql EIA,Hepatitis B virus surface Ag [Presence] in Serum from donor by Immunoassay,MICRO,1679
13942-8,Sperm Motile Smn Ql Micro,Spermatozoa Motile [Presence] in Semen by Light microscopy,FERT,1680
22463-4,Reagin Ab Ser Donr Ql,Reagin Ab [Presence] in Serum from donor,MICRO,1681
10622-9,Sperm Norm NFr Smn,Spermatozoa Normal/100 spermatozoa in Semen,FERT,1682
19088-4,Collect Start Date Ur,Collection of urine specimen start date,SPEC,1683
47441-1,HCV Ab Ser Donr Ql,Hepatitis C virus Ab [Presence] in Serum from donor,MICRO,1684
19089-2,Collect Start Tme Ur,Collection of urine specimen start time,SPEC,1685
15174-6,Cryocrit Ser Spun Westergren,Cryocrit of Serum by Spun Westergren,Chem,1686
5000-5,CMV DNA XXX Ql PCR,Cytomegalovirus DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1687
19086-8,Collect End Date Ur,Collection of urine specimen end date,SPEC,1688
19087-6,Collect End Tme Ur,Collection of urine specimen end time,SPEC,1689
7558-0,Oyster IgE Qn,Oyster IgE Ab [Units/volume] in Serum,Allergy,1690
29280-5,D Dimer PPP Ql LA,Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination,COAG,1691
43399-5,JAK2 p.V617F Bld/T Ql,JAK2 gene p.V617F [Presence] in Blood or Tissue by Molecular genetics method,MOLPATH.MUT,1692
13462-7,Apo A-I/Apo B SerPl-mRto,Apolipoprotein A-I/Apolipoprotein B [Mass ratio] in Serum or Plasma,Chem,1693
49295-9,Prot Pattern CSF Elph-Imp,Protein Fractions [interpretation] in Cerebral spinal fluid by Electrophoresis Narrative,Chem,1694
43441-5,Bacteria BAL Aerobe Cult,Bacteria identified in Bronchoalveolar lavage by Aerobe culture,MICRO,1695
21482-5,Prot 24H Ur-mCnc,Protein [Mass/volume] in 24 hour Urine,Chem,1696
2597-3,Magnesium RBC-sCnc,Magnesium [Moles/volume] in Red Blood Cells,Chem,1697
2669-0,Normetanephrine SerPl-mCnc,Normetanephrine [Mass/volume] in Serum or Plasma,Chem,1698
70205-0,Clonazepam SerPl Scn-mCnc,Clonazepam [Moles/volume] in Serum or Plasma by Screen method,DRUG/TOX,1699
25964-8,Normetanephrine 24H Ur-mCnc,Normetanephrine [Moles/volume] in 24 hour Urine,Chem,1700
13327-2,HPIV Ag XXX Ql IF,Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence,MICRO,1701
26517-3,Polys NFr CSF,Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid,HEM/BC,1702
3193-0,Fact V Act/Nor PPP,Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay,COAG,1703
71797-5,ZPP RBC-mCnc,Protoporphyrin.zinc [Moles/volume] in Red Blood Cells,Chem,1704
6367-7,C tetani IgG Ser EIA-aCnc,Clostridium tetani IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,1705
41480-5,BKV DNA # Ur PCR,BK virus DNA [#/volume] (viral load) in Urine by Probe & target amplification method,MICRO,1706
31788-3,C neoform Ag CSF Ql,Cryptococcus sp Ag [Presence] in Cerebral spinal fluid,MICRO,1707
31843-6,H pylori Ag Stl Ql,Helicobacter pylori Ag [Presence] in Stool,MICRO,1708
888-8,Blood group antibodies SerPl,Blood group antibodies identified in Serum or Plasma,BLDBK,1709
25987-9,Testost Free SerPl RIA-sCnc,Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA),Chem,1710
40464-0,Drugs Ur Cfm,Drugs identified in Urine by Confirmatory method,DRUG/TOX,1711
13227-4,C diphtheriae IgG Ser-aCnc,Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum,MICRO,1712
58787-3,C diphtheriae IgG Ser EIA-aCnc,Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,1713
32284-2,BKV DNA SerPl PCR-aCnc,BK virus DNA [Units/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,1714
19287-2,Cannabinoids Tested Ur Scn,Cannabinoids tested for in Urine by Screen method Nominal,DRUG/TOX,1715
17852-5,U urealyticum XXX Ql Cult,Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture,MICRO,1716
6078-0,Roach IgE Qn,Cockroach IgE Ab [Units/volume] in Serum,Allergy,1717
15388-2,M hominis XXX Ql Cult,Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture,MICRO,1718
31036-7,Gatifloxacin Islt MIC,Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC),ABXBACT,1719
23871-7,HCV NS5 Ab Ser Ql IB,Hepatitis C virus NS5 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1720
15917-8,Peanut IgE RAST Ql,Peanut IgE Ab RAST class in Serum,Allergy,1721
9610-7,HCV C33c Ab Ser Ql IB,Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot (IB),MICRO,1722
9609-9,HCV22-3 Ab Ser Ql IB,Hepatitis C virus 22-3 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1723
3187-2,Fact IX Act/Nor PPP,Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay,COAG,1724
43993-5,Age at delivery,Age at delivery,OB.US,1725
23860-0,RBC # Fld Auto,Erythrocytes [#/volume] in Body fluid by Automated count,HEM/BC,1726
3096-5,UUN 24H Ur-mRate,Urea nitrogen [Mass/time] in 24 hour Urine,Chem,1727
6998-9,Ceftriaxone Islt Grad Strip,Ceftriaxone [Susceptibility] by Gradient strip,ABXBACT,1728
25630-5,B19V IgG Titr Ser,Parvovirus B19 IgG Ab [Titer] in Serum,MICRO,1729
15076-3,Glucose Ur-mCnc,Glucose [Moles/volume] in Urine,Chem,1730
19098-3,RBC Amn Ql,Erythrocytes [Presence] in Amniotic fluid,HEM/BC,1731
12229-1,Macrophages NFr CSF Manual,Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count,HEM/BC,1732
20446-1,HSV IgG Ser EIA-Imp,Herpes simplex virus IgG Ab [interpretation] in Serum by Immunoassay,MICRO,1733
6059-0,C albicans IgE Qn,Candida albicans IgE Ab [Units/volume] in Serum,Allergy,1734
13337-1,CD8+HLA-DR+ Cells NFr Bld,CD8+HLA-DR+ cells/100 cells in Blood,CELLMARK,1735
21112-8,Birth Date,Birth date,MISC,1736
25435-9,HSV IgM Ser Ql,Herpes simplex virus IgM Ab [Presence] in Serum,MICRO,1737
49835-2,CD19+IgD+ cells NFr XXX,CD19+IgD+ cells/100 cells in Unspecified specimen,CELLMARK,1738
32632-2,HEXA gene Mut Anal Bld/T,HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,MOLPATH.MUT,1739
70239-9,Testost SerPl DL=1.0 ng/dL-mCnc,Testosterone [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L,Chem,1740
5096-3,C immitis Ab Titr Ser CF,Coccidioides immitis Ab [Titer] in Serum by Complement fixation,MICRO,1741
7774-3,Cow Whey IgE Qn,Cow whey IgE Ab [Units/volume] in Serum,Allergy,1742
5052-6,Aspergillus Ab Ser Ql ID,Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID),MICRO,1743
29675-6,B19V IgG Ser Ql,Parvovirus B19 IgG Ab [Presence] in Serum,MICRO,1744
29660-8,B19V IgG Ser Ql EIA,Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay,MICRO,1745
7981-4,B19V IgM Ser Ql,Parvovirus B19 IgM Ab [Presence] in Serum,MICRO,1746
40658-7,B19V IgM Ser Ql EIA,Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay,MICRO,1747
32147-1,Reducing Subs Ur-mCnc,Reducing substances [Mass/volume] in Urine,UA,1748
22111-9,B henselae IgM Titr Ser,Bartonella henselae IgM Ab [Titer] in Serum,MICRO,1749
22362-8,HTLV1+2 Ab Ser Ql,HTLV 1+2 Ab [Presence] in Serum,MICRO,1750
15093-8,FEP Bld-mCnc,Protoporphyrin Free [Moles/volume] in Blood,Chem,1751
3198-9,Fact VII Act/Nor PPP,Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay,COAG,1752
70240-7,Testost Free SerPl DL=1.0 ng/dL-mCnc,Testosterone Free [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L,Chem,1753
10386-1,Albumin Gvn Vol,Albumin given [Volume],BLDBK,1754
13589-7,aPCR Bld Ql PCR,Activated protein C resistance [Presence] in Blood by Probe & target amplification method,COAG,1755
70214-2,Oxazepam Ur Cfm-mCnc,Oxazepam [Moles/volume] in Urine by Confirmatory method,DRUG/TOX,1756
8087-9,PCA Ab Ser-aCnc,Parietal cell Ab [Units/volume] in Serum,SERO,1757
8220-6,Opiates Ur-mCnc,Opiates [Mass/volume] in Urine,DRUG/TOX,1758
70213-4,Nordiazepam Ur Cfm-mCnc,Nordiazepam [Moles/volume] in Urine by Confirmatory method,DRUG/TOX,1759
23876-6,HIV1 RNA Plas bDNA-aCnc,HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe & signal amplification method,MICRO,1760
42621-3,M hominis DNA Bld Ql PCR,Mycoplasma hominis DNA [Presence] in Blood by Probe & target amplification method,MICRO,1761
4477-6,C1INH SerPl-mCnc,Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma,HEM/BC,1762
6138-2,H halodes IgE Qn,Helminthosporium halodes IgE Ab [Units/volume] in Serum,Allergy,1763
14703-3,Dopamine SerPl-mCnc,Dopamine [Moles/volume] in Serum or Plasma,Chem,1764
6037-6,Barley IgE Qn,Barley IgE Ab [Units/volume] in Serum,Allergy,1765
7632-3,Privet IgE Qn,Privet IgE Ab [Units/volume] in Serum,Allergy,1766
10580-9,Liquefaction Time Smn,Liquefaction [Time] in Semen,FERT,1767
6460-0,Bacteria Spt Cult,Bacteria identified in Sputum by Culture,MICRO,1768
20416-4,HCV RNA # SerPl PCR,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,1769
13941-0,Lymphocytes NFr Fld Manual,Lymphocytes/100 leukocytes in Body fluid by Manual count,HEM/BC,1770
47252-2,HCV RNA SerPl PCR-Log#,Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe & target amplification method,MICRO,1771
41487-0,C parvum Ag Stl Ql EIA,Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay,MICRO,1772
14116-8,IgG Synth Rate Ser+CSF Calc-mRate,IgG synthesis rate [Mass/time] in Serum & CSF by calculation,Chem,1773
29539-4,HIV1 RNA Plas bDNA-Log#,HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe & signal amplification method,MICRO,1774
33630-5,HIV PI gene Mut Det Islt,HIV protease gene mutations detected [Identifier] in Isolate,ABXBACT,1775
21821-4,"t(9,22)(ABL1,BCR) Bld/T Ql","t(9,22)(ABL1,BCR) Translocation [Presence] in Blood or Tissue by Molecular genetics method",MOLPATH.TRNLOC,1776
33893-9,Karyotyp Mar,Karyotype [Identifier] in Bone marrow Nominal,MOLPATH,1777
20398-4,ANA Homogen Titr Ser,Nuclear Ab Pattern Homogenous [Titer] in Serum,SERO,1778
15114-2,Arsenic Bld-mCnc,Arsenic [Moles/volume] in Blood,DRUG/TOX,1779
5234-0,ENA Jo1 Ab Ser Ql EIA,Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay,SERO,1780
16074-7,Walnut IgE RAST Ql,Walnut IgE Ab RAST class in Serum,Allergy,1781
70212-6,Nordiazepam SerPl Scn-mCnc,Nordiazepam [Moles/volume] in Serum or Plasma by Screen method,DRUG/TOX,1782
15014-4,ALP Intest CFr SerPl,Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma,Chem,1783
20431-3,Smear XXX,Microscopic observation [Identifier] in Unspecified specimen by Smear,MICRO,1784
49588-7,1st trimester scn+NT Patient-Imp,First trimester maternal screen with nuchal translucency [interpretation] Narrative,Chem,1785
611-4,Bacteria Fld Cult,Bacteria identified in Body fluid by Culture,MICRO,1786
70211-8,Mycophenolate SerPl-mCnc,Mycophenolate [Moles/volume] in Serum or Plasma,DRUG/TOX,1787
31112-6,Retics/100 RBC NFr Manual,Reticulocytes/100 erythrocytes in Blood by Manual,HEM/BC,1788
25418-5,MuV IgG Ser EIA-aCnc,Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,1789
65757-7,Kidney Path Bx report,Pathology biopsy report in Kidney Narrative,PATH,1790
65752-8,Liver Path Bx report,Pathology biopsy report in Liver Narrative,PATH,1791
65751-0,Muscle Path Bx report,Pathology biopsy report in Muscle Narrative,PATH,1792
65754-4,Skin Path Bx report,Pathology biopsy report in Skin Narrative,PATH,1793
15058-1,Dopamine Ur-mCnc,Dopamine [Moles/volume] in Urine,Chem,1794
24521-7,Epineph Ur-mCnc,Epinephrine [Moles/volume] in Urine,Chem,1795
14853-6,Norepineph Ur-mCnc,Norepinephrine [Moles/volume] in Urine,Chem,1796
25383-1,Cow Milk IgE RAST Ql,Cow milk IgE Ab RAST class in Serum,Allergy,1797
6234-9,Saltwort IgE Qn,Saltwort IgE Ab [Units/volume] in Serum,Allergy,1798
3786-1,Methaqualone Ur Ql,Methaqualone [Presence] in Urine,DRUG/TOX,1799
11060-1,Reducing Subs Stl Ql,Reducing substances [Presence] in Stool,Chem,1800
20469-3,Acetone SerPl Ql Scn,Acetone [Presence] in Serum or Plasma by Screen method,DRUG/TOX,1801
50970-3,XXX blood group Ab Titr SerPl AHG,XXX blood group Ab [Titer] in Serum or Plasma by Antihuman globulin,BLDBK,1802
22315-6,HAV IgM Ser-aCnc,Hepatitis A virus IgM Ab [Units/volume] in Serum,MICRO,1803
17713-9,Topiramate SerPl-mCnc,Topiramate [Mass/volume] in Serum or Plasma,DRUG/TOX,1804
19125-4,Meconium Amn Ql,Meconium [Presence] in Amniotic fluid,Chem,1805
49578-8,Amicaproate CtO SerPl-mCnc,Aminocaproate cutoff [Mass/volume] in Serum or Plasma,DRUG/TOX,1806
2749-0,pH Gast,pH of Gastric fluid,Chem,1807
11559-2,OxyHgb MFr Bld,Fractional oxyhemoglobin in Blood,Chem,1808
7415-3,C sphaerospermum IgE Qn,Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum,Allergy,1809
34696-5,Collection meth0d Smn,Collection method [Type] of Semen,SPEC,1810
7901-2,H pylori IgA Ser-aCnc,Helicobacter pylori IgA Ab [Units/volume] in Serum,MICRO,1811
49700-8,Metaneph Free SerPl-mCnc,Metanephrine Free [Moles/volume] in Serum or Plasma,Chem,1812
13627-5,RBC Smn Ql Micro,Erythrocytes [Presence] in Semen by Light microscopy,FERT,1813
15192-8,Variant Lymphs Bld Ql Auto,Lymphocytes Variant [Presence] in Blood by Automated count,HEM/BC,1814
2030-5,COHgb MFr BldA,Carboxyhemoglobin/Hemoglobin.total in Arterial blood,Chem,1815
11034-6,AChR Bind Ab Ser-sCnc,Acetylcholine receptor binding Ab [Moles/volume] in Serum,SERO,1816
5838-8,CMV XXX Ql Cult,Cytomegalovirus [Presence] in Unspecified specimen by Organism specific culture,MICRO,1817
24312-1,T pallidum Ab Ser Ql Aggl,Treponema pallidum Ab [Presence] in Serum by Agglutination,MICRO,1818
70198-7,Acetamin SerPl Scn-mCnc,Acetaminophen [Moles/volume] in Serum or Plasma by Screen method,DRUG/TOX,1819
550-4,B pert Ag XXX Ql IF,Bordetella pertussis Ag [Presence] in Unspecified specimen by Immunofluorescence,MICRO,1820
25148-8,CaOx Cry #/area UrnS HPF,Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field,UA,1821
14117-6,IgG index Ser+CSF,IgG index in Serum & CSF,Chem,1822
26509-0,Neuts Band NFr CSF,Neutrophils.band form/100 leukocytes in Cerebral spinal fluid,HEM/BC,1823
12209-3,Eosinophil NFr Fld Manual,Eosinophils/100 leukocytes in Body fluid by Manual count,HEM/BC,1824
666-8,India Ink Prep XXX,Microscopic observation [Identifier] in Unspecified specimen by India ink prep,MICRO,1825
12215-0,VLCFA SerPl-sCnc,Fatty acids.very long chain [Moles/volume] in Serum or Plasma,Chem,1826
19734-3,Chicken Drop IgE Qn,Chicken droppings IgE Ab [Units/volume] in Serum,Allergy,1827
2638-5,MBP CSF-mCnc,Myelin basic protein [Mass/volume] in Cerebral spinal fluid,Chem,1828
14875-9,Phe SerPl-sCnc,Phenylalanine [Moles/volume] in Serum or Plasma,Chem,1829
20643-3,Glutamine SerPl-sCnc,Glutamine [Moles/volume] in Serum or Plasma,Chem,1830
20636-7,Alanine SerPl-sCnc,Alanine [Moles/volume] in Serum or Plasma,Chem,1831
5005-4,EBV DNA XXX Ql PCR,Epstein Barr virus DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1832
25473-0,Metaneph SerPl-sCnc,Metanephrine [Moles/volume] in Serum or Plasma,Chem,1833
20661-5,Valine SerPl-sCnc,Valine [Moles/volume] in Serum or Plasma,Chem,1834
3861-2,Nordiazepam Ur Ql,Nordiazepam [Presence] in Urine,DRUG/TOX,1835
12361-2,Oxazepam Ur Ql,Oxazepam [Presence] in Urine,DRUG/TOX,1836
15097-9,VMA Ur-mCnc,Vanillylmandelate [Moles/volume] in Urine,Chem,1837
14121-8,Pyruvate Bld-sCnc,Pyruvate [Moles/volume] in Blood,Chem,1838
46268-9,ABO+Rh Gp p transf rx Bld BPU,ABO & Rh group [Type] in Blood from Blood product unit--after transfusion reaction,BLDBK,1839
3436-3,CarboxyTHC Ur-mCnc,Carboxy tetrahydrocannabinol [Mass/volume] in Urine,DRUG/TOX,1840
41163-7,T pallidum DNA XXX Ql PCR,Treponema pallidum DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1841
20648-2,Isoleucine SerPl-sCnc,Isoleucine [Moles/volume] in Serum or Plasma,Chem,1842
20649-0,Leucine SerPl-sCnc,Leucine [Moles/volume] in Serum or Plasma,Chem,1843
24139-8,Roach IgG Qn,Cockroach IgG Ab [Units/volume] in Serum,Allergy,1844
11183-1,Macadamia IgE Qn,Macadamia IgE Ab [Units/volume] in Serum,Allergy,1845
44607-0,HIV1 Ser EIA-Imp,HIV 1 [interpretation] in Serum by Immunoassay,MICRO,1846
8015-0,RUBV IgM Ser-aCnc,Rubella virus IgM Ab [Units/volume] in Serum,MICRO,1847
6239-8,Lenscale IgE Qn,Lenscale IgE Ab [Units/volume] in Serum,Allergy,1848
5116-9,C diphtheriae Ab Ser EIA-aCnc,Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay,MICRO,1849
1777-2,ALP Bone SerPl-cCnc,Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma,Chem,1850
22568-0,ASO Ab Titr Ser,Streptolysin O Ab [Titer] in Serum,MICRO,1851
13538-4,CO2 Ur-sCnc,"Carbon dioxide, total [Moles/volume] in Urine",Chem,1852
14976-5,Lecithin/Sphingomyelin Amn-Rto,Lecithin/Sphingomyelin [Ratio] in Amniotic fluid,Chem,1853
19201-3,PSA Free SerPl-aCnc,Prostate Specific Ag Free [Units/volume] in Serum or Plasma,Chem,1854
18482-0,Yeast XXX Ql Cult,Yeast [Presence] in Unspecified specimen by Organism specific culture,MICRO,1855
32789-0,Visc Smn Ql,Viscosity of Semen Qualitative,SPEC,1856
7445-0,A-Lactalb IgE Qn,Lactalbumin alpha IgE Ab [Units/volume] in Serum,Allergy,1857
35670-9,Tobramycin SerPl-mCnc,Tobramycin [Mass/volume] in Serum or Plasma,DRUG/TOX,1858
50927-3,Tobramycin SerPl-sCnc,Tobramycin [Moles/volume] in Serum or Plasma,DRUG/TOX,1858
17819-4,Albumin ?Tm MFr Ur Elph,Albumin/Protein.total in unspecified time Urine by Electrophoresis,Chem,1859
17811-1,Alpha1 Glob ?Tm MFr Ur Elph,Alpha 1 globulin/Protein.total in unspecified time Urine by Electrophoresis,Chem,1860
17813-7,Alpha2 Glob ?Tm MFr Ur Elph,Alpha 2 globulin/Protein.total in unspecified time Urine by Electrophoresis,Chem,1861
17815-2,B-Globulin ?Tm MFr Ur Elph,Beta globulin/Protein.total in unspecified time Urine by Electrophoresis,Chem,1862
17817-8,Gamma glob ?Tm MFr Ur Elph,Gamma globulin/Protein.total in unspecified time Urine by Electrophoresis,Chem,1863
21027-8,PA PPP-Imp,Platelet aggregation [interpretation] in Platelet poor plasma,COAG,1864
13088-0,CH100 SerPl-aCnc,Complement total hemolytic CH100 [Units/volume] in Serum or Plasma,HEM/BC,1865
34165-1,Imm Granulocytes Bld Ql Auto,Granulocytes Immature [Presence] in Blood by Automated count,HEM/BC,1866
8072-1,Insulin Ab Ser-aCnc,Insulin Ab [Units/volume] in Serum,SERO,1867
20660-7,Tyrosine SerPl-sCnc,Tyrosine [Moles/volume] in Serum or Plasma,Chem,1868
20401-6,ANA Speckled Titr Ser,Nuclear Ab pattern.speckled [Titer] in Serum,SERO,1869
533-0,Mycobacterium Bld Cult,Mycobacterium sp identified in Blood by Organism specific culture,MICRO,1870
20651-6,Methionine SerPl-sCnc,Methionine [Moles/volume] in Serum or Plasma,Chem,1871
9360-9,B quintana IgG Titr Ser,Bartonella quintana IgG Ab [Titer] in Serum,MICRO,1872
23870-9,HCV100+5-1-1 Ab Ser Ql IB,Hepatitis C virus 100+5-1-1 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1873
59408-5,SaO2 % BldA PulseOx,Oxygen saturation in Arterial blood by Pulse oximetry,HEMODYN.MOLEC,1874
14678-7,Cortis PM SerPl-mCnc,Cortisol [Moles/volume] in Serum or Plasma --evening specimen,Chem,1875
15086-2,Oxalate Ur-mCnc,Oxalate [Moles/volume] in Urine,Chem,1876
4991-6,B burgdor DNA XXX Ql PCR,Borrelia burgdorferi DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1877
22070-7,HP gene Mut Anal Bld/T,HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,MOLPATH.MUT,1878
6286-9,Wormwood IgE Qn,Wormwood IgE Ab [Units/volume] in Serum,Allergy,1879
32220-6,L/K Microsom1 Ab Ser-aCnc,Liver kidney microsomal 1 Ab [Units/volume] in Serum,SERO,1880
9326-0,PS IgG Ser Ql IA,Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay,COAG,1881
9361-7,B quintana IgM Titr Ser,Bartonella quintana IgM Ab [Titer] in Serum,MICRO,1882
20637-5,Arginine SerPl-sCnc,Arginine [Moles/volume] in Serum or Plasma,Chem,1883
20640-9,Citrulline SerPl-sCnc,Citrulline [Moles/volume] in Serum or Plasma,Chem,1884
20644-1,Glycine SerPl-sCnc,Glycine [Moles/volume] in Serum or Plasma,Chem,1885
20656-5,Serine SerPl-sCnc,Serine [Moles/volume] in Serum or Plasma,Chem,1886
20658-1,Threonine SerPl-sCnc,Threonine [Moles/volume] in Serum or Plasma,Chem,1887
20657-3,Taurine SerPl-sCnc,Taurine [Moles/volume] in Serum or Plasma,Chem,1888
6029-3,A pullulans IgE Qn,Aureobasidium pullulans IgE Ab [Units/volume] in Serum,Allergy,1889
20642-5,Glutamate SerPl-sCnc,Glutamate [Moles/volume] in Serum or Plasma,Chem,1890
20645-8,Histidine SerPl-sCnc,Histidine [Moles/volume] in Serum or Plasma,Chem,1891
20655-7,Proline SerPl-sCnc,Proline [Moles/volume] in Serum or Plasma,Chem,1892
18903-5,Chloramphen Susc Islt,Chloramphenicol [Susceptibility],ABXBACT,1893
17788-1,LUC NFr Bld Auto,Large unstained cells/100 leukocytes in Blood by Automated count,HEM/BC,1894
14246-3,PS IgM Ser-aCnc,Phosphatidylserine IgM Ab [Units/volume] in Serum,COAG,1895
3218-5,Fact X Act/Nor PPP,Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay,COAG,1896
49058-1,aPTT Time BldCRRT,Activated partial thromboplastin time (aPTT) in Blood drawn from CRRT circuit by Coagulation assay,COAG,1897
6061-6,Carrot IgE Qn,Carrot IgE Ab [Units/volume] in Serum,Allergy,1898
20781-1,Cryptosp Stl Ql Acid fast Stn,Cryptosporidium sp [Presence] in Stool by Acid fast stain,MICRO,1899
32217-2,vWF multimers PPP Ql,von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma,COAG,1900
22412-1,S rectivirgula Ab Ser Ql,Saccharopolyspora rectivirgula Ab [Presence] in Serum,MICRO,1901
20652-4,Ornithine SerPl-sCnc,Ornithine [Moles/volume] in Serum or Plasma,Chem,1902
6733-0,Pigeon Serum Ab Ql ID,Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID),Allergy,1903
20650-8,Lysine SerPl-sCnc,Lysine [Moles/volume] in Serum or Plasma,Chem,1904
10853-0,I belli XXX Ql Acid fast Mod Kiny Stn,Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified,MICRO,1905
5869-3,HPIV1 Ag XXX Ql IF,Parainfluenza virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence,MICRO,1906
7059-9,Vancomycin Islt Grad Strip,Vancomycin [Susceptibility] by Gradient strip,ABXBACT,1907
15050-8,Creat Amn-mCnc,Creatinine [Moles/volume] in Amniotic fluid,Chem,1908
29767-1,Bilirub Fld-mCnc,Bilirubin.total [Moles/volume] in Body fluid,Chem,1909
20638-3,Asparagine SerPl-sCnc,Asparagine [Moles/volume] in Serum or Plasma,Chem,1910
12201-0,Cryoglob Ser Ql 1D Cold Inc,Cryoglobulin [Presence] in Serum by 1 day cold incubation,Chem,1911
20499-0,PG MFr Amn,Phosphatidylglycerol/Surfactant.total in Amniotic fluid,Chem,1912
50758-2,HSV1 IgM Titr Ser IF,Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence,MICRO,1913
26927-4,HSV2 IgM Titr Ser IF,Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence,MICRO,1914
16195-0,Benzodiaz Ur Ql Cfm,Benzodiazepines [Presence] in Urine by Confirmatory method,DRUG/TOX,1915
6081-4,Coconut IgE Qn,Coconut IgE Ab [Units/volume] in Serum,Allergy,1916
721-1,Hgb Free Plas-mCnc,Free Hemoglobin [Mass/volume] in Plasma,HEM/BC,1917
31209-0,Islet Cell512 Ab Ser-aCnc,Islet cell 512 Ab [Units/volume] in Serum,SERO,1918
1779-8,ALP Liver SerPl-cCnc,Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma,Chem,1919
2334-1,Gastrocult Gast Ql,Hemoglobin.gastrointestinal [Presence] in Gastric fluid,Chem,1920
16085-3,Wheat IgE RAST Ql,Wheat IgE Ab RAST class in Serum,Allergy,1921
29591-5,EV RNA XXX Ql PCR,Enterovirus RNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1922
24103-4,Plasma Cells # Bld Manual,Plasma cells [#/volume] in Blood by Manual count,HEM/BC,1923
6038-4,Amer Beech IgE Qn,American Beech IgE Ab [Units/volume] in Serum,Allergy,1924
38168-1,Maj XM SerPl LISS-Imp,Major crossmatch [interpretation] by Low ionic strenght saline (LISS),BLDBK,1925
51844-9,Cortis Sal-mCnc,Cortisol [Moles/volume] in Saliva,Chem,1926
15568-9,Soybean IgE RAST Ql,Soybean IgE Ab RAST class in Serum,Allergy,1927
43734-3,aPTT PPP 1:1 saline,aPTT in Platelet poor plasma by Coagulation 1:1 saline,COAG,1928
75513-2,Mixing dRVVT,dRVVT with 1:1 PNP (LA mix),COAG,1929
16982-1,HTLV1+2 Ab Ser Ql IB,HTLV 1+2 Ab [Presence] in Serum by Immunoblot (IB),MICRO,1930
20420-6,PACP Ser-mCnc,Prostatic acid phosphatase [Mass/volume] in Serum,Chem,1931
6125-9,Gluten IgE Qn,Gluten IgE Ab [Units/volume] in Serum,Allergy,1932
30374-3,Basophils NFr CSF,Basophils/100 leukocytes in Cerebral spinal fluid,HEM/BC,1933
14812-2,Lidocain SerPl-mCnc,Lidocaine [Moles/volume] in Serum or Plasma,DRUG/TOX,1934
10526-2,Cyto Spt,Microscopic observation [Identifier] in Sputum by Cyto stain,CYTO,1935
7796-6,Platelet Clump Bld Ql Smear,Platelet clump [Presence] in Blood by Light microscopy,HEM/BC,1936
5959-2,PT imm NP PPP,Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma,COAG,1937
29559-2,H ducreyi DNA XXX Ql PCR,Haemophilus ducreyi DNA [Presence] in Unspecified specimen by Probe & target amplification method,MICRO,1938
18743-5,Autopsy report,Autopsy report,ATTACH.CLINRPT,1939
25447-4,Insulin Free SerPl-aCnc,Insulin Free [Moles/volume] in Serum or Plasma,Chem,1940
6121-8,F moniliforme IgE Qn,Fusarium moniliforme IgE Ab [Units/volume] in Serum,Allergy,1941
49838-6,Neural tube defect risk pop,Neural tube defect risk in population,Chem,1942
6090-5,Cottonwood IgE Qn,Cottonwood IgE Ab [Units/volume] in Serum,Allergy,1943
30192-9,AChR Mod Ab/AChR Total SFr Ser,Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum,SERO,1944
6287-7,Baker's yeast IgE Qn,Baker's yeast IgE Ab [Units/volume] in Serum,Allergy,1945
6349-5,C trach XXX Ql Cult,Chlamydia trachomatis [Presence] in Unspecified specimen by Organism specific culture,MICRO,1946
4635-9,Hgb Free Ser-mCnc,Free Hemoglobin [Mass/volume] in Serum,HEM/BC,1947
46128-5,tTG IgA Ser EIA-aCnc,Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay,SERO,1948
2711-0,SaO2% BldV,Oxygen saturation in Venous blood,HEMODYN.MOLEC,1949
7797-4,Rouleaux Bld Ql Smear,Rouleaux [Presence] in Blood by Light microscopy,HEM/BC,1950
8277-6,BSA,Body surface area,BDYSURF.ATOM,1951
765-8,Neuts Hyperseg Bld Ql Smear,Neutrophils.hypersegmented [Presence] in Blood by Light microscopy,HEM/BC,1952
1926-5,Base excess BldC Calc-sCnc,Base excess in Capillary blood,Chem,1953
7795-8,Pappenheimer Bod Bld Ql Smear,Pappenheimer bodies [Presence] in Blood by Light microscopy,HEM/BC,1954
20456-0,Yeast Like Fungi UrnS Ql Micro,Fungi.yeastlike [Presence] in Urine sediment by Light microscopy,UA,1955
2716-9,OxyHgb MFr BldV,Fractional oxyhemoglobin in Venous blood,Chem,1956
5819-8,Waxy Casts #/area UrnS LPF,Waxy casts [#/area] in Urine sediment by Microscopy low power field,UA,1957
5807-3,RBC Casts #/area UrnS LPF,RBC casts [#/area] in Urine sediment by Microscopy low power field,UA,1958
38995-7,Mixed Cell Casts #/area UrnS LPF,Mixed cellular casts [#/area] in Urine sediment by Microscopy low power field,UA,1959
46138-4,Urate Cry #/area UrnS HPF,Urate crystals [#/area] in Urine sediment by Microscopy high power field,UA,1960
5335-5,RUBV IgM Ser EIA-aCnc,Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay,MICRO,1961
25154-6,Unident Crys #/area UrnS HPF,Unidentified crystals [#/area] in Urine sediment by Microscopy high power field,UA,1962
33215-5,Agran Neuts Bld Ql Smear,Neutrophils.agranular [Presence] in Blood by Light microscopy,HEM/BC,1963
5788-5,Oval fat bodies #/area UrnS HPF,Oval fat bodies (globules) [#/area] in Urine sediment by Microscopy high power field,UA,1964
2272-3,Fat Ur Ql,Fat [Presence] in Urine,Chem,1965
10380-4,Stomatocytes Bld Ql Smear,Stomatocytes [Presence] in Blood by Light microscopy,HEM/BC,1966
7817-0,B burgdor IgG Ser-aCnc,Borrelia burgdorferi IgG Ab [Units/volume] in Serum,MICRO,1967
5062-5,B burgdor IgG Ser EIA-aCnc,Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay,MICRO,1968
5786-9,Epith Casts #/area UrnS LPF,Epithelial casts [#/area] in Urine sediment by Microscopy low power field,UA,1969
33216-3,Agran Platelets Bld Ql Smear,Platelets agranular [Presence] in Blood by Light microscopy,HEM/BC,1970
18311-1,Pelger Huet Cells Bld Ql Smear,Pelger Huet cells [Presence] in Blood by Light microscopy,HEM/BC,1971
11281-3,Auer Bodies Bld Ql Smear,Auer rods [Presence] in Blood by Light microscopy,HEM/BC,1972
30003-8,Microalbumin 24H Ur-mCnc,Microalbumin [Mass/volume] in 24 hour Urine,Chem,1973
5784-4,Cystine Cry UrnS Ql Micro,Cystine crystals [Presence] in Urine sediment by Light microscopy,UA,1974
5775-2,Ca Phos Cry UrnS Ql Micro,Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy,UA,1975
5789-3,Fatty Casts #/area UrnS LPF,Fatty casts [#/area] in Urine sediment by Microscopy low power field,UA,1976
5773-7,Ca Carbonate Cry UrnS Ql Micro,Calcium carbonate crystals [Presence] in Urine sediment by Light microscopy,UA,1977
25886-3,Creat 24H Ur-mCnc,Creatinine [Moles/volume] in 24 hour Urine,Chem,1978
14958-3,Microalbumin/Creat 24H Ur-mRto,Microalbumin/Creatinine [Mass ratio] in 24 hour Urine,Chem,1979
33647-9,M Protein MFr SerPl Elph,Protein.monoclonal/Protein.total in Serum or Plasma by Electrophoresis,Chem,1980
716-1,Heinz Bod Bld Ql Smear,Heinz bodies [Presence] in Blood by Light microscopy,HEM/BC,1981
5798-4,Leucine Cry UrnS Ql Micro,Leucine crystals [Presence] in Urine sediment by Light microscopy,UA,1982
2027-1,CO2 BldV-sCnc,"Carbon dioxide, total [Moles/volume] in Venous blood",Chem,1983
5815-6,Tyrosine Cry UrnS Ql Micro,Tyrosine crystals [Presence] in Urine sediment by Light microscopy,UA,1984
5766-1,Amm Urate Cry UrnS Ql Micro,Ammonium urate crystals [Presence] in Urine sediment by Light microscopy,UA,1985
30350-3,Hgb BldV-mCnc,Hemoglobin [Mass/volume] in Venous blood,HEM/BC,1986
27200-5,ANA Ser-aCnc,Nuclear Ab [Units/volume] in Serum,SERO,1987
25149-6,Ca Phos Cry #/area UrnS HPF,Calcium phosphate crystals [#/area] in Urine sediment by Microscopy high power field,UA,1988
25158-7,Oval fat bodies UrnS Ql Micro,Oval fat bodies (globules) [Presence] in Urine sediment by Light microscopy,UA,1989
18487-9,Broad Casts #/area UrnS LPF,Broad casts [#/area] in Urine sediment by Microscopy low power field,UA,1990
24015-0,FLUAV+FLUBV Ag XXX Ql,Influenza virus A+B Ag [Presence] in Unspecified specimen,MICRO,1991
6437-8,FLUAV+FLUBV Ag XXX Ql EIA,Influenza virus A+B Ag [Presence] in Unspecified specimen by Immunoassay,MICRO,1992
20457-8,Filament Fungi UrnS Ql Micro,Fungi.filamentous [Presence] in Urine sediment by Light microscopy,UA,1993
5812-3,Sulfonamide cry UrnS Ql Micro,Sulfonamide crystals [Presence] in Urine sediment by Light microscopy,UA,1994
5771-1,Bilirub Cry UrnS Ql Micro,Bilirubin crystals [Presence] in Urine sediment by Light microscopy,UA,1995
25147-0,Ca Carbonate Cry #/area UrnS HPF,Calcium carbonate crystals [#/area] in Urine sediment by Microscopy high power field,UA,1996
40729-6,HSV IgM Ser Ql EIA,Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay,MICRO,1997
53835-5,"1,5-Anhydroglucitol SerPl-mCnc","1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma",Chem,1998
5777-8,Cholest Cry UrnS Ql Micro,Cholesterol crystals [Presence] in Urine sediment by Light microscopy,UA,1999
20455-2,WBC UrnS Ql Micro,Leukocytes [Presence] in Urine sediment by Light microscopy,UA,2000
45068-4,C trach+GC DNA Cvx Ql PCR,Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by Probe and target amplification method,MICRO,2001
33905-1,Trichomonas #/area UrnS HPF,Trichomonas sp [#/area] in Urine sediment by Microscopy high power field,UA,2001
30394-1,Granulocytes # Bld,Granulocytes [#/volume] in Blood,HEM/BC,2002
5795-0,Hippurate Cry UrnS Ql Micro,Hippurate crystals [Presence] in Urine sediment by Light microscopy,UA,2003
18312-9,Platelet Satel Bld Ql Smear,Platelet satellitism [Presence] in Blood by Light microscopy,HEM/BC,2004
5776-0,Ca Sulfate Cry UrnS Ql Micro,Calcium sulfate crystals [Presence] in Urine sediment by Light microscopy,UA,2005
27071-0,CD45 Cells # Bld,CD45 cells [#/volume] in Blood,CELLMARK,2006
11043-7,Cryofib Plas Ql,Cryofibrinogen [Presence] in Plasma,Chem,2007
32033-3,PS IgM Ser IA-aCnc,Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay,COAG,2008
20578-1,Vancomycin SerPl-mCnc,Vancomycin [Mass/volume] in Serum or Plasma,DRUG/TOX,2009
31012-8,Vancomycin SerPl-sCnc,Vancomycin [Moles/volume] in Serum or Plasma,DRUG/TOX,2009
33256-9,WBC nRBC cor # Bld Auto,Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood by Automated count,HEM/BC,2010
708-8,Blasts # Bld Manual,Blasts [#/volume] in Blood by Manual count,HEM/BC,2011
18309-5,nRBC/100 WBC Bld Manual-Rto,Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count,HEM/BC,2012
5156-5,EBV NA IgG Ser Ql EIA,Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay,MICRO,2013
51928-0,ENA RNP Ab Ser EIA-aCnc,Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay,SERO,2014
33569-5,ENA SS-A Ab Ser EIA-aCnc,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay,SERO,2015
45142-7,ENA SS-B Ab Ser EIA-aCnc,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay,SERO,2016
43182-5,ENA SM Ab Ser EIA-aCnc,Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay,SERO,2017
53348-9,11DOC DBS-sCnc,11-Deoxycorticosterone [Moles/volume] in Dried blood spot,Chem,3000
53339-8,11DC DBS-sCnc,11-Deoxycortisol [Moles/volume] in Dried blood spot,Chem,3000
32854-2,17OHP DBS Ql,17-Hydroxyprogesterone [Presence] in Dried blood spot,CHEM,3000
38473-5,17OHP DBS-mCnc,17-Hydroxyprogesterone [Mass/volume] in Dried blood spot,Chem,3000
53337-2,17OHCS+Androst/Cortis DBS-sRto,17-Hydroxyprogesterone+Androstenedione/Cortisol [Molar Ratio] in Dried blood spot,Chem,3000
53342-2,21DC DBS-sCnc,21-Deoxycortisol [Moles/volume] in Dried blood spot,Chem,3000
53182-2,3-OH-decenoylcarn DBS-sCnc,3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Dried blood spot,Chem,3000
53189-7,3OH-Dodecanoylcarn DBS-sCnc,3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Dried blood spot,Chem,3000
53188-9,3-OH-dodecenoylcarn DBS-sCnc,3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Dried blood spot,Chem,3000
50106-4,3OH-Isovalerylcarn DBS-sCnc,3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Dried blood spot,Chem,3000
53171-5,3OH-Isovalerylcarn/C0 DBS-sRto,3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in Dried blood spot,Chem,3000
53172-3,3OH-Isovalerylcarn/C8 DBS-sRto,3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot,Chem,3000
50109-8,3OH-Linoleoylcarn DBS-sCnc,3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Dried blood spot,Chem,3000
50113-0,3OH-Oleoylcarn DBS-sCnc,3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Dried blood spot,Chem,3000
50121-3,3OH-Palmitoleylcarn DBS-sCnc,3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Dried blood spot,Chem,3000
50125-4,3OH-Palmitoylcarn DBS-sCnc,3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Dried blood spot,Chem,3000
53201-0,3OH-Palmitoylcarn/C16 DBS-sRto,3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Chem,3000
50132-0,3OH-stearoylcarn DBS-sCnc,3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Dried blood spot,Chem,3000
53196-2,3OH-Tdecadienoylcar DBS-sCnc,3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in Dried blood spot,Chem,3000
50281-5,3OH-Tdecanoylcarn DBS-sCnc,3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Dried blood spot,Chem,3000
53197-0,3OH-Tdecenoylcarn DBS-sCnc,3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Dried blood spot,Chem,3000
50157-7,Acetylcarn DBS-sCnc,Acetylcarnitine (C2) [Moles/volume] in Dried blood spot,Chem,3000
53152-5,Aile+Ile+Leu+Hyp DBS-sCnc,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in Dried blood spot,Chem,3000
53154-1,Aile+Ile+Leu+Hyp/Alanine DBS-sRto,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in Dried blood spot,Chem,3000
53153-3,Aile+Ile+Leu+Hyp/Phe DBS-sRto,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in Dried blood spot,Chem,3000
53393-5,Aile+Ile+Leu+Hyp+Val/Phe+Tyr DBS-sRto,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine [Molar ratio] in Dried blood spot,Chem,3000
46733-2,Amino acidemias DBS-Imp,Amino acidemias newborn screen interpretation,Chem,3000
53344-8,Androst DBS-sCnc,Androstenedione [Moles/volume] in Dried blood spot,Chem,3000
47562-4,Arginine DBS-sCnc,Arginine [Moles/volume] in Dried blood spot,Chem,3000
53398-4,Arginine/Phe DBS-sRto,Arginine/Phenylalanine [Molar ratio] in Dried blood spot,Chem,3000
53062-6,Argininosuccinate DBS-sCnc,Argininosuccinate [Moles/volume] in Dried blood spot,Chem,3000
53200-2,Argininosuccinate/Arginine DBS-sRto,Argininosuccinate/Arginine [Molar ratio] in Dried blood spot,Chem,3000
38478-4,Biotinidase DBS Ql,Biotinidase [Presence] in Dried blood spot,Chem,3000
75217-0,Biotinidase DBS-cCnc,Biotinidase [Enzymatic activity/volume] in Dried blood spot,Chem,3000
38479-2,BCKAD DBS Ql,Branched chain keto-acid dehydrogenase complex [Presence] in Dried blood spot,Chem,3000
38481-8,Carnitine Free DBS-sCnc,Carnitine free (C0) [Moles/volume] in Dried blood spot,Chem,3000
53236-6,C0+C2+C3+C16+C18/Cit DBS-sRto,Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in Dried blood spot,Chem,3000
73700-7,CCHD NBS interp,CCHD newborn screening interpretation,Chem,3000
73697-5,CCHD NBS used Patient,CCHD newborn screening protocol used [Type],Chem,3000
54083-1,CFTR Mut Anal DBS,CFTR gene mutations found [Identifier] in Dried blood spot Nominal,Chem,3000
14463-4,C trach Cvx Ql Cult,Chlamydia trachomatis [Presence] in Cervix by Organism specific culture,MICRO,3000
14464-2,C trach Vag Ql Cult,Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture,MICRO,3000
14465-9,C trach Urth Ql Cult,Chlamydia trachomatis [Presence] in Urethra by Organism specific culture,MICRO,3000
45094-0,C trach Conjunct Ql Cult,Chlamydia trachomatis [Presence] in Conjunctival specimen by Organism specific culture,MICRO,3000
80367-6,C trach Rectum Ql Cult,Chlamydia trachomatis [Presence] in Rectum by Organism specific culture,MICRO,3000
70164-9,C trach+GC pnl Vag PCR,Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by Probe and target amplification method,PANEL.MICRO,3000
6351-1,C trach Ag Conjunct Ql IF,Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunofluorescence,MICRO,3000
45084-1,C trach DNA Vag Ql PCR,Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Vaginal fluid by Probe and target amplification method,MICRO,3000
45086-6,C trach DNA Nph Ql PCR,Chlamydia trachomatis DNA [Presence] in Nasopharynx by Probe and target amplification method,MICRO,3000
80363-5,C trach DNA Rectum Ql PCR,Chlamydia trachomatis DNA [Presence] in Rectum by Probe and target amplification method,MICRO,3000
53926-2,C trach rRNA Vag Ql PCR,Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by Probe and target amplification method,MICRO,3000
57288-3,C trach rRNA Nph Ql PCR,Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe and target amplification method,MICRO,3000
80364-3,C trach rRNA Rectum Ql PCR,Chlamydia trachomatis rRNA [Presence] in Rectum by Probe and target amplification method,MICRO,3000
80360-1,C trach+GC rRNA Ur Ql PCR,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe and target amplification method,MICRO,3000
80361-9,C trach+GC rRNA Cvx Ql PCR,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe and target amplification method,MICRO,3000
80362-7,C trach+GC rRNA Vag Ql PCR,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe and target amplification method,MICRO,3000
80365-0,C trach+GC rRNA Rectum Ql PCR,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Rectum by Probe and target amplification method,MICRO,3000
2077-6,Chloride Sweat-sCnc,Chloride [Moles/volume] in Sweat,Chem,3000
42892-0,Citrulline DBS-sCnc,Citrulline [Moles/volume] in Dried blood spot,Chem,3000
54092-2,Citrulline/Arginine DBS-sRto,Citrulline/Arginine [Molar ratio] in Dried blood spot,Chem,3000
53157-4,Citrulline/Phe DBS-sRto,Citrulline/Phenylalanine [Molar ratio] in Dried blood spot,Chem,3000
53399-2,Citrulline/Tyr DBS-sRto,Citrulline/Tyrosine [Molar ratio] in Dried blood spot,Chem,3000
57838-5,Confirm dRVVT,dRVVT W excess phospholipid (LA confirm),COAG,3000
68916-6,Confirm dRVVT/normal,dRVVT W excess phospholipid actual/?normal (normalized LA confirm),COAG,3000
50410-0,dRVVT screen to confirm ratio,dRVVT/?dRVVT W excess phospholipid (screen to confirm ratio),COAG,3000
6683-7,Reptilase time,Reptilase time,COAG,3000
68326-8,Reptilase time/normal,Reptilase time actual/?Normal,COAG,3000
34571-0,Screen aPTT,aPTT.lupus sensitive (LA screen),COAG,3000
48022-8,Screen aPTT/normal,aPTT.lupus sensitive actual/?normal (normalized LA screen),COAG,3000
75507-4,aPTT % correction,aPTT.lupus sensitive W excess phospholipid percent correction,COAG,3000
75510-8,Mixing aPTT,aPTT.lupus sensitive with 1:1 PNP (LA mix),COAG,3000
75509-0,Mixing aPTT/normal,aPTT.lupus sensitive with 1:1 PNP actual/?Normal (normalized LA mix),COAG,3000
75506-6,Confirm aPTT,aPTT.lupus sensitive W excess phospholipid (LA confirm),COAG,3000
75508-2,Confirm aPTT/normal,aPTT.lupus sensitive W excess phospholipid actual/?Normal (normalized LA confirm),COAG,3000
75884-7,aPTT screen to confirm ratio,aPTT.lupus sensitive/?aPTT.lupus sensitive W excess phospholipid (screen to confirm ratio),COAG,3000
68325-0,Thrombin time/normal,Thrombin time actual/?Normal,COAG,3000
5894-1,Prothrombin time/nomal,Prothrombin time (PT) actual/?Normal,COAG,3000
53346-3,Cortis DBS-sCnc,Cortisol [Moles/volume] in Dried blood spot,Chem,3000
46769-6,Cystic Fibrosis DBS-Imp,Cystic fibrosis newborn screen interpretation,Chem,3000
45197-1,Decanoylcarn DBS-sCnc,Decanoylcarnitine (C10) [Moles/volume] in Dried blood spot,Chem,3000
45198-9,Decenoylcarn DBS-sCnc,Decenoylcarnitine (C10:1) [Moles/volume] in Dried blood spot,Chem,3000
45199-7,Dodecanoylcarn DBS-sCnc,Dodecanoylcarnitine (C12) [Moles/volume] in Dried blood spot,Chem,3000
45200-3,Dodecenoylcarn DBS-sCnc,Dodecenoylcarnitine (C12:1) [Moles/volume] in Dried blood spot,Chem,3000
75511-6,dRVVT % correction,dRVVT W excess phospholipid percent correction,COAG,3000
46735-7,Endocrine Disorders DBS-Imp,Endocrine disorders newborn screen interpretation,Chem,3000
46736-5,FOD DBS-Imp,Fatty acid oxidation defects newborn screen interpretation,Chem,3000
64121-7,5th most predominant Hb DBS,Fifth most predominant hemoglobin in Dried blood spot,Chem,3000
64120-9,4th most predominant Hb DBS,Fourth most predominant hemoglobin in Dried blood spot,Chem,3000
54085-6,Galactose DBS-sCnc,Galactose [Moles/volume] in Dried blood spot,Chem,3000
33288-2,Gal1PUT DBS Ql,Galactose 1 phosphate uridyl transferase [Presence] in Dried blood spot,Chem,3000
42906-8,Gal1PUT DBS-cCnc,Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Dried blood spot,Chem,3000
46737-3,Galactosemias DBS-Imp,Galactosemias newborn screen interpretation,Chem,3000
53183-0,Glut+3OHdecanoylcarn DBS-sCnc,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Dried blood spot,Chem,3000
53184-8,Glut+3OHdecanoylcarn/C5OH DBS-sRto,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot,Chem,3000
53403-2,Glut+3OHdecanoylcarn/C4 DBS-sRto,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot,Chem,3000
53185-5,Glut+3OHdecanoylcarn/C8 DBS-sRto,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot,Chem,3000
53186-3,Glut+3OHdecanoylcarn/C16 DBS-sRto,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Chem,3000
67710-4,Glut+3OHhexanoylcarn DBS-sCnc,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Dried blood spot,Chem,3000
67711-2,Glut+3OHhexanoylcarn/C8 DBS-sRto,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot,Chem,3000
67701-3,Glut+3OHhexanoylcarn/C16 DBS-sRto,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Chem,3000
46740-7,Hemoglobin disorders DBS-Imp,Hemoglobin disorders newborn screen interpretation,Chem,3000
64122-5,Hb pres ID based on avail contr DBS,Hemoglobins that can be presumptively identified based on available controls in Dried blood spot,Chem,3000
45211-0,Hexanoylcarn DBS-sCnc,Hexanoylcarnitine (C6) [Moles/volume] in Dried blood spot,Chem,3000
38486-7,Homocystine DBS Ql,Homocystine [Presence] in Dried blood spot,Chem,3000
19111-4,Mother's hospital #,Mother's hospital number,CLIN,3000
45216-9,Isovaleryl+MeButyrylcarn DBS-sCnc,Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Dried blood spot,Chem,3000
53239-0,Isovaleryl+MeButyrylcarn/C2 DBS-sRto,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot,Chem,3000
53238-2,Isovaleryl+MeButyrylcarn/C0 DBS-sRto,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in Dried blood spot,Chem,3000
53401-6,Isovaleryl+MeButyrylcarn/C8 DBS-sRto,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot,Chem,3000
53240-8,Isovaleryl+MeButyrylcarn/C3 DBS-sRto,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot,Chem,3000
45217-7,Linoleoylcarn DBS-sCnc,Linoleoylcarnitine (C18:2) [Moles/volume] in Dried blood spot,Chem,3000
46779-5,M/SCHADD DBS-Imp,Medium/Short chain acyl-CoA dehydrogenase deficiency newborn screen interpretation,Chem,3000
47700-0,Methionine DBS-sCnc,Methionine [Moles/volume] in Dried blood spot,Chem,3000
53397-6,Methionine/Aile+Ile+Leu+Hyp DBS-sRto,Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Molar ratio] in Dried blood spot,Chem,3000
53156-6,Methionine/Phe DBS-sRto,Methionine/Phenylalanine [Molar ratio] in Dried blood spot,Chem,3000
53187-1,MeGlutarylcarn DBS-sCnc,Methylglutarylcarnitine (C6-DC) [Moles/volume] in Dried blood spot,Chem,3000
45222-7,Me-malonylcarn DBS-sCnc,Methylmalonylcarnitine (C4-DC) [Moles/volume] in Dried blood spot,Chem,3000
53181-4,Me-malonylcarn/C5OH DBS-sRto,Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot,Chem,3000
67709-6,C4-DC+C5-OH DBS-sCnc,Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Dried blood spot,Chem,3000
64117-5,Most predominant Hb DBS,Most predominant hemoglobin in Dried blood spot,Chem,3000
30099-6,N gonorrhoea Conjunct Ql Cult,Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture,MICRO,3000
688-2,N gonorrhoea Cvx Ql Cult,Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture,MICRO,3000
693-2,N gonorrhoea Vag Ql Cult,Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture,MICRO,3000
697-3,N gonorrhoea Urth Ql Cult,Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture,MICRO,3000
80368-4,N gonorrhoea Rectum Ql Cult,Neisseria gonorrhoeae [Presence] in Rectum by Organism specific culture,MICRO,3000
21415-5,N gonorrhoea DNA Urth Ql PCR,Neisseria gonorrhoeae DNA [Presence] in Urethra by Probe and target amplification method,MICRO,3000
32705-6,N gonorrhoea DNA Vag Ql PCR,Neisseria gonorrhoeae Ag [Presence] in Genital specimen,MICRO,3000
53879-3,N gonorrhoea rRNA Vag Ql PCR,Neisseria gonorrhoeae Ag [Presence] in Urethra,MICRO,3000
57289-1,N gonorrhoea rRNA Nph Ql PCR,Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by Probe and target amplification method,MICRO,3000
80366-8,N gonorrhoea rRNA Rectum Ql PCR,Neisseria gonorrhoeae rRNA [Presence] in Rectum by Probe and target amplification method,MICRO,3000
43384-7,Neisseria Urth Cult,Neisseria sp identified in Urethra by Organism specific culture,MICRO,3000
80369-2,Neisseria Rectum Cult,Neisseria sp identified in Rectum by Organism specific culture,MICRO,3000
54108-6,NB hearing scn Ear-L,Newborn hearing screen of Ear - left,Chem,3000
54109-4,NB hearing scn Ear-R,Newborn hearing screen of Ear - right,Chem,3000
54106-0,NB hearing scn meth,Newborn hearing screen method,Chem,3000
49544-0,NB screen recommended f/u Patient-Imp,Newborn screening recommended follow-up [interpretation],Chem,3000
77018-0,Noninv fet 13+18+21 aneu pnl cfDNA seq,Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing ,PANEL.MOLPATH,3000
77019-8,Noninv fet 18+21 aneu pnl Plas.cfDNA Seq,Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing ,PANEL.MOLPATH,3000
75547-0,NIP aneu microdel pnl WBC.DNA+cfDNA,Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA,PANEL.MOLPATH,3000
73967-2,NPT fetal anpldy Pnl Plas.cfDNA,Noninvasive prenatal fetal aneuploidy test panel - Plasma cell-free DNA,PANEL.MOLPATH,3000
53175-6,Octanoylcarn DBS-sCnc,Octanoylcarnitine (C8) [Moles/volume] in Dried blood spot,Chem,3000
53176-4,Octanoylcarn/C2 DBS-sRto,Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot,Chem,3000
53177-2,Octanoylcarn/C10 DBS-sRto,Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot,Chem,3000
53202-8,Oleoylcarn DBS-sCnc,Oleoylcarnitine (C18:1) [Moles/volume] in Dried blood spot,Chem,3000
46744-9,OA DBS-Imp,Organic acidemias newborn screen interpretation,Chem,3000
59407-7,SaO2 % Bld Preductal PulseOx,Oxygen saturation in Blood Preductal by Pulse oximetry,Chem,3000
59418-4,SaO2 % Bld Postductal PulseOx,Oxygen saturation in Blood Postductal by Pulse oximetry,Chem,3000
73696-7,SaO2%.pre-post MFrDiff Bld.pre+post,Oxygen saturation.preductal-oxygen saturation.postductal [Mass fraction difference] in Bld.preductal and Bld.postductal,Chem,3000
53198-8,Palmitoleylcarn DBS-sCnc,Palmitoleylcarnitine (C16:1) [Moles/volume] in Dried blood spot,Chem,3000
53199-6,Palmitoylcarn DBS-sCnc,Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot,Chem,3000
29571-7,Phe DBS Ql,Phenylalanine [Presence] in Dried blood spot,Chem,3000
29573-3,Phe DBS-sCnc,Phenylalanine [Moles/volume] in Dried blood spot,Chem,3000
35572-7,Phe/Tyr DBS-sRto,Phenylalanine/Tyrosine [Molar ratio] in Dried blood spot,Chem,3000
53160-8,Propionylcarn DBS-sCnc,Propionylcarnitine (C3) [Moles/volume] in Dried blood spot,Chem,3000
53163-2,Propionylcarn/C2 DBS-sRto,Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot,Chem,3000
53162-4,Propionylcarn/C0 DBS-sRto,Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in Dried blood spot,Chem,3000
53164-0,Propionylcarn/C16 DBS-sRto,Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Chem,3000
75211-3,C3+C16 DBS-sCnc,Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot,Chem,3000
49048-2,Protein feed time Patient,Protein feed time,Chem,3000
64118-3,2nd most predominant Hb DBS,Second most predominant hemoglobin in Dried blood spot,Chem,3000
46765-4,Sickle Cell Anemia DBS-Imp,Sickle cell anemia newborn screen interpretation,Chem,3000
53241-6,Stearoylcarn DBS-sCnc,Stearoylcarnitine (C18) [Moles/volume] in Dried blood spot,Chem,3000
53231-7,Succinylacetone DBS-sCnc,Succinylacetone [Moles/volume] in Dried blood spot,Chem,3000
62320-7,TREC # DBS PCR,T-cell receptor excision circle [#/volume] in Dried blood spot by Probe and target amplification method,Chem,3000
53190-5,Tdecadienoylcarn DBS-sCnc,Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Dried blood spot,Chem,3000
53192-1,Tdecanoylcarn DBS-sCnc,Tetradecanoylcarnitine (C14) [Moles/volume] in Dried blood spot,Chem,3000
53191-3,Tdecenoylcarn DBS-sCnc,Tetradecenoylcarnitine (C14:1) [Moles/volume] in Dried blood spot,Chem,3000
53193-9,Tdecenoylcarn/C2 DBS-sRto,Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot,Chem,3000
53194-7,Tdecenoylcarn/C12:1 DBS-sRto,Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Dried blood spot,Chem,3000
53195-4,Tdecenoylcarn/C16 DBS-sRto,Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Chem,3000
70159-9,Tdecenoylcarn/C14 DBS-sRto,Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in Dried blood spot,Chem,3000
64119-1,3rd most predominant Hb DBS,Third most predominant hemoglobin in Dried blood spot,Chem,3000
47784-4,Threonine DBS-sCnc,Threonine [Moles/volume] in Dried blood spot,Chem,3000
29574-1,TSH DBS Ql,Thyrotropin [Presence] in Dried blood spot,Chem,3000
29575-8,TSH DBS-aCnc,Thyrotropin [Units/volume] in Dried blood spot,Chem,3000
31145-6,T4 DBS-mCnc,Thyroxine (T4) [Moles/volume] in Dried blood spot,Chem,3000
38506-2,T4 DBS Ql,Thyroxine (T4) [Presence] in Dried blood spot,Chem,3000
48633-2,Trypsinogen I Free DBS-mCnc,Trypsinogen I Free [Mass/volume] in Dried blood spot,Chem,3000
53159-0,Tryptophan DBS-sCnc,Tryptophan [Moles/volume] in Dried blood spot,Chem,3000
35571-9,Tyrosine DBS-sCnc,Tyrosine [Moles/volume] in Dried blood spot,Chem,3000
47799-2,Valine DBS-sCnc,Valine [Moles/volume] in Dried blood spot,Chem,3000
53151-7,Valine/Phe DBS-sRto,Valine/Phenylalanine [Molar ratio] in Dried blood spot,Chem,3000
18782-3,X-ray unspecified site study ,X-ray unspecified site study ,Rad,4000
28564-3,X-ray head study ,X-ray head study ,Rad,4000
28613-8,X-ray spine unspecified study ,X-ray spine unspecified study ,Rad,4000
24946-6,X-ray spine cervical study ,X-ray spine cervical study ,Rad,4000
24983-9,X-ray spine thoracic study ,X-ray spine thoracic study ,Rad,4000
24972-2,X-ray spine lumbar study ,X-ray spine lumbar study ,Rad,4000
24762-7,X-ray hip study ,X-ray hip study ,Rad,4000
28561-9,X-ray pelvis study ,X-ray pelvis study ,Rad,4000
24704-9,X-ray femur study ,X-ray femur study ,Rad,4000
28565-0,X-ray knee study ,X-ray knee study ,Rad,4000
25011-8,X-ray tibia and fibula study ,X-ray tibia and fibula study ,Rad,4000
24541-5,X-ray ankle study ,X-ray ankle study ,Rad,4000
24709-8,X-ray foot study ,X-ray foot study ,Rad,4000
24909-4,X-ray shoulder study ,X-ray shoulder study ,Rad,4000
28567-6,X-ray humerus study ,X-ray humerus study ,Rad,4000
24891-4,X-ray radius and ulna study ,X-ray radius and ulna study ,Rad,4000
24676-9,X-ray elbow study ,X-ray elbow study ,Rad,4000
24619-9,X-ray wrist study ,X-ray wrist study ,Rad,4000
28582-5,X-ray hand study ,X-ray hand study ,Rad,4000
25045-6,CT Unspecified body region ,CT Unspecified body region ,Rad,4000
24725-4,CT Head ,CT Head ,Rad,4000
28566-8,CT spine study ,CT spine study ,Rad,4000
24932-6,CT spine cervical study ,CT spine cervical study ,Rad,4000
24978-9,CT spine thoracic study ,CT spine thoracic study ,Rad,4000
24963-1,CT spine lumbar study ,CT spine lumbar study ,Rad,4000
24627-2,CT Chest ,CT Chest ,Rad,4000
41806-1,CT Abdomen ,CT Abdomen ,Rad,4000
24866-6,CT pelvis study ,CT pelvis study ,Rad,4000
24690-0,CT extremity study ,CT extremity study ,Rad,4000
25056-3,MR Unspecified body region ,MR Unspecified body region ,Rad,4000
18756-7,MRI spine study ,MRI spine study ,Rad,4000
24590-2,MR Brain ,MR Brain ,Rad,4000
24935-9,MRI spine cervical study ,MRI spine cervical study ,Rad,4000
24980-5,MRI spine thoracic study ,MRI spine thoracic study ,Rad,4000
24968-0,MRI spine lumbar study ,MRI spine lumbar study ,Rad,4000
24629-8,MRI chest study ,MRI chest study ,Rad,4000
24556-3,MRI abdomen study ,MRI abdomen study ,Rad,4000
24872-4,MRI pelvis and hips study ,MRI pelvis and hips study ,Rad,4000
24707-2,MRI foot study ,MRI foot study ,Rad,4000
24710-6,MRI forearm study ,MRI forearm study ,Rad,4000
28576-7,MRI joint study ,MRI joint study ,Rad,4000
24720-5,MRI hand study ,MRI hand study ,Rad,4000
24605-8,Mammogram diagnostic views study ,Mammogram diagnostic views study ,Rad,4000
24606-6,Mammogram screening views study ,Mammogram screening views study ,Rad,4000
24888-0,Nuclear medicine pulmonary VQ scan study ,Nuclear medicine pulmonary VQ scan study ,Rad,4000
30695-1,Nuclear medicine thyroid scan study ,Nuclear medicine thyroid scan study ,Rad,4000
44136-0,PT Unspecified body region ,PT Unspecified body region ,Rad,4000
25043-1,CT guidance for aspiration of unspecified site study ,CT guidance for aspiration of unspecified site study ,Rad,4000
25044-9,CT guidance for biopsy of unspecified site study ,CT guidance for biopsy of unspecified site study ,Rad,4000
25069-6,Fluoroscopic guidance for biopsy of unspecified site study ,Fluoroscopic guidance for biopsy of unspecified site study ,Rad,4000
25059-7,Ultrasound guidance for biopsy of unspecified site study ,Ultrasound guidance for biopsy of unspecified site study ,Rad,4000
25061-3,US Unspecified body region ,US Unspecified body region ,Rad,4000
24731-2,Ultrasound of head study ,Ultrasound of head study ,Rad,4000
24842-7,Ultrasound of neck study ,Ultrasound of neck study ,Rad,4000
24558-9,Ultrasound of abdomen study ,Ultrasound of abdomen study ,Rad,4000
28614-6,Ultrasound of liver study ,Ultrasound of liver study ,Rad,4000
24601-7,Ultrasound of breast study ,Ultrasound of breast study ,Rad,4000
24869-0,Ultrasound of pelvis study ,Ultrasound of pelvis study ,Rad,4000
29680-3,Ultrasound of eye ,Ultrasound of eye ,Rad,4000
10177-4,Hx of Respiratory disorders,Hx of Respiratory disorders,Lab,5000
10180-8, Hx of Throat+Neck disorders, Hx of Throat+Neck disorders,Lab,5000
10155-0,Hx of Allergies,Hx of Allergies,Lab,5000
74774-1,"Glucose [Mass/Volume] in Serum, Plasma or Blood","Glucose [Mass/Volume] in Serum, Plasma or Blood",Lab,5000
